GHO indicators

2024-01-19

Available codes for the COUNTRY dimension:

IndicatorCode IndicatorName Language
AIR_61 Household and ambient air pollution attributable DALYs (per 100 000 capita) EN
AIR_8 Ambient air pollution attributable DALYs in children under 5 years EN
AIR_90 Ambient air pollution attributable DALYs (per 100 000 population, age-standardized) EN
AMR_GI_002 Status of National coordination center establishment EN
AMR_GI_003 Status of National plans to implement and strengthen antimicrobial surveillance EN
AIR_7 Ambient air pollution attributable DALYs EN
AMRGLASS_COORD02 Establishment of National Coordination Centre (NCC) EN
AMRGLASS_COORD04 Establishment of national reference laboratory (NRL) EN
AMRGLASS_QA01 EQA provided to the national reference laboratory (NRL) EN
AMRGLASS_QA04 GLASS pathogens testing covered by EQA EN
AMRGLASS_QA05 Types of AST standards followed by countries EN
AMRGLASS_SURVL01 Number of national surveillance sites in each country providing data to GLASS: hospital category EN
AMRGLASS_COORD03 Nomination of National Focal Point (NFP) EN
AMRGLASS_QA03 EQA provided to local laboratories participating in GLASS EN
AMRGLASS_SURVL02 Number of National surveillance sites in each country providing data to GLASS: outpatient facility category EN
AIR_63 Household and ambient air pollution attributable DALYs in children under 5 years (’000) EN
AIR_9 Ambient air pollution attributable DALYs (per 100 000 population) EN
AMR_GI_001 Status of countries enrolled in GLASS EN
AMRGLASS_COORD01 Functioning national AMR surveillance plan EN
GDO_q3x3a_2 Existence of legislation to file appeals protecting the rights of people with dementia EN
GDO_q3x3a_4 Existence of legislation to promote monitoring of human rights conditions of people with dementia in facilities where they reside EN
GDO_q3x3b_1 Existence of legislation to end coercieve practices for people with dementia EN
GDO_q3x4_2 Existence of legislation to end discrimination against people with dementia EN
GDO_q3x4_1 Existence of legislation for advanced care directives for people with dementia EN
GDO_q4x1x2 Existence of approved government dementia standards/ guidelines/ protocols EN
GDO_q4x2_3 Existence of standards/ guidelines/ protocols for management of dementia EN
AMRGLASS_SURVL03 Number of local clinical laboratories in each country performing AST to support national AMR surveillance sites EN
anc1 Antenatal care coverage - at least one visit (in the two or three years preceding the survey) (% EN
anc15 Antenatal care coverage - at least one visit (in the five years preceding the survey) (%) EN
anc4 Antenatal care coverage - at least four visits (in the two or three years preceding the survey) (%) EN
AIR_62 Household and ambient air pollution attributable DALYs (per 100 000 capita, age-standardized) EN
AMRGLASS_QA02 EQA provided for bacterial identification and AST EN
anc45 Antenatal care coverage - at least four visits (in the five years preceding the survey) (%) EN
GDO_q4x3x4_3 Existence of standards/ guidelines/ protocols of care in nursing & residential care facilities for people with dementia EN
GDO_q5x1x1_1 Identification of different sectors in dementia care coordination (Health) EN
asfr1 Adolescent fertility rate (per 1000 women aged 15-19 years) EN
ASSISTIVETECH_METNEED Prevalence of met need of assistive products (%) EN
Camp_airtime Process evaluation was employed to assess implementation EN
Camp_media_planning Campaign utilized media planning EN
Camp_news Earned media/public relations were used to promote the campaign EN
Camp_tv_radio Campaign aired on television and/or radio EN
carep Children aged < 5 years with pneumonia symptoms taken to a health facility (%) EN
GDO_q4x1 Existence of dementia standards/ guidelines/ protocols EN
GDO_q4x1x1_SQ001 Implementation level of dementia standards/ guidelines/ protocols (National) EN
GDO_q4x3x4_2 Existence of standards/ guidelines/ protocols for palliative and end-of-life care for people with dementia EN
BP_04 Raised blood pressure (SBP>=140 OR DBP>=90) (age-standardized estimate) EN
CaseCS Congenital syphilis number of cases, reported EN
CC_3 Climate change attributable deaths per 100’000 capita EN
CC_5 Climate change attributable deaths (’000) in children under 5 years EN
CC_6 Climate change attributable deaths per 100’000 children under 5 years EN
GDO_q5x1x1_4 Identification of different sectors in dementia care coordination (Employment) EN
GDO_q5x1x1_8 Identification of different sectors in dementia care coordination (Private sector) EN
GDO_q5x1x1_other Identification of different sectors in dementia care coordination (Other) EN
GDO_q6x1_3 Number of geriatricians or psychogeriatricians (per 100,000) EN
GDO_q6x2_2 Inclusion of basic dementia competencies in training of specialists EN
Camp_aud_research Formative research was conducted EN
Camp_gov_prog Campaign was part of a comprehensive tobacco control programme EN
Camp_mat_tested Campaign was pre-tested EN
GDO_q8x1 Existence of community-based health or social care services for dementia EN
GDO_q8x2_4 Availability of activities of daily living support services in community for dementia EN
CCO_2 Human development index rank EN
CATARACTSURGICALEFFECTIVE Effective cataract surgical coverage of adults aged 50 and over (%) EN
CC_1 Climate change attributable deaths EN
CC_4 Climate change attributable DALYs per 100’000 capita EN
cci2030 Composite coverage index (%) EN
GDO_q5x1 Availability of mechanisms to coordinate dementia care across sectors EN
GDO_q5x1x1_6 Identification of different sectors in dementia care coordination (Housing) EN
GDO_q6x1_2 Number of neurologists (per 100,000) EN
GDO_q6x2_4 Inclusion of basic dementia competencies in training of pharmaceutical personnel EN
GDO_q6x2_5 Inclusion of basic dementia competencies in training of social workers EN
GDO_q8x2_5 Availability of palliative and end-of-life care services in community for dementia EN
CHILDMORT5TO14 Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years) EN
CHOLERA_0000000001 Number of reported cases of cholera EN
CM_01 Number of under-five deaths EN
CM_02 Number of infant deaths EN
DEVICES07 Types of lists recommending health technology for high burden diseases EN
MALARIA003 Estimated number of malaria deaths EN
MCV2 Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%) EN
MDG_0000000006_AGE1519 Unmet need for family planning, among girls aged 15-19 (%) EN
MDG_0000000007 Under-five mortality rate (probability of dying by age 5 per 1000 live births) EN
MDG_0000000011 Median consumer price ratio of selected generic medicines - Public EN
MDG_0000000014 Children aged <5 years with fever who received treatment with any antimalarial (%) EN
MDG_0000000016 Deaths due to malaria (per 100 000 population) EN
GDO_q8x2_6 Availability of social and financial protection for dementia EN
GDO_q8x3_5 Accessibility of palliative and end-of-life care services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] EN
GDO_q8x4_2 Majority provider of behaviour and psychological management in community for dementia [public, private] EN
GDO_q8x4_4 Majority provider of activities of daily living support services in community for dementia [public, private] EN
MALARIA001 Malaria - number of reported deaths EN
AIR_1 Ambient air pollution attributable deaths EN
AIR_11 Household air pollution attributable deaths EN
AIR_13 Household air pollution attributable deaths per 100’000 capita EN
AIR_14 Household air pollution attributable deaths per 100’000 children under 5 years EN
AIR_17 Household air pollution attributable DALYs (per 100 000 population) EN
GDO_q3x3a_1 Existence of legislation for supported decision making for people with dementia EN
GDO_q3x3a_3 Existence of legislation to promote community-based services for people with dementia EN
GDO_q4x1x1_SQ002 Implementation level of dementia standards/ guidelines/ protocols (Sub-national) EN
AIR_2_1 Ambient air pollution in urban areas (Annual PM10 [μg/m3]) EN
AIR_3_1 Percent of urban inhabitants living in cities covered by PM measurements EN
AIR_39 Household air pollution attributable DALYs (per 100 000, age-standardized) EN
AIR_41 Ambient air pollution attributable deaths EN
AIR_43 Ambient air pollution attributable DALYs EN
AIR_44 DALYs attributable to ambient air pollution (age-standardized) EN
MDG_0000000023 Prevalence of tuberculosis (per 100 000 population) EN
MDG_0000000029 Prevalence of HIV among adults aged 15 to 49 (%) EN
MDG_0000000030 Smear-positive tuberculosis case-detection rate (%) EN
GDO_q4x2_2 Existence of standards/ guidelines/ protocols for diagnosis of dementia EN
GDO_q4x2_4 Existence of standards/ guidelines/ protocols for other post-diagnostic supports of people with dementia EN
GDO_q4x3x4_1 Existence of standards/ guidelines/ protocols for advance care directives, power of attorney or guardianship for people with dementia EN
GDO_q5x1x1_2 Identification of different sectors in dementia care coordination (Social) EN
MDG_0000000010 Median availability of selected generic medicines (%) - Public EN
MDG_0000000013 Children aged <5 years sleeping under insecticide-treated nets (%) EN
MDG_0000000017 Deaths due to tuberculosis among HIV-negative people (per 100 000 population) EN
MDG_0000000022 Tuberculosis detection rate under DOTS (%) EN
MDG_0000000025 Births attended by skilled health personnel (%) EN
CCO_WHS9_85 Literacy rate among adults aged >= 15 years (%) EN
CHOLERA_0000000003 Cholera case fatality rate EN
cpmo Contraceptive prevalence - modern methods (%) EN
DEVICES01 Total density per 100 000 population: Health posts EN
DEVICES02 Total density per 100 000 population: Health centres EN
DEVICES06 Availability of national standards or recommended lists of medical devices EN
DEVICES10 Total density per million population: Positron Emission tomography EN
BP_05 Mean systolic blood pressure (crude estimate) EN
BP_06 Mean systolic blood pressure (age-standardized estimate) EN
Camp_eval_impact Outcome evaluation was employed to assess effectiveness EN
Camp_nat At least one national mass media campaign ran during the survey period EN
CATARACTSURGICAL Cataract surgical coverage of adults aged 50 and over (%) EN
DEVICES13 Type of nomenclature system EN
DEVICES14 Use of nomenclature system EN
DEVICES18 Availability of national list of approved medical devices for procurement or reimbursement EN
AIR_15 Household air pollution attributable DALYs EN
AIR_2 Ambient air pollution (Annual PM10 [ug/m3]) EN
CC_2 Climate change attributable DALYs (’000) EN
CC_8 Climate change attributable DALYs per 100’000 children under 5 years EN
CCO_1 Poverty headcount ratio at $1.25 a day (PPP) (% of population) EN
GDO_q5x1x1_3 Identification of different sectors in dementia care coordination (Education) EN
GDO_q5x1x1_5 Identification of different sectors in dementia care coordination (Justice) EN
GDO_q5x1x3 Presence of formal agreement/joint plan for dementia care coordination EN
GDO_q5x2 Availability of dementia care coordination standards/ guidelines/ protocols EN
GDO_q6x2_1 Inclusion of basic dementia competencies in training of physicians EN
AIR_45 Ambient air pollution attributable YLLs EN
GDO_q7x1_AVAIL Availability of dementia diagnostic rate EN
GDO_q8x2_2 Availability of behaviour and psychological management in community for dementia EN
AIR_10 Ambient air pollution attributable DALYs per 100’000 children under 5 years EN
AIR_12 Household air pollution attributable deaths in children under 5 years EN
NCD_BMI_25A Prevalence of overweight among adults, BMI ≥ 25 (age-standardized estimate) (%) EN
MDG_0000000034 Antiretroviral therapy coverage among people with advanced HIV infection (%), WHO 2006 guidelines EN
AIR_16 Household air pollution attributable DALYs in children under 5 years EN
AIR_3 Percentage of the total population living in cities > 100’000 inhabitants EN
AIR_35 Joint effects of air pollution attributable deaths EN
AIR_36 Joint effects of air pollution attributable deaths in children under 5 years EN
AIR_42 Ambient air pollution attributable death rate (per 100 000 population, age-standardized) EN
MALARIA002 Estimated number of malaria cases EN
MALARIA005 Malaria incidence per 100 000 population EN
MH_13 Beds for mental health in general hospitals (per 100,000) EN
MH_16 Beds in mental hospitals (per 100,000) EN
MH_18 Mental health units in general hospitals (per 100,000) EN
MH_22 Occupational therapists in mental health sector (per 100,000) EN
MH_3 Stand-alone mental health legislation EN
MDG_0000000003 Adolescent birth rate (per 1000 women aged 15-19 years) EN
MDG_0000000005_AGE1519 Contraceptive prevalence, among girls aged 15-19 (%) EN
MDG_0000000015 Prevalence of condom use by adults during higher-risk sex (15-49) (%) EN
MDG_0000000021 Population aged 15-24 years with comprehensive correct knowledge of HIV/AIDS (%) EN
MDG_0000000024 Tuberculosis treatment success under DOTS (%) EN
AIR_46 YLLs attributable to ambient air pollution (age-standardized) EN
AIR_5 Ambient air pollution attributable death rate (per 100 000 population) EN
AIR_6 Ambient air pollution attributable deaths per 100’000 children under 5 years EN
AIR_60 Household and ambient air pollution attributable DALYs (’000) EN
NCD_BMI_18A Prevalence of underweight among adults, BMI < 18 (age-standardized estimate) (%) EN
NCD_BMI_30C Prevalence of obesity among adults, BMI ≥ 30 (crude estimate) (%) EN
NCD_BMI_MINUS2A Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (age-standardized estimate) (%) EN
NCD_BMI_MINUS2C Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (crude estimate) (%) EN
GDO_q3x4_3 Existence of legislation to end discrimination against carers of people with dementia EN
GDO_q4x2_1 Existence of standards/ guidelines/ protocols for prevention and risk reduction of dementia EN
GDO_q4x2_5 Existence of standards/ guidelines/ protocols for treatment and support of carers and families of people with dementia EN
bcgv BCG immunization coverage among one-year-olds (%) EN
BP_03 Raised blood pressure (SBP>=140 OR DBP>=90) (crude estimate) EN
CC_7 Climate change attributable DALYs (’000) in children under 5 years EN
cci Composite coverage index (%) EN
CCO_3 Gender inequality index rank EN
GDO_q4x3x4_4 Existence of standards/ guidelines/ protocols of care in hospital for people with dementia EN
CM_03 Number of neonatal deaths EN
csection5 Births by caesarean section (in the five years preceding the survey) (%) EN
DEVICES03 Total density per 100 000 population: District/rural hospitals EN
DEVICES04 Total density per 100 000 population: Provincial hospitals EN
GDO_q5x1x1_7 Identification of different sectors in dementia care coordination (Civil society) EN
GDO_q5x1x2 Implementation level [national/subnational] of dementia care coordination EN
DEVICES08 Total density per million population: Magnetic Resonance Imaging EN
DEVICES09 Total density per million population: Computed tomography units EN
DEVICES11 Total density per million population: Gamma camera or Nuclear medicine EN
DEVICES12 Total density per million population: Linear Accelerator EN
DEVICES16 Unit in the Ministry of Health responsible for the management of medical devices EN
DEVICES17 Procurement of medical devices carried out at the national level EN
DEVICES19 National guidelines, policies or recommendations on the procurement of medical devices EN
E1_nat_tv_radio Ban on advertising: National TV and radio EN
E10_promo_discounts Ban on promotional discounts EN
E11_brand_stretching Ban on non-tobacco goods AND services identified with tobacco brand names EN
E11_compliance Compliance of ban on non-tobacco goods AND services identified with tobacco brand names EN
E12_brand_sharing Ban on brand name of non-tobacco products used for tobacco product EN
E12_compliance Compliance of ban on brand name of non-tobacco products used for tobacco product EN
E13_compliance Compliance of ban on appearance of tobacco brands in TV and/or films (product placement) EN
E14_compliance Compliance of ban on appearance of tobacco products in TV and/or films EN
E14b_movies_anti_tob_ads Requirement to present prescribed anti-tobacco ads before, during or after the broadcasting or showing of any visual entertainment media product that depicts tobacco products, use or images EN
E15_compliance Compliance of ban on sponsored events EN
E15_sponsored_events Sponsored events EN
E15a_sponsorship Complete ban on sponsorship EN
E15b_sponsor_contribution Ban on any form of contribution (financial or other support) to any event, activity or individual EN
MENING_1 Number of suspected meningitis deaths reported EN
MENING_2 Number of suspected meningitis cases reported EN
MH_10 Mental health outpatient facilities (per 100,000) EN
MH_11 Mental health day treatment facilities (per 100,000) EN
DEVICES20 Availability of technical specifications of medical devices to support procurement or donations EN
DEVICES21 Total density per million population: Telecobalt Unit EN
DEVICES22 Total density per million population: Radiotherapy units EN
E_Group Enforcing bans on tobacco advertising, promotion and sponsorship EN
E10_compliance Compliance of ban on promotional discounts EN
E13_brand_placement Ban on appearance of tobacco brands in TV and/or films (product placement) EN
E14_prod_tv_films Appearance of tobacco products in TV and/or films EN
MH_24 Mental health units in general hospitals admissions (per 100,000) EN
MH_25 Stand-alone policy or plan for mental health EN
MH_5 Government expenditures on mental hospitals as a percentage of total government expenditures on mental health (%) EN
MH_6 Psychiatrists working in mental health sector (per 100,000) EN
MORT_200 Deaths per 1 000 live births EN
dptv DTP3 immunization coverage among one-year-olds (%) EN
MDG_0000000026 Maternal mortality ratio (per 100 000 live births) EN
MDG_0000000033 Antiretroviral therapy coverage among people with HIV infection eligible for ART according to 2010 guidelines (%) EN
MH_12 Age-standardized suicide rates (per 100 000 population) EN
MH_14 Community residential facilities (per 100,000) EN
MH_15 Beds in community residential facilities (per 100,000) EN
MH_19 Mental hospital admissions (per 100,000) EN
MH_20 Outpatient visits (per 100,000) EN
MH_21 Total workforce in mental health sector (per 100,000) EN
MH_23 Other non-specialized doctors in mental health sector (per 100,000) EN
GDO_q6x2_3 Inclusion of basic dementia competencies in training of nurses EN
GDO_q6x2_6 Inclusion of basic dementia competencies in training of personal support workers EN
GDO_q8x2_1 Availability of diagnostic services in community for dementia EN
GDO_q8x2_3 Availability of psychosocial and rehabilitation services in community for dementia EN
GDO_q8x3_2 Accessibility of behaviour and psychological management in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] EN
GDO_q8x4_5 Majority provider of palliative and end-of-life care services in community for dementia [public, private] EN
GDO_q8x4_6 Majority provider of social and financial protection for dementia [public, private] EN
GDO_q8x5_3 Estimated number of people receiving psychosocial and rehabilitation services in community for dementia EN
MALARIA004 Number of under-five deaths from malaria EN
MDG_0000000001 Infant mortality rate (probability of dying between birth and age 1 per 1000 live births) EN
MDG_0000000005 Contraceptive prevalence (%) EN
MDG_0000000018 Deaths due to tuberculosis among HIV-positive people (per 100 000 population) EN
MDG_0000000019 Prevalence of HIV among adults aged >=15 years (per 100 000 population) EN
MDG_0000000020 Incidence of tuberculosis (per 100 000 population per year) EN
AIR_18 Household air pollution attributable DALYs per 100’000 children under 5 years EN
AIR_4 Ambient air pollution attributable deaths in children under 5 years EN
AIR_50 Ambient air pollution attributable deaths (per 100 000 population, age-standardized) EN
AIR_51 Household air pollution attributable death rate (per 100 000 population) EN
AIR_52 Household air pollution attributable death rate (per 100 000 population, age-standardized) EN
CHOLERA_0000000002 Number of reported deaths from cholera EN
cpmt Contraceptive prevalence - modern and traditional methods (%) EN
csection Births by caesarean section (in the two or three years preceding the survey) (%) EN
MORT_400 Deaths per 100 000 population EN
MORTADO Adolescent mortality rate (per 100 000 population) EN
RADON_Q803 Inclusion of radon in national cancer control strategy EN
Rev_imp_other Annual tax revenues - import duties and all other taxes (excluding corporate taxes on tobacco companies) EN
NCD_BMI_MEAN Mean BMI (kg/m²) (age-standardized estimate) EN
NCD_BMI_MEANC Mean BMI (kg/m²) (crude estimate) EN
NCD_BMI_PLUS1A Prevalence of overweight among children and adolescents, BMI > +1 standard deviations above the median (age-standardized estimate) (%) EN
NCD_BMI_PLUS2C Prevalence of obesity among children and adolescents, BMI > +2 standard deviations above the median (crude estimate) (%) EN
NCD_CCS_Aspirin General availability of aspirin (100 mg) in the public health sector EN
Rev_type Annual tax revenues - tobacco products included EN
RHR_IPV Intimate partner violence prevalence among ever partnered women (%) EN
MH_4 Government expenditures on mental health as a percentage of total government expenditures on health (%) EN
MORT_600 Projection of number of deaths EN
mslv Measles immunization coverage among one-year-olds (%) EN
RHR_NPSV Non-partner sexual violence prevalence (%) EN
ROTAC Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%) EN
RS_194 Number of registered vehicles EN
RS_198 Estimated road traffic death rate (per 100 000 population) EN
RS_204 Existence of a national drink-driving law EN
RS_205 Definition of drink-driving by BAC EN
RS_207 Blood Alcohol Concentration (BAC) limit for drivers EN
RADON_Q801 Existence of national radon risk communication strategy EN
RateCS Congenital syphilis rate per 100 000 live births, reported EN
Rev_VAT Annual tax revenues - value added tax (vat) and other sales taxes EN
RS_193 Income level EN
RS_228 Existence of a national road safety strategy EN
RS_238 Existence of a universal access telephone number for pre-hospital care EN
NCD_CCS_CCBlkrs General availability of CC blockers in the public health sector EN
NCD_CCS_CervCy General availability of cervical cytology at the primary health care level EN
NCD_CCS_cervicalcancerpgmcvg Coverage of national cervical cancer screening program (%) EN
RS_209 Existence of a national seat-belt law EN
NCD_CCS_ACE General availability of ACE inhibitors in the public health sector EN
NCD_CCS_betablockers General availability of beta blockers in the public health sector EN
NCD_CCS_BowelCancer General availability of colon cancer screening at the primary health care level EN
MH_9 Psychologists working in mental health sector (per 100,000) EN
MORT_500 Number of deaths EN
MORT_700 Projection of deaths per 100 000 population EN
Rev_curr Annual tax revenues - currency EN
Rev_govt_total Annual tax revenues - total revenues EN
RS_1845 Population EN
RS_196 Estimated number of road traffic deaths EN
RS_208 Attribution of road traffic deaths to alcohol (%) EN
NCD_CCS_chemo General availability of chemotherapy in the public health system EN
NCD_CCS_CRDPlan Existence of operational policy/strategy/action plan for chronic respiratory diseases EN
NCD_CCS_diabtest General availability of diabetes testing (by blood glucose measurement, OGTT) at the primary health care level EN
NCD_CCS_dietpaaware Implementation of diet and/or physical activity public awareness program EN
NCD_BMI_PLUS2A Prevalence of obesity among children and adolescents, BMI > +2 standard deviations above the median (age-standardized estimate) (%) EN
NCD_CCS_breastcancerscreening Existence of national screening program for breast cancer EN
NCD_CCS_cervicalcancermethod Most widely used screening method in national cervical cancer screening program EN
NCD_CCS_cervicalcancerscreening Existence of national screening program for cervical cancer EN
NCD_CCS_CholMsmt General availability of total cholesterol measurement at the primary health care level EN
RS_214 Existence of national speed limits EN
RS_217 Maximum speed limits EN
NCD_CCS_CancerRegNational Existence of population-based cancer registry EN
NCD_CCS_cervicalcancerpgmtype Type of national cervical cancer screening program EN
NCD_CCS_hpv Existence of national HPV vaccination programme EN
NCD_CCS_integNCDplan Existence of an operational, multisectoral national NCD policy, strategy or action plan that integrates several NCDs and their risk factors EN
RS_225 Existence of a road safety lead agency EN
RS_237 Existence of a formal pre-hospital care system EN
RS_242 Vehicle standards EN
RSUD_10 National survey on substance use among children and adolescents EN
RSUD_11 Data on substance use disorders disseminated in national annual reports EN
RSUD_110 Ministry/office that takes primary responsibility for prevention for substance use EN
RSUD_12 Substance use policy at the national level EN
RS_212 Seat-belt wearing rate (%) EN
RS_246 Distribution of road traffic deaths by type of road user (%) EN
RS_576 Gross national income per capita (Atlas method) EN
RSUD_100 Government unit/official responsible for prevention for substance use EN
RSUD_14 Policy documents on the pharmacological treatment of substance use disorders EN
RSUD_15 Guidelines on the pharmacological treatment of substance use disorders EN
RSUD_17 Legislative provision for compulsory treatment EN
RSUD_120 Five years change in international cooperation for prevention for substance use EN
RSUD_18 Drug courts EN
RSUD_13 Substance use policy at the national level, level of integration EN
RSUD_140 Ministry/office that takes primary responsibility for treatment of substance use disorders EN
RSUD_150 Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for treatment of substance use disorders EN
NCD_CCS_DiabetesReg Existence of a diabetes registry EN
NCD_CCS_DietPlan Existence of operational policy/strategy/action plan to reduce unhealthy diet related to NCDs EN
NCD_CCS_HbA1c General availability of diabetes testing (by HbA1c) at the primary health care level EN
NCD_CCS_Insulin General availability of insulin in the public health sector EN
NCD_CCS_NCDGuide Existence of evidence-based national guidelines/protocols/standards for the management of major NCDs through a primary care approach EN
NCD_CCS_NCDIndicators Existence of a set of national NCD indicators and has set time-bound national targets for these indicators EN
NCD_CCS_DiabetesTest General availability of diabetes testing (by blood glucose measurement, OGTT, or HbA1c) at the primary health care level EN
NCD_CCS_DiabPlan Existence of operational policy/strategy/action plan for diabetes EN
DEVICES00 Total density per 100 000 population: Hospitals EN
DEVICES05 Total density per 100 000 population: Specialized hospitals EN
DEVICES15 Health technology (medical device) national policy EN
DEVICES23 Total density per million females aged from 50 to 69 years old: Mammography units EN
MDG_0000000025_AGE1519 Births attended by skilled health personnel, among girls aged 15-19 (%) EN
MDG_0000000027 Children aged <5 years stunted (%) EN
MDG_0000000031 Smear-positive tuberculosis treatment-success rate (%) EN
MDG_0000000032 Maternal mortality ratio (per 100 000 live births) - Country reported estimates EN
MENING_3 Number of meningitis epidemic districts EN
MH_1 Mental health policy EN
MH_17 Mental hospitals (per 100,000) EN
MH_2 Mental health plan EN
NCD_BMI_18C Prevalence of underweight among adults, BMI < 18 (crude estimate) (%) EN
NCD_BMI_25C Prevalence of overweight among adults, BMI ≥ 25 (crude estimate) (%) EN
NCD_BMI_30A Prevalence of obesity among adults, BMI ≥ 30 (age-standardized estimate) (%) EN
NCD_BMI_PLUS1C Prevalence of overweight among children and adolescents, BMI > +1 standard deviations above the median (crude estimate) (%) EN
E1_compliance Compliance of ban on advertising on national TV and radio EN
NCD_CCS_OralMorph General availability of oral morphine in the public health sector EN
NCD_CCS_palliative_home General availability of palliative care in community or home-based care in the public health system EN
RSUD_190 Five years change in international cooperation for treatment of substance use disorders EN
RSUD_2 Point prevalence (%), drug use disorders, 15+ years EN
NCD_CCS_Nicotine General availability of nicotine replacement therapy in the public health sector EN
NCD_CCS_oralhealthplan Existence of operational policy/strategy/action plan for oral health EN
NCD_CCS_palliative_prim General availability of palliative care in primary health care in the public health system EN
NCD_CCS_photocoag General availability of retinal photocoagulation in the public health system EN
NCD_CCS_Metformin General availability of metformin in the public health sector EN
NCD_CCS_Mkting Existence of any policies on marketing of foods to children EN
RSUD_16 Legislative provision for treatment and rehabilitation of substance use disorders EN
RSUD_230 Compulsory treatment for people with alcohol use disorders in the criminal justice system EN
RSUD_260 Five-year change in government resources for treatment of substance use disorders EN
RSUD_20 Confidentiality of health records on substance use disorders protected by law EN
RSUD_200 Confidentiality of people in treatment for substance use disorders EN
RSUD_21 Government unit for substance use disorder treatment EN
RSUD_240 Compulsory treatment for people with drug use disorders in the criminal justice system EN
RSUD_250 Five-year change in government resources for prevention for substance use EN
RSUD_170 Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for prevention for alcohol and drugs EN
RSUD_19 Programmes diverting clients from the justice system towards treatment EN
RSUD_27 Government benefits for alcohol use disorders, subsidy or disability pension EN
RSUD_280 Financing methods for treatment for drug use disorders EN
RSUD_30 Sector for inpatient treatment of alcohol dependence EN
RSUD_300 Government benefits for people with alcohol use disorders EN
RSUD_31 Sector for outpatient treatment of alcohol dependence EN
RSUD_320 Main sector for treatment for alcohol use disorders EN
RSUD_270 Financing methods for treatment for alcohol use disorders EN
RSUD_23 Financing method for substance use disorder treatment EN
RSUD_26 Governement benefits for persons with substance use disorders EN
RSUD_28 Government benefits for drug use disorders, subsidy or disability pension EN
RSUD_29 Sector for inpatient detoxification of alcohol use disorders EN
RSUD_340 Treatment programmes for children and adolescents with alcohol use disorders EN
RSUD_350 Treatment programmes for children and adolescents with drug use disorders EN
E16_csr_promo_self Ban on tobacco companies/tobacco industry publicizing their “Corporate Social Responsibility” activities EN
NCD_CCS_PAPlan Existence of operational policy/strategy/action plan to reduce physical inactivity EN
NCD_CCS_renaltrans General availability of renal replacement by transplantation in the public health system EN
E21_vending_machines Complete ban on tobacco vending machines EN
E24_internet_sales_ban Ban on internet sales of tobacco products EN
E26_direct_ad_fines Law requires fines for violations of direct advertising bans EN
E19_indirect_ad_fines Law requires fines for violations of indirect advertising bans EN
E19_movies_anti_tob_ads Required anti-tobacco ads for any visual entertainment media product that depicts tobacco products, use or images EN
E2_intl_tv_radio Ban on advertising: International TV and radio (broadcast from abroad, including satellite) EN
NCD_CCS_SatFat Existence of national policies on saturated fatty acids / trans-fats EN
NCD_CCS_SSBTAX Existence of tax on sugar-sweetened beverages EN
NCD_CCS_stroke Provision for care of acute stroke and rehabilitation in more than 50% of public sector health facilities EN
E15d_csr_ban Ban on Corporate Social Responsibility activities (CSR) EN
E18_csr_anti_tobacco_media Ban on tobacco companies funding or making contributions (including in-kind contributions) to smoking prevention media campaigns, including those directed at youth EN
RSUD_3 Age-standardized death rates, alcohol and drug use disorders, per 100 000 EN
RSUD_310 Government benefits for people with drug use disorders EN
RSUD_32 Sector for the treatment of alcohol-induced psychoses and other alcohol-induced psychiatric conditions EN
E14a_prod_tv_films Ban on appearance of tobacco products in TV and/or films EN
E15c_sponsor_publicity Banning the publicity of financial or other sponsorship or support by the tobacco industry of events, activities, individuals EN
E17_csr_promo_others Ban on entities other than tobacco companies/tobacco industry publicizing the Corporate Social Responsibility activities of the tobacco companies EN
MH_7 Nurses working in mental health sector (per 100,000) EN
MH_8 Social workers working in mental health sector (per 100,000) EN
MORT_100 Number of deaths EN
MORT_300 Distribution of causes of death among children aged < 5 years (%) EN
MORT_MATERNALNUM Number of maternal deaths EN
RADON_Q706 Existence of training/education on prevention/mitigation EN
RADON_Q802 Inclusion of radon measurements in property transactions EN
Rev_excise Annual tax revenues - total excise (specific and ad valorem) EN
Rev_year Annual tax revenues - year EN
NCD_CCS_AlcPlan Existence of operational policy/strategy/action plan to reduce the harmful use of alcohol EN
NCD_CCS_BreastCancer General availability of breast cancer screening (by palpation or mammogram) at the primary health care level EN
NCD_CCS_Bronchodilators General availability of bronchodilators in the public health sector EN
NCD_CCS_CancerPlan Existence of operational policy/strategy/action plan for cancer EN
E5_billboards Ban on advertising: Billboards and outdoor advertising EN
NCD_CCS_PeakFlow General availability of peak flow measurement at the primary health care level EN
NCD_CCS_rheumfollowup Has systems for follow-up/recall to deliver long-term penicillin prophylaxis to patients with rheumatic fever and rheumatic heart disease EN
NCD_CCS_Statins General availability of statins in the public health sector EN
NCD_CCS_SurvMonRep9NCD Existence of an NCD surveillance and monitoring system in place to enable reporting against the nine global NCD targets EN
NCD_CCS_coronary General availability of coronary bypass or stenting in the public health system EN
NCD_CCS_CVDPlan Existence of operational policy/strategy/action plan for cardiovascular diseases EN
E23_subnat_complete_bans_exist Subnational advertising, promotion and sponsorship bans - at least one jurisdiction has a comprehensive ban in place EN
NCD_CCS_rheumreg Existence of a register of patients who had rheumatic fever and rheumatic heart disease EN
NCD_CCS_Steroid General availability of steroid inhalers in the public health sector EN
RSUD_380 Specialized treatment facilities for drug use disorders EN
RSUD_390 Self-help groups EN
NCD_GLUC_02 Mean fasting blood glucose (mmol/l) (crude estimate) EN
NCD_GLUC_03 Raised fasting blood glucose (>= 7.0 mmol/L) (crude estimate) EN
NCD_PAA Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%) EN
NCD_PAC_ADO Insufficiently active (crude estimate) EN
NCD_CCS_UrineAlbumin General availability of urine testing for albumin EN
NCD_DTH_TOT Total NCD Deaths (in thousands) EN
RSUD_33 Sector for residential long-term rehabilitation of alcohol use disorders EN
RSUD_330 Main sector for treatment for drug use disorders EN
RSUD_34 Sector for inpatient detoxification of drug use disorders EN
RSUD_35 Sector for inpatient treatment of drug dependence EN
NCD_GLUC_04 Raised fasting blood glucose (>=7.0 mmol/L) (age-standardized estimate) EN
NCD_PAC Prevalence of insufficient physical activity among adults aged 18+ years (crude estimate) (%) EN
NCD_UNDER70 Premature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths EN
NHAGGHEGDP General government expenditure on health as percentage of gross domestic product EN
NHAOOPSTHE Out-of-Pocket expenditure on health as percentage of total health expenditure?? EN
NHAPREPAIDTHE Prepaid plans as percentage of total health expenditure? EN
NTCP_FTE Number of full-time equivalent staff in national agency EN
RSUD_400 Main substance at treatment entry EN
RSUD_420 Guidelines on pharmacological treatment for substance use disorders EN
RSUD_360 Specialized treatment facilities for substance use disorders EN
RSUD_37 Sector for substitution maintenance therapy of opioid dependence EN
RSUD_40 Treatment setting for substance use disorders, most common EN
RSUD_41 Specialized treatment services for drug use disoders and HIV/AIDS EN
RSUD_410 Reported treatment coverage for substance dependence EN
NHABASIS Basis for NHA estimate EN
RSUD_43 Open access services for substance use disorders EN
RSUD_440 Pharmacotherapy with buprenorphine EN
RSUD_450 Pharmacotherapy with buprenorphine/naloxone EN
RSUD_46 Length of stay for inpatient detoxification, days EN
RSUD_48 Length of stay for inpatient long-term residential treatment, days EN
RSUD_49 Opioid agonist pharmacotherapy for the treatment of opioid dependence (detoxification or maintenance) EN
RSUD_50 Timeframe of opioid agonist treatment EN
RSUD_510 Registration of naloxone for injection for opioid overdose EN
RSUD_52 Methadone used for detoxification or maintenance EN
RSUD_54 Buprenorphine used for the treatment of opioid dependence EN
RSUD_55 Buprenorphine used for detoxification or maintenance EN
RSUD_44 Treatment slots for alcohol and drug use disorders, outpatient, per 10 000 EN
RSUD_45 Beds for the treatment of substance use disorders, per 100 000 EN
RSUD_47 Length of stay for inpatient short-term treatment, days EN
RSUD_470 Timeframe for maintenance treatment of opioid dependence EN
RS_210 Applicability of seat-belt law to all occupants EN
RS_213 Existence of a national child-restraint law EN
RS_219 Applicability of national motorcycle helmet law to all occupants EN
RS_223_BIS Law requires helmet to be fastened EN
RS_229 Availability of funding for national road safety strategy EN
RSUD_1 Point prevalence (%), alcohol use disorders, 15+ years EN
RSUD_57 Buprenorphine/naloxone used for detoxification or maintenance EN
E20_subnational_exists Subnational laws or regulations exist banning some or all types of tobacco advertising, promotion and sponsorship EN
RSUD_130 Government unit/official responsible for treatment of substance use disorders EN
NCD_CCS_dialysis General availability of dialysis in the public health system EN
E27_indirect_ad_fines Law requires fines for violations of indirect advertising bans EN
NCD_CCS_MultisecComm Existence of a national multisectoral commission, agency or mechanism for NCDs EN
NCD_CCS_NCDUnit_Operational Existence of an Operational Unit, Branch, or Dept. in Ministry of Health with responsibility for NCDs EN
NCD_CCS_paaware Implementation of physical activity public awareness program EN
RSUD_500 Registration of medications for opioid withdrawal EN
RSUD_51 Methadone used for the treatment of opioid dependence EN
E3_compliance Compliance of ban on advertising on local magazines and newspapers EN
E4_intl_print Ban on advertising: International magazines and newspapers EN
NTD_1 Number of new reported cases of Buruli ulcer EN
NCDMORT3070 Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease EN
nmr Neonatal mortality rate (deaths per 1000 live births) EN
NTCP_agcy National agency for tobacco control exists EN
NTCP_budget_year Budget year EN
E6_pt_of_sale Ban on advertising: Point of sale EN
E8_direct_ad_fines Law requires fines for violations of direct advertising bans EN
ebreast5 Early initiation of breastfeeding (in the five years preceding the survey) (%) EN
EC_indirect_compliance Compliance with bans on promotion and sponsorship EN
EMFLIMITELECTRIC900 Electric field limit at 900 MHz (V/m) EN
EMFLIMITELECTRICLF Electric field (kV/m) EN
EMFLIMITPOWERDENSITY1800 Power density limit at 1800 MHz (W/m^2) EN
NTD_LEISHCNUM Number of cases of cutaneous leishmaniasis reported EN
NTD_LEPR3 Leprosy - Number of cases registered for treatment EN
NTD_LEPR4 Leprosy registered prevalence rate per 1 000 000 population EN
NTD_LEPR7 Leprosy - New leprosy cases with G2D rate per 1 000 000 population EN
NTD_4 Number of new reported cases of human African trypanosomiasis (T.b. gambiense) EN
NTD_5 Number of new reported cases of human African trypanosomiasis (T.b. rhodesiense) EN
NTD_7 Population in areas that warrant treatment with antibiotics, facial cleanliness and environmental improvement for elimination of trachoma as a public health problem EN
NTCP_curr Reported currency EN
NTCP_govt_exp Annual budget for tobacco control in currency reported EN
NTD_2 Dracunculiasis certification status of countries at the beginning of the year EN
NTD_6 Status of elimination of trachoma as a public health problem EN
NTD_TRA5 Number of people operated for trachomatous trichiasis EN
RSUD_590 Prevention programmes for specific populations for alcohol EN
RSUD_62 Supervision requirements for buprenorphine administration EN
NTD_LEISHVEND Status of endemicity of visceral leishmaniasis EN
RSUD_490 Registration of medications for opioid dependence EN
RSUD_5 Age-standardized DALYs, alcohol and drug use disorders, per 100 000 EN
RSUD_53 Methadone formulation used for the treatment of opiod dependence EN
RSUD_530 Screening and brief intervention for substance use in primary health care EN
NTD_8 Number of people who received treatment with antibiotics for trachoma EN
NTD_BEJELSTATUS Status of bejel endemicity EN
NTD_DRACASES Dracunculiasis cases EN
NTD_LEISHCEND Status of endemicity of cutaneous leishmaniasis EN
NTD_LEISHCNUM_IM Number of imported cases of cutaneous leishmaniasis reported EN
NTD_LEISHVNUM Number of cases of visceral leishmaniasis reported EN
NTD_LEISHVNUM_IM Number of imported cases of visceral leishmaniasis reported EN
RSUD_630 Programmes readily available EN
RSUD_64 Prescription requirements for methadone EN
RSUD_65 Prescription requirements for buprenorphine EN
RSUD_660 Treatment programmes for women with alcohol use disorders EN
RSUD_680 Special housing services for alcohol use disorders EN
RSUD_560 Recommendations for screening and brief interventions for substance use in antenatal services EN
RSUD_580 Prevention programmes for alcohol EN
RSUD_59 Buprenorphine provision in clinical and community-based settings EN
RSUD_520 Availability of naloxone EN
RSUD_540 Screening and brief intervention for substance use in antenatal services EN
RSUD_550 Recommendations for screening and brief interventions for substance use in primary health care EN
RSUD_56 Buprenorphine/naloxone used for the treatment of opioid dependence EN
RSUD_570 Groups and agencies involved in prevention programs EN
RSUD_60 Buprenorphine/naloxone provision in clinical and community-based settings EN
RSUD_61 Supervision requirements for methadone administration EN
RSUD_70 Pharmacotherapy used for the management of cannabis withdrawal EN
RSUD_71 Essential list of medicines EN
RSUD_72 Essential list of medicines, pharmacotherapy for substance use disorders EN
EMFLIMITELECTRICRF Electric field (V/m) EN
EMFLIMITMAGNETIC Magnetic flux density (microT) EN
EQ_CONDOMUSE People who identify the use of condoms as a way to avoid AIDS (%) EN
EMFLIMITELECTRIC1800 Electric field limit at 1800 MHz (V/m) EN
EMFLIMITPOWERDENSITY900 Power density limit at 900 MHz (W/m^2) EN
EMFPOWERFREQUENCY Power frequency (Hz) EN
FINPROTECTION_CATA_ESTIMATE_AVAILABLE Availability of estimates on large health expenditures as a share of total expenditure or income EN
FINPROTECTION_CATA_TOT_25_LEVEL_SH Population with household spending on health greater than 25% of total household budget (SDG 3.8.2, estimated data) (%) EN
RSUD_160 Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for treatment of substance use disorders EN
RSUD_180 Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for prevention for alcohol and drugs EN
RSUD_210 Voluntary treatment for people with alcohol use disorders in the criminal justice system EN
RSUD_22 Budget line for substance use disorder treatment EN
RSUD_220 Voluntary treatment for people with drug use disorders in the criminal justice system EN
NCD_CCS_PM3_Surv Has a STEPS survey or a comprehensive health examination survey every 5 years EN
NCD_CCS_rheum Provision for secondary prevention of rheumatic fever and rheumatic heart disease in more than 50% of public sector health facilities EN
NCD_CCS_riskstrat Availability of cardiovascular risk stratification in 50% or more primary health care facilities EN
NCD_CCS_SaltPol Existence of any policies to reduce population salt consumption EN
NCD_CCS_Spirom General availability of spirometry at the primary health care level EN
NCD_CCS_sulphonylurea General availability of sulphonylurea(s) in the public health sector EN
NCD_CCS_targets Existence of a set of time-bound national targets based on WHO guidance EN
NCD_CCS_Thiazide General availability of thiazide diuretics in the public health sector EN
NCD_CCS_thrombolytic General availability of thrombolytic therapy in the public health system EN
NCD_CCS_TobPlan Existence of operational policy/strategy/action plan to decrease tobacco use EN
RSUD_290 Hypothecated taxes to be spent on prevention and treatment for substance use disorders EN
RSUD_36 Sector for outpatient treatment of drug dependence EN
RSUD_370 Specialized treatment facilities for alcohol use disorders EN
RSUD_38 Sector for residential long-term rehabilitation of drug use disorders EN
RSUD_39 Treatment system for substance use disorders EN
RSUD_42 Specialized treatment services for substance use disorders and TB EN
E22_subnational_exists Subnational bans on tobacco advertising, promotion and sponsorship EN
E25_ban_display_pt_of_sale Ban on display of tobacco products at points of sale EN
E3_nat_print Ban on advertising: Local magazines and newspapers EN
E5_compliance Compliance of ban on advertising on billboards and outdoor advertising EN
E6_compliance Compliance of ban on advertising at point of sale EN
E6b_ban_display_pt_of_sale Ban on display of tobacco products at points of sale EN
E7_internet Ban on advertising: Internet EN
RSUD_610 Prevention programmes for specific populations for drugs EN
RSUD_620 HIV, Hepatitis counselling and treatment availability in specialized facilities and services EN
RSUD_66 Prescription requirements for buprenorphine/naloxone EN
RSUD_690 Special housing services for drug use disorders EN
RSUD_74 Budget line for substance use disorder prevention EN
RSUD_75 Funding method for substance use disorder prevention EN
RSUD_750 Standards of care for professionals providing treatment for alcohol and drug use disorders EN
RSUD_77 Programmes for the prevention of substance use disorders for special populations EN
NTD_TSOL3 Number of pigs in the country EN
NTD_YAWSEND Status of yaws endemicity EN
NUTRITION_570 Early initiation of breastfeeding (%) EN
NUTRITION_ANT_WHZ_NE2 Overweight prevalence among children under 5 years of age (% weight-for-height >+2 SD), survey-based estimates EN
RSUD_770 Postgraduate training programme in prevention EN
RSUD_8 Epidemiological data collection system for substance use disorders EN
RSUD_81 Clinical supervision of health care staff EN
RSUD_810 Continuing professional development in treatment EN
RSUD_820 Epidemiological data collection for substance use EN
RSUD_83 Standards of care for health professionals, maintenance EN
NUTRITION_WH_2 Wasting prevalence among children under 5 years of age (% weight-for-height <-2 SD), survey-based estimates EN
NUTSEVWASTINGPREV Severe wasted prevalence among children under 5 years of age (%), model-based estimates EN
NUTSTUNTINGPREV Stunting prevalence among children under 5 years of age (% height-for-age <-2 SD), model-based estimates EN
NTD_LEPR11 Number of female leprosy new cases EN
NTD_LEPR2 New leprosy case detection rate per 1 000 000 population EN
NTD_LEPR8 Leprosy - Number of new leprosy cases among children (less than 15 years of age) EN
NTD_LEPR9 Number of new leprosy cases with G2D among children (less than 15 years of age) EN
NTD_ONCHSTATUS Status of endemicity of onchocerciasis EN
NTD_ONCTREAT Reported number of individuals treated for onchocerciasis EN
NTD_PINTASTATUS Status of pinta endemicity EN
NTD_RAB2 Reported number of human rabies deaths EN
NTD_TSOL2 Presence of porcine cysticercosis EN
RSUD_730 Open access interventions for drugs EN
RSUD_76 Prevention activities for substance use disorders, main focus EN
RSUD_800 Postgraduate training programme in treatment EN
RSUD_86 NGOs for drug use disorders EN
NTD_TSOL4 Practice of backyard pig production EN
NTD_YAWSNUM Number of cases of yaws reported EN
NUTOVERWEIGHTPREV Overweight prevalence among children under 5 years of age (% weight-for-height >+2 SD), model-based estimates EN
NUTRITION_564 Children aged <5 years wasted for age (%) EN
NUTRITION_ANT_HAZ_NE2 Stunting prevalence among children under 5 years of age (% height-for-age <-2 SD), survey-based estimates EN
NUTOVERWEIGHTNUM Overweight numbers among children under 5 years of age (millions), model-based estimates EN
NUTRITION_2005 Proportion of children aged 6-23 months who receive a minimum acceptable diet EN
NUTRITION_579 Exclusive breastfeeding under 6 months (%) EN
RSUD_84 Standards of care for health professionals, human rights EN
RSUD_840 Regular reports on epidemiological and service delivery data for substance use EN
RSUD_85 NGOs for alcohol use disorders EN
RSUD_850 System of monitoring alcohol involvement in forensic pathology EN
RSUD_87 Self-help groups for substance use disorders EN
RSUD_870 Epidemiological data collection system for substance use among children and adolescents EN
EMFSTANDARD Existence of standards EN
NUTSEVWASTINGNUM Severe wasted numbers among children under 5 years of age (millions), model-based estimates EN
NUTSTUNTINGNUM Stunting numbers among children under 5 years of age (millions), model-based estimates EN
RSUD_63 Supervision requirements for buprenorphine/naloxone administration EN
RSUD_67 Commencement of treatment with opioid agonists EN
RSUD_69 Pharmacotherapy used for the management of benzodiazepine withdrawal EN
RSUD_7 Psychoactive substance causing entry into treatment EN
RSUD_700 Employment services for alcohol use disorders EN
RSUD_710 Employment services for drug use disorders EN
FINPROTECTION_IMP_PG_190 Increase in poverty gap due to household health expenditures at the $1.90 a day poverty line, in cents of international dollars EN
FINPROTECTION_IMP_PG_190_STD Increase in poverty gap due to household health expenditures, expressed as a proportion of the $1.90 a-day poverty line (%) EN
RSUD_720 Open access interventions for alcohol EN
RSUD_73 Government unit for substance use disorder prevention EN
RSUD_740 Health professionals providing treatment for alcohol and drug use disorders EN
RSUD_79 Harm reduction programmes for IDUs EN
NUTRITION_WH_3 Severe wasted prevalence among children under 5 years of age (% weight-for-height <-3 SD), survey-based estimates EN
NUTUNDERWEIGHTNUM Underweight numbers among children under 5 years of age (millions), model-based estimates EN
NUTUNDERWEIGHTPREV Underweight prevalence among children under 5 years of age (%), model-based estimates EN
O_Avail_community Treatment for tobacco dependence available in the community EN
O_Avail_hosp Treatment for tobacco dependence available in hospitals EN
O_Avail_off_hlth_prof Treatment for tobacco dependence available in offices of health professionals EN
O_Bup_where Bupropion - place available EN
FINPROTECTION_IMP_NP_190_LEVEL_SH Total population pushed below the $1.90 a day poverty line by household health expenditures (%) EN
FINPROTECTION_IMP_NP310_POP Population pushed below the $3.20 a day poverty line by household health expenditures (%, national, rural, urban) EN
FINPROTECTION_IMP_PG_310 Increase in poverty gap due to household health expenditures at the $3.10a day poverty line, in cents of international dollars EN
FINPROTECTION_IMP_PG_310_STD Increase in poverty gap due to household health expenditures, expressed as a proportion of the $3.20 a-day poverty line (%, national, rural, urban) EN
E9_compliance Compliance of ban on free distribution of tobacco products in the mail or through other means EN
E9_free_distrib Ban on free distribution of tobacco products in the mail or through other means EN
ebreast Early initiation of breastfeeding (in the two or three years preceding the survey) (%) EN
NCD_GLUC_01 Mean fasting blood glucose (mmol/l) (age-standardized estimate) EN
NTCP_govt_obj Government objectives on tobacco control exist EN
NTD_3 Annual incidence of dracunculiasis cases EN
RSUD_430 Pharmacotherapy with methadone EN
RSUD_460 Access restrictions to maintenance treatment EN
RSUD_480 Registration of medications for alcohol dependence and withdrawal EN
fpsmo Demand for family planning satisfied - modern methods (%) EN
RSUD_80 Health professionals mostly involved in treatment of substance use disorders EN
RSUD_82 Standards of care for health professionals EN
RSUD_830 Service delivery data collection for substance use EN
RSUD_860 System of monitoring drugs involvement in forensic pathology EN
RSUD_88 Groups and agencies for the prevention of substance use disorders EN
RSUD_880 Epidemiological data collection system for substance use among children and adolescents EN
RSUD_58 Methadone provision in clinical and community-based settings EN
FINPROTECTION_IMPOV_ESTIMATE_AVAILABLE Availability of estimates on impoverishment due to out-of-pocket health expenditures EN
GDO_q10x1x1 Availability of generic anti-dementia medication EN
GDO_q10x1x2 Availability of at least one anti-dementia medication approved for on-label use reimbursement EN
RSUD_89 Opioid agonist pharmacotherapy for the treatment of opioid dependence (maintenance) EN
RSUD_890 Treatment programmes for children and adolescents with alcohol use disorders EN
SA_0000001398 Alcohol, consumption of pure alcohol by type of beverage (%) EN
SA_0000001400_ARCHIVED Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol) EN
FINPROTECTION_IMP_NP190_POP Population pushed below the $1.90 a day poverty line by household health expenditures (%) EN
fps Demand for family planning satisfied - modern and traditional methods (%) EN
RSUD_9 Service delivery data collection system for substance use disorders EN
SA_0000001398_ARCHIVED Alcohol, consumption of pure alcohol by type of beverage (%) EN
SA_0000001400 Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol) EN
SA_0000001401 Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average EN
SA_0000001402_ARCHIVED Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010 EN
SA_0000001403 Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) EN
SA_0000001403_ARCHIVED Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) EN
SA_0000001401_ARCHIVED Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average EN
SA_0000001402 Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010 EN
SA_0000001405_ARCHIVED Alcohol, tourist consumption (in litres of pure alcohol) EN
SA_0000001406 Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) EN
O_Avail_other Treatment for tobacco dependence available in other settings EN
O_Bup_ins Bupropion - cost covered EN
O_Ins_community Treatment for tobacco dependence in the community cost covered EN
O_Ins_hlth_clin Treatment for tobacco dependence in health clinics or other primary care facilities cost covered EN
OA_DMFT Decayed, missing, or filled teeth EN
obesewm Obesity prevalence in non-pregnant women aged 15-49 years, BMI >= 30 (%) EN
OCC_11 Occupational carcinogens attributable deaths per 100’000 capita EN
O_Ins_hosp Treatment for tobacco dependence in hospitals cost covered EN
SA_0000001405 Alcohol, tourist consumption (in litres of pure alcohol) EN
NUTWASTINGNUM Wasted numbers among children under 5 years of age (millions), model-based estimates EN
NUTWASTINGPREV Wasted prevalence among children under 5 years of age (%), model-based estimates EN
OCC_16 Occupational ergonomic stressors attributable DALYs (’000) EN
OCC_17 Occupational ergonomic stressors attributable deaths per 100’000 capita EN
OCC_20 Occupational injuries attributable DALYs (’000) EN
GDO_q10x2_HOSUE Availability of atleast one housing adjustment for people with dementia EN
GDO_q11x2x1 Dementia nongovernmental organization equipped with office EN
O_Ins_other Treatment for tobacco dependence in other settings cost covered EN
O_NRT_EML Nicotine replacement therapy on the Essential Medicines List EN
O_NRT_sold Nicotine replacement therapy - legally sold EN
O_Quitline Access to a toll-free quit line EN
O_Varen_ins Varenicline - cost covered EN
O_Varen_sold Varenicline - legally sold EN
O_Avail_hlthSPACEclin Treatment for tobacco dependence available in health clinics or other primary care facilities EN
O_Group Offering help to quit tobacco use EN
O_NRT_ins Nicotine replacement therapy - cost covered EN
GDO_q12x2_2 Existence of psycho-social supports for dementia carers EN
GDO_q12x2_3 Existence of respite care for dementia carers EN
GDO_q12x2_4 Existence of information on legal rights for dementia carers EN
GDO_q12x2x1x1_1PUB Majority provider of dementia carer training and education (Public sector) EN
GDO_q10x2_TECH Availability of atleast one assistive technology for people with dementia EN
GDO_q11x1 Existence of dementia national nongovernmental organization EN
O_Varen_where Varenicline - place available EN
GBD_DALYRTAGE Age-standardized DALYs (per 100,000) EN
GDO_q11x2x2_1 Dementia nongovernmental organization office branches (Sub-national) EN
GDO_q11x2x2_2 Dementia nongovernmental organization office branches (Local) EN
GDO_q11x2x2_3 Dementia nongovernmental organization office branches (National only) EN
GDO_q11x2x6 Dementia nongovernmental organization’s involvement in policy development EN
GDO_q12x1x3 Existence of implementation plan for dementia carer support services EN
GDO_q12x2_5 Existence of financial benefits/social protection for dementia carers EN
GDO_q12x1 Existence of dementia carer support services EN
GDO_q12x1x1 Implementation level [national/subnational] of dementia carer support services EN
GDO_q12x1x2 Existence of dedicated resources for dementia carer support services EN
NTD_LEPR5 Number of new G2D leprosy cases EN
NTD_ONCHEMO Estimated number of individuals in the country requiring preventive chemotherapy for onchocerciasis EN
NTD_TSOL1 Status of endemicity of Taenia solium EN
EC_direct_compliance Compliance with bans on direct advertising EN
EMFLIMITELECTRIC Electric field (kV/m) EN
EMFLIMITPOWERDENSITY Power density (W/m^2) EN
EMFSAR Specific absorption rate (SAR) (W/kg) EN
EMFSTATUS Legislative status EN
EQ_OVERWEIGHTADULT Prevalence of overweight and obesity EN
FINPROTECTION_CATA_TOT_10_LEVEL_MILLION Population with household spending on health greater than 10% of total household budget (SDG 3.8.2, estimated data) (millions) EN
FINPROTECTION_CATA_TOT_10_LEVEL_SH Population with household spending on health greater than 10% of total household budget (SDG 3.8.2, estimated data) (%) EN
FINPROTECTION_CATA_TOT_10_POP Population with household spending on health greater than 10% of total household budget (SDG 3.8.2, reported data) (%) EN
FINPROTECTION_CATA_TOT_25_LEVEL_MILLION Population with household spending on health greater than 25% of total household budget (SDG 3.8.2, estimated data) (millions) EN
FINPROTECTION_CATA_TOT_25_POP Population with household spending on health greater than 25% of total household budget (SDG 3.8.2, reported data) (%) EN
FINPROTECTION_IMP_NP_190_LEVEL_MILLION Total population pushed below the \(1.90 a day poverty line by household health expenditures (millions) |EN | |RSUD_600 |Prevention programmes for drugs |EN | |RSUD_640 |Standards of treatment and care for public specialized treatment facilities |EN | |RSUD_650 |Special treatment programmes for gambling disorder |EN | |RSUD_670 |Treatment programmes for women with drug use disorders |EN | |RSUD_68 |Pharmacotherapy used for the management of alcohol withdrawal |EN | |RSUD_760 |Educational attainment in prevention |EN | |RSUD_78 |Screening and brief interventions for substance use and substance use disorders |EN | |RSUD_780 |Continuing professional development in prevention |EN | |RSUD_790 |Educational attainment in treatment |EN | |GDO_q12x2x1x1_1NGO |Majority provider of dementia carer training and education (NGO) |EN | |SA_0000001404_ARCHIVED |Alcohol, drinkers only per capita (15+)consumption in litres of pure alcohol |EN | |GDO_q12x2x1x1_2NGO |Majority provider of psycho-social supports for dementia carers (NGO) |EN | |SA_0000001414 |Alcohol, former drinkers (%) |EN | |SA_0000001409 |Alcohol, abstainers lifetime (%) |EN | |SA_0000001410 |Abstainers (15-19 years), lifetime (%) |EN | |SA_0000001411 |Alcohol, abstainers past 12 months (%) |EN | |SA_0000001412 |Abstainers (15-19 years), past 12 months (%) |EN | |SA_0000001416 |Alcohol, heavy episodic drinking (15+), drinkers only, past 30 days (%) |EN | |SA_0000001415_ARCHIVED |Alcohol, heavy episodic drinking (population) past 30 days (%) |EN | |SA_0000001416_ARCHIVED |Alcohol, heavy episodic drinking (15+), drinkers only, past 30 days (%) |EN | |SA_0000001419 |Age-standardized DALYs, breast cancer, per 100,000 |EN | |SA_0000001422 |Age-standardized DALYs, drownings, per 100,000 |EN | |SA_0000001426 |Age-standardized DALYs, liver cancer, per 100,000 |EN | |GDO_q12x2x1x1_1 |Accessibility of dementia carer training and education [Capital/capital and main cities/capital, main cities, rural areas] |EN | |GDO_q12x2x1x1_1PRV |Majority provider of dementia carer training and education (Private sector) |EN | |GDO_q12x2x1x1_2 |Accessibility of psycho-social supports for dementia carers [Capital/capital and main cities/capital, main cities, rural areas] |EN | |GDO_q12x2x1x1_3PUB |Majority provider of respite care for dementia carers (Public sector) |EN | |GDO_q12x2x1x1_4NGO |Majority provider of information on legal rights for dementia carers (NGO) |EN | |SA_0000001433 |Age-standardized DALYs, road traffic accidents, per 100,000 |EN | |GDO_q12x2x1x1_2PRV |Majority provider of psycho-social supports for dementia carers (Private sector) |EN | |GDO_q12x2x1x1_3PRV |Majority provider of respite care for dementia carers (Private sector) |EN | |GDO_q12x2x1x1_4 |Accessibility of information on legal rights for dementia carers [Capital/capital and main cities/capital, main cities, rural areas] |EN | |GDO_q12x2x1x1_4PUB |Majority provider of information on legal rights for dementia carers (Public sector) |EN | |GDO_q12x2x1x1_5NGO |Majority provider of information on financial benefits/social protection for dementia carers (NGO) |EN | |GDO_q12x2x1x1_5 |Accessibility of financial benefits/social protection for dementia carers [Capital/capital and main cities/capital, main cities, rural areas] |EN | |GDO_q12x2x1x1_5PRV |Majority provider of information on financial benefits/social protection for dementia carers (Private sector) |EN | |SA_0000001413_ARCHIVED |Alcohol, consumers past 12 months (%) |EN | |SA_0000001420 |Age-standardized DALYs, colon and rectum cancers, per 100,000 |EN | |GDO_q14x1 |Availability of dementia-friendly initiatives that improve accessibility |EN | |GDO_q14x2_2 |Existence of dementia-friendly initiative to improve accessibility of public transportation |EN | |OCC_22 |Occupational injuries attributable DALYs per 100'000 capita |EN | |OCC_6 |Occupational airborne particulates attributable DALYs ('000) |EN | |OCC_7 |Occupational airborne particulates attributable deaths per 100'000 capita |EN | |OCC_9 |Occupational carcinogens attributable deaths |EN | |SA_0000001421 |Age-standardized DALYs, diabetes mellitus, per 100,000 |EN | |SA_0000001423 |Age-standardized DALYs, falls, per 100,000 |EN | |SA_0000001427 |Age-standardized DALYs, liver cirrhosis, per 100,000 |EN | |SA_0000001430 |Age-standardized DALYs, oesophagus cancer, per 100,000 |EN | |SA_0000001431 |Age-standardized DALYs, poisoning, per 100,000 |EN | |SA_0000001432 |Age-standardized DALYs, prematurity and low birth rate, per 100,000 |EN | |ORGANTOTALDECRATE |Total actual deceased donors (per million) |EN | |ort |Children aged < 5 years with diarrhoea receiving oral rehydration therapy and continued feeding (%) |EN | |overwgt3 |Overweight prevalence in children aged <three years (%) |EN | |OCC_15 |Occupational ergonomic stressors attributable deaths |EN | |OCC_5 |Occupational airborne particulates attributable deaths |EN | |ODA_3 |Donor disbursements (Million, constant 2009 US\)) EN
ODA_4 Disbursements to recipient countries (Million, constant 2009 US$) EN
ORGANLIVERNUM Liver transplants (absolute number) EN
ORGANTOTALRATE Total organs transplanted (per million) EN
NUTRITION_WA_2 Underweight prevalence among children under 5 years of age (% weight-for-age <-2 SD), survey-based estimates EN
O_Avail_hlth_clin Treatment for tobacco dependence available in health clinics or other primary care facilities EN
O_Bup_sold Bupropion - legally sold EN
FINPROTECTION_IMP_NP_310_LEVEL_MILLION Total population pushed below the $3.20 a day poverty line by household health expenditures (millions) EN
FINPROTECTION_IMP_NP_310_LEVEL_SH Total population pushed below the \(3.20 a day poverty line by household health expenditures (%, regional, global) |EN | |fullv |Full immunization coverage among one-year-olds (%) |EN | |GB_XPD_RSDV |Research and development (R&amp;D) expenditure as a proportion of GDP |EN | |GDO_q10x1 |National regulator approval of anti-dementia medication |EN | |GDO_q10x2_1AVAIL |Availability of atleast one adult hygiene products for people with dementia |EN | |RSUD_900 |Treatment programmes for children and adolescents with drug use disorders |EN | |SA_0000001404 |Alcohol, drinkers only per capita (15+)consumption in litres of pure alcohol |EN | |overwgt5 |Overweight prevalence in children aged <five years (%) |EN | |P_Group |Protecting people from tobacco smoke |EN | |P1_compliance |Compliance of ban on smoking in HEALTH-CARE FACILITIES |EN | |P12_fines_establishment |National smoking ban: FINES ON THE ESTABLISHMENT |EN | |GDO_q12x2x5x3 |Estimated number of dementia carers receiving financial benefits/social protection |EN | |ODA_1 |Donor commitments (Million, constant 2009 US\)) EN
ODA_2 Commitments to recipient countries (Million, constant 2009 US\() |EN | |ORGANKIDNEYRATE |Kidney transplants (per million) |EN | |ORGANLIVERRATE |Liver transplants (per million) |EN | |ORGANPOP |Population (millions) |EN | |ORGANTOTALDECNUM |Total actual deceased donors (absolute number) |EN | |GDO_q13x3x1 |Implementation level [national/subnational] of dementia risk reduction campaign |EN | |GDO_q14x2_1 |Existence of dementia-friendly initiative to improve accessibility of public spaces |EN | |GDO_q12x2x1x1_5PUB |Majority provider of information on financial benefits/social protection for dementia carers (Public sector) |EN | |GDO_q12x2x2x3 |Estimated number of dementia carers receiving psycho-social supports |EN | |GDO_q12x2x3x3 |Estimated number of dementia carers receiving respite care |EN | |GDO_q12x2x4x3 |Estimated number of dementia carers receiving information on legal rights |EN | |GDO_q13x1 |Existence of at least one functioning dementia awareness campaign |EN | |GDO_q13x1x1 |Implementation level [national/subnational] of dementia awareness campaign |EN | |P1_healthcare |National smoking ban in HEALTH-CARE FACILITIES |EN | |GDO_q14x2_3 |Existence of dementia-friendly initiative for assistance with home modification |EN | |GDO_q14x2_4 |Existence of dementia-friendly initiative with assistive technology for loss of capacity |EN | |GDO_q14x2_5 |Existence of dementia-friendly initiative supporting community places for older people |EN | |GDO_q13x3 |Existence of at least one functioning risk reduction campaign |EN | |GDO_q15x1 |Inclusion of dementia training and education for non-health workers |EN | |GDO_q15x2_1 |Existence of dementia training for volunteers |EN | |P10_subnat_auth_exists |Subnational smoking bans - authority exists |EN | |GDO_q15x2_5 |Existence of dementia training for community workers |EN | |GDO_q16x1 |Routine monitoring of people with dementia |EN | |GDO_q16x1x1_1 |Data sources used to routinely monitor people with dementia (Clinical records) |EN | |GDO_q16x1x1_3 |Data sources used to routinely monitor people with dementia (Administrative data) |EN | |GDO_q16x1x1_4 |Data sources used to routinely monitor people with dementia (Facility survey or records) |EN | |P13_fines_smoker |National smoking ban: FINES ON THE PATRON |EN | |P15_complaints |National smoking ban: CITIZEN COMPLAINTS AND INVESTIGATIONS |EN | |P16_subnat_complete_bans_exist |Comprehensive bans in place subnationally |EN | |P2_compliance |Compliance of ban on smoking in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES |EN | |P2_education |National smoking ban in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES |EN | |P4_compliance |Compliance of ban on smoking in GOVERNMENT FACILITIES |EN | |P11_fines_any |National smoking ban: FINES FOR VIOLATIONS |EN | |P4_govt |National smoking ban in GOVERNMENT FACILITIES |EN | |P5_compliance |Compliance of ban on smoking in INDOOR OFFICES |EN | |P9_all_other |National smoking ban in ALL OTHER INDOOR PUBLIC PLACES |EN | |PC_sfe_compliance |Compliance with regulations on smoke-free environments (national legislation) |EN | |GDO_q15x2_7 |Existence of dementia training for financial service staff |EN | |GDO_q15x2_8 |Existence of dementia training for retail and hospitality staff |EN | |P14_funds_for_enforce |National smoking ban: DEDICATED FUNDS FOR ENFORCEMENT |EN | |P8_compliance |Compliance of ban on smoking in PUBLIC TRANSPORT |EN | |PercposANC |Antenatal care attendees who were positive for syphilis (%), reported |EN | |PercposMSM |Men who have sex with men (MSM) with active syphilis (%) |EN | |SA_0000001435 |Age-standardized DALYs, other unintentional injuries, per 100,000 |EN | |SA_0000001436 |Age-standardized DALYs, violence, per 100,000 |EN | |SA_0000001440 |Age-standardized death rates, diabetes mellitus, per 100,000 |EN | |pncall3 |Postnatal care visit within two days of birth (in the three years preceding the survey) (%) |EN | |pnchome |Postnatal care visit within two days of birth - born outside a health facility (in the x years preceding the survey) (%) |EN | |P3_compliance |Compliance of ban on smoking in UNIVERSITIES |EN | |P3_universities |National smoking ban in UNIVERSITIES |EN | |P6_compliance |Compliance of ban on smoking in RESTAURANTS |EN | |P6_restaurants |National smoking ban in RESTAURANTS |EN | |P7_compliance |Compliance of ban on smoking in PUBS AND BARS |EN | |SA_0000001437 |Age-standardized death rates, alcohol use disorders, per 100,000 |EN | |SA_0000001438 |Age-standardized death rates, breast cancer, per 100,000 |EN | |SA_0000001442 |Age-standardized death rates, falls, per 100,000 |EN | |SA_0000001446 |Age-standardized death rates, liver cirrhosis, per 100,000 |EN | |SA_0000001448 |Age-standardized death rates, mouth and oropharynx cancer, per 100,000 |EN | |SA_0000001441 |Age-standardized death rates, drownings, per 100,000 |EN | |SA_0000001443 |Age-standardized death rates, fires, per 100,000 |EN | |SA_0000001452 |Age-standardized death rates, road traffic accidents, per 100,000 |EN | |SA_0000001454 |Age-standardized death rates, other unintentional injuries, per 100,000 |EN | |P8_pub_transp |National smoking ban in PUBLIC TRANSPORT |EN | |PCV3 |Pneumoccocal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%) |EN | |SA_0000001429 |Age-standardized DALYs, mouth and oropharynx cancer, per 100,000 |EN | |SA_0000001406_ARCHIVED |Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) |EN | |SA_0000001409_ARCHIVED |Alcohol, abstainers lifetime (%) |EN | |SA_0000001411_ARCHIVED |Alcohol, abstainers past 12 months (%) |EN | |SA_0000001413 |Alcohol, consumers past 12 months (%) |EN | |O_Ins_off_hlth_prof |Treatment for tobacco dependence in offices of health professionals cost covered |EN | |O_NRT_where |Nicotine replacement therapy - place available |EN | |OCC_1 |Occupational risk factors attributable deaths |EN | |OCC_10 |Occupational carcinogens attributable DALYs ('000) |EN | |OCC_12 |Occupational carcinogens attributable DALYs per 100'000 capita |EN | |OCC_13 |Occupational noise attributable DALYs ('000) |EN | |OCC_14 |Occupational noise attributable DALYs per 100'000 capita |EN | |OCC_18 |Occupational ergonomic stressors attributable DALYs per 100'000 capita |EN | |OCC_19 |Occupational injuries attributable deaths |EN | |OCC_2 |Occupational risk factors attributable DALYs ('000) |EN | |OCC_21 |Occupational injuries attributable deaths per 100'000 capita |EN | |OCC_3 |Occupational risk factors attributable deaths per 100'000 capita |EN | |OCC_4 |Occupational risk factors attributable DALYs per 100'000 capita |EN | |OCC_8 |Occupational airborne particulates attributable DALYs per 100'000 capita |EN | |GDO_q11x2x3 |Dementia nongovernmental organization staff primarily salaried/volunteer |EN | |GDO_q11x2x5 |Provision of governmental funding to dementia nongovernmental organization for activities/services |EN | |GDO_q12x2x1x1_2PUB |Majority provider of psycho-social supports for dementia carers (Public sector) |EN | |GDO_q12x2x1x1_3 |Accessibility of respite care for dementia carers [Capital/capital and main cities/capital, main cities, rural areas] |EN | |GDO_q12x2x1x1_3NGO |Majority provider of respite care for dementia carers (NGO) |EN | |GDO_q12x2x1x1_4PRV |Majority provider of information on legal rights for dementia carers (Private sector) |EN | |SA_0000001453 |Age-standardized death rates, self-inflicted injury, per 100,000 |EN | |SA_0000001455 |Age-standardized death rates, violence, per 100,000 |EN | |SA_0000001457 |Liver cirrhosis, age-standardized death rates (15+), per 100,000 population |EN | |GDO_q12x2x1x3 |Estimated number of dementia carers receiving training and education |EN | |SA_0000001449 |Age-standardized death rates, oesophagus cancer, per 100,000 |EN | |SA_0000001456 |Age-standardized death rates (15+ years), alcoholic liver disease, per 100,000 |EN | |GDO_q15x2_4 |Existence of dementia training for legal professionals |EN | |GDO_q15x2_6 |Existence of dementia training for school children |EN | |GDO_q16x1x1_other |Data sources used to routinely monitor people with dementia (Other) |EN | |GDO_q16x1x2_1 |Electronic availability of data sources used to routinely monitor people with dementia |EN | |GDO_q16x2_1 |Availability of routine hospital admissions records for people with dementia for monitoring purposes |EN | |GDO_q16x2_2 |Availability of routine outpatient visit records for people with dementia for monitoring purposes |EN | |GDO_q16x2_4 |Availability of routine pharmaceutical records for people with dementia for monitoring purposes |EN | |GDO_q17x2 |Dementia integrated into other national research plan/programme |EN | |GDO_q16x2_5 |Availability of routine antipsychotic prescription records for people with dementia for monitoring purposes |EN | |GDO_q16x3 |Availability and status of dementia reporting in the past two years |EN | |GDO_q17x1 |Existence of a current dementia research plan/programme |EN | |GDO_q17x2x2 |Implementation level [national/subnational] of research plan in which dementia is integrated |EN | |GDO_q17x2x1_4 |Identification of other research plans in which dementia is integrated (NCD) |EN | |PercposSW |Sex workers with active syphilis (%) |EN | |PerctestedANC |Women accessing antenatal care (ANC) services who were tested for syphilis (%), reported |EN | |pncall |Postnatal care visit within two days of birth (in the x years preceding the survey) (%) |EN | |GDO_q17x2x1_3 |Identification of other research plans in which dementia is integrated (Neuro or neurodegenerative disease) |EN | |pnchome5 |Postnatal care visit within two days of birth - born outside a health facility (in the five years preceding the survey) (%) |EN | |R_Ad_val_average |Average - taxes as a % of cigarette price - ad valorem excise |EN | |R_admin_duty_free_allowance |Tax administration: If duty free imports are limited, duty free allowance (number of cigarette sticks) |EN | |GDO_q18x2x3_3 |Total expenditure on dementia implementation research (local currency, self-report) |EN | |GDO_q19x2 |Number of people with dementia involved in research routinely monitored |EN | |GDO_q19x3x1_1 |Number of investigational pharmaceutical trials for dementia |EN | |GDO_q18x2x1_1 |Total expenditure on dementia research (local currency, self-report) |EN | |GDO_q19x3 |Availability of investigational pharmaceutical trials for dementia |EN | |SA_0000001458 |Age-standardized death rates (15+ years), poisoning, per 100,000 |EN | |SA_0000001460 |Age-standardized death rates (15+ years), violence, per 100,000 |EN | |SA_0000001461 |Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI |EN | |R_Curr_mp |Most sold brand of cigarettes - currency reported |EN | |R_Curr_premium_cost |Premium brand of cigarettes - currency reported |EN | |poliov |Polio immunization coverage among one-year-olds (%) |EN | |R_admin_duty_free_limited |Tax administration: Bans or limits on duty free imports by travellers |EN | |R_afford_price_dispersion |Affordability: Price dispersion: share of cheapest brand price in premium brand price (the higher the % the smaller the gap) |EN | |R_afford_tax_auto_adjust |Affordability: Specific tax component automatically adjusted for inflation (or other) |EN | |SA_0000001463_ARCHIVED |Alcoholic psychosis, incidence, per 100,000 |EN | |SA_0000001464_ARCHIVED |Cautions and arrests for drink-driving, per 100,000 population |EN | |SA_0000001469 |Treatment admissions (inpatient), alcoholic psychosis, per 100,000 |EN | |SA_0000001470 |Alcohol-related road traffic crashes, per 100,000 population |EN | |SA_0000001471 |Alcohol-related road traffic crashes (% of all traffic crashes) |EN | |SA_0000001471_ARCHIVED |Alcohol-related road traffic crashes (% of all traffic crashes) |EN | |SA_0000001464 |Cautions and arrests for drink-driving, per 100,000 population |EN | |SA_0000001465 |Hospital discharges, alcohol-related injuries and poisoning, per 100,000 |EN | |SA_0000001472 |Alcohol-related injury mortality, per 1,000 |EN | |SA_0000001461_ARCHIVED |Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI |EN | |SA_0000001463 |Alcoholic psychosis, incidence, per 100,000 |EN | |SA_0000001467 |Perceived trend in alcohol-related harm and consequences |EN | |SA_0000001414_ARCHIVED |Alcohol, former drinkers (%) |EN | |SA_0000001417 |Alcohol, patterns of drinking score |EN | |SA_0000001417_ARCHIVED |Alcohol, patterns of drinking score |EN | |SA_0000001418 |Age-standardized DALYs, alcohol use disorders, per 100,000 |EN | |SA_0000001424 |Age-standardized DALYs, fires, per 100,000 |EN | |SA_0000001425 |Age-standardized DALYs, ischaemic heart disease, per 100,000 |EN | |SA_0000001434 |Age-standardized DALYs, self-inflicted injury, per 100,000 |EN | |SA_0000001439 |Age-standardized death rates, colon and rectum cancers, per 100,000 |EN | |ORGANKIDNEYNUM |Kidney transplants (absolute number) |EN | |ORGANTOTALNUM |Total organs transplanted (absolute number) |EN | |ors |Children aged < 5 years with diarrhoea receiving oral rehydration salts (%) |EN | |P_count_places_sf |National smoking ban: NUMBER OF PLACES SMOKE-FREE |EN | |GDO_q14x2_6 |Existence of dementia-friendly initiative supporting social opportunities |EN | |GDO_q15x2_2 |Existence of dementia training for police and fire services |EN | |GDO_q15x2_3 |Existence of dementia training for first responders |EN | |GDO_q16x1x1_2 |Data sources used to routinely monitor people with dementia (Household surveys) |EN | |GDO_q16x1x2_2 |Data used to routinely monitor people with dementia can be disaggregated |EN | |GDO_q16x2_3 |Availability of routine outpatient intervention and treatment records for people with dementia for monitoring purposes |EN | |SA_0000001473 |Alcohol-related disease mortality, per 100,000 (15+ years) |EN | |SA_0000001475 |Annual revenues from alcohol excise tax in millions US\) EN
GDO_q18x2x3_1 Total expenditure on dementia basic research (local currency, self-report) EN
GDO_q18x2x3_2 Total expenditure on dementia clinical/translational research (local currency, self-report) EN
GDO_q1x1x1 Inclusion of dementia in a branch of government [health, ageing, social services, mental health, noncommunicable disease] EN
GDO_q2x1 Existence of dementia national plan EN
GDO_q2x1x2 Availability of funding for dementia national plan EN
GDO_q2x2x1_other Identification of other plans in which dementia is integrated (Other) EN
GDO_q2x4_4 Inclusion of multisectoral collaboration as a guiding principles of the dementia plan EN
GDO_q2x4_5 Inclusion of universal health coverage as a guiding principle of the dementia plan EN
R_excise_specific_reliance Tax structure: Greater reliance on specific tax in mixed excise regime EN
R_excise_type Tax structure: Type of excise tax applied EN
R_excise_uniform_varied Tax structure: Uniform excise tax EN
R_Price_premium_estimate Premium brand of cigarettes - price in currency reported EN
R_Sp_excise_average Average - taxes as a % of cigarette price - specific excise EN
R_total_tax_average Average - taxes as a % of cigarette price - total tax EN
R_total_tax_estimate Most sold brand of cigarettes - taxes as a % of price - total tax EN
R_VAT_average Average - taxes as a % of cigarette price - value added tax EN
RADON_Q302 National radon concentration levels EN
RADON_Q303 Existence of national radon database EN
SA_0000001476 Alcohol expenditure as a per cent of total household expenditure EN
SA_0000001476_ARCHIVED Alcohol expenditure as a per cent of total household expenditure EN
SA_0000001502 Adopted written national policy on alcohol EN
GDO_q20 Total number of published dementia research output EN
GDO_q2x1x3 Targets for monitoring implementation of dementia national plan EN
GDO_Q2x2x1_AGE Identification of other plans in which dementia is integrated (Ageing) EN
GDO_Q2x2x1_MENTAL Identification of other plans in which dementia is integrated (Mental health) EN
GDO_Q2x2x1_NCD Identification of other plans in which dementia is integrated (NCD) EN
GDO_q2x5_1 Inclusion of dementia-friendly communities as a specific action of the dementia plan EN
GDO_q2x5_3 Inclusion of dementia diagnosis, care and support as a specific action of the dementia plan EN
GDO_q2x5_6 Inclusion of improved information system as a specific action of the dementia plan EN
GDO_q3x1 Existence of dementia legislation EN
GDO_q2x3 Existence of dementia sub-national plan(s) EN
GDO_q2x3x1_1 Percentage of sub-national regions covered by dementia plan EN
GDO_q2x5_7 Inclusion of research and innovation as a specific action of the dementia plan EN
SA_0000001470_ARCHIVED Alcohol-related road traffic crashes, per 100,000 population EN
GDO_q1x2 Existence of dementia representative in ministry EN
GDO_q2x2 Dementia integrated into other national plan EN
GDO_Q2x2x1_DISAB Identification of other plans in which dementia is integrated (Disability) EN
SA_0000001543_ARCHIVED Government monopoly on retail sales EN
SA_0000001545 Licence required for retail sales EN
SA_0000001546_ARCHIVED Excise tax as a per cent of the retail price of alcoholic beverages EN
SA_0000001548 Excise tax as a per cent of the total retail price for 1 litre of pure alcohol EN
SA_0000001549_ARCHIVED Duty paid or excise stamp on alcohol container EN
R_Sp_excise_estimate Most sold brand of cigarettes - taxes as a % of price - specific excise EN
RADON_Q201 Existence of any national radon activity EN
RADON_Q301 Existence of national radon survey(s) EN
RADON_Q401 Existence of national radon action plan EN
RADON_Q403 Radon in building regulations for new buildings EN
GDO_q2x4_1 Inclusion of human rights as a guiding principle of the dementia plan EN
GDO_q2x4_2 Inclusion of equity as a guiding principle of the dementia plan EN
GDO_q2x4_3 Inclusion of empowerment as a guiding principle of the dementia plan EN
SA_0000001477 Social costs of alcohol use in millions US$ EN
SA_0000001503 Alcoholic beverage legally defined EN
SA_0000001504_ARCHIVED Alcohol use is banned EN
SA_0000001504 Alcohol use is banned EN
SA_0000001506 National legislation to prevent illegal alcohol EN
SA_0000001507 Advertising restrictions on national television EN
SA_0000001507_ARCHIVED Advertising restrictions on national television EN
SA_0000001509_ARCHIVED Advertising restrictions on national radio EN
GDO_q2x5_2 Inclusion of dementia risk reduction as a specific action of the dementia plan EN
GDO_q2x5_4 Inclusion of dementia workforce training as a specific action of the dementia plan EN
R_afford_gdp Affordability - percentage of GDP per capita required to purchase 2000 cigarettes of the most sold brand EN
SA_0000001513 Advertising restrictions on billboards EN
SA_0000001514_ARCHIVED Advertising restrictions at point-of-sale EN
R_Curr_lowest_cost Cheapest brand of cigarettes - currency reported EN
R_excise_min_specific Tax structure: Minimum specific tax applied in ad valorem or mixed excise regime EN
R_excise_proportion Tax structure: Excise tax proportion of price EN
R_Group Raising taxes on tobacco EN
R_imp_duty_average Average - taxes as a % of cigarette price - import duties EN
R_imp_duty_estimate Most sold brand of cigarettes - taxes as a % of price - import duties EN
SA_0000001545_ARCHIVED Licence required for retail sales EN
SA_0000001550_ARCHIVED Excise tax on alcoholic beverages EN
SA_0000001553 Restrictions on alcohol use in public places EN
R_Other_estimate Most sold brand of cigarettes - taxes as a % of price - other taxes EN
SA_0000001502_ARCHIVED Adopted written national policy on alcohol EN
SA_0000001503_ARCHIVED Alcoholic beverage legally defined EN
SA_0000001506_ARCHIVED National legislation to prevent illegal alcohol EN
SA_0000001508 Advertising restrictions on cable television EN
SA_0000001508_ARCHIVED Advertising restrictions on cable television EN
SA_0000001510 Advertising restrictions on local radio EN
SA_0000001512_ARCHIVED Advertising restrictions at cinemas EN
GDO_q2x5_5 Inclusion of support for dementia carers and families as a specific action of the dementia plan EN
GDO_q3x1x1_1 Implementation level [national/subnational] of dementia legislation EN
SA_0000001542_ARCHIVED Government monopoly on production EN
SA_0000001543 Government monopoly on retail sales EN
SA_0000001544_ARCHIVED Licence required for production EN
P5_indoor_off National smoking ban in INDOOR OFFICES EN
P7_pubs National smoking ban in PUBS AND BARS EN
PerctreatedANC Antenatal care attendees positive for syphilis who received treatment (%), reported EN
pncall5 Postnatal care visit within two days of birth (in the five years preceding the survey) (%) EN
pnchome3 Postnatal care visit within two days of birth - born outside a health facility (in the three years preceding the survey) (%) EN
SA_0000001444 Age-standardized death rates, ischaemic heart disease, per 100,000 EN
SA_0000001445 Age-standardized death rates, liver cancer, per 100,000 EN
SA_0000001450 Age-standardized death rates, poisoning, per 100,000 EN
SA_0000001451 Age-standardized death rates, prematurity and low birth rate, per 100,000 EN
SA_0000001457_ARCHIVED Liver cirrhosis, age-standardized death rates (15+), per 100,000 population EN
SA_0000001459 Road traffic crash deaths, age-standardized death rates (15+), per 100,000 population EN
SA_0000001459_ARCHIVED Road traffic crash deaths, age-standardized death rates (15+), per 100,000 population EN
GDO_q17x1x1 Implementation level [national/subnational] of dementia research plan/programme EN
GDO_q17x2x1_1 Identification of other research plans in which dementia is integrated (Mental health) EN
GDO_q17x2x1_2 Identification of other research plans in which dementia is integrated (Ageing) EN
GDO_q18x2 Availability of funding for dementia-specific research plan/programme EN
SA_0000001547_ARCHIVED Excise duty (average) per hectolitre in Euros EN
SA_0000001549 Duty paid or excise stamp on alcohol container EN
SA_0000001550 Excise tax on alcoholic beverages EN
SA_0000001553_ARCHIVED Restrictions on alcohol use in public places EN
GDO_q1x1 Inclusion of dementia in ministry portfolio EN
R_Ad_val_estimate Most sold brand of cigarettes - taxes as a % of price - ad valorem excise EN
SA_0000001509 Advertising restrictions on national radio EN
SA_0000001511 Advertising restrictions in print media EN
SA_0000001512 Advertising restrictions at cinemas EN
SA_0000001513_ARCHIVED Advertising restrictions on billboards EN
SA_0000001516 Restrictions on product placement on national television EN
SA_0000001551 Value-added tax (VAT) on alcohol (%) EN
SA_0000001647 Awareness activities EN
SA_0000001649 National drinking guidelines EN
SA_0000001680 Perceived trend in production EN
SA_0000001681 Perceived trend in imports EN
SA_0000001555_ARCHIVED Health warning labels on alcohol containers EN
SA_0000001647_ARCHIVED Awareness activities EN
SA_0000001648 Information, education, prevention EN
SA_0000001654 Surveys, research EN
SA_0000001676 Production in 1000s hectolitres EN
SA_0000001693 Level of adoption of national alcohol policy EN
RADON_Q601 Existence of official protocols for radon measurements EN
RADON_Q604 Authorization/accreditation required for official radon measurement providers EN
SA_0000001684 Sales of wine in 1000s hectolitres EN
SA_0000001685 Sales of spirits in 1000s hectolitres EN
SA_0000001688_ARCHIVED Total (recorded+unrecorded) alcohol per capita (15+) consumption EN
SA_0000001689 Age-standardized DALYs, cerebrovascular disease, per 100,000 EN
SA_0000001691_ARCHIVED Central coordinating entity for alcohol policy implementation EN
SA_0000001692 Framework of national alcohol policy EN
SA_0000001693_ARCHIVED Level of adoption of national alcohol policy EN
TB_new_oth New cases: other EN
TB_new_su New cases: pulmonary smear unknown/not done EN
TB_newret_oth Treatment history unknown EN
TB_ret_rel_clindx Relapse cases: Pulmonary, clinically diagnosed EN
SA_0000001523 Prices for alcoholic beverages (average, US\() |EN | |SA_0000001525_ARCHIVED |Off-premise sales restrictions on days |EN | |SA_0000001694_ARCHIVED |Sectors represented in national alcohol policy |EN | |SA_0000001696_ARCHIVED |Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities) |EN | |SA_0000001697_ARCHIVED |Adopted written national policy on alcohol, year adopted |EN | |SA_0000001521 |Random breath testing (RBT) use |EN | |SA_0000001523_ARCHIVED |Prices for alcoholic beverages (average, US\)) EN
SA_0000001526 Off-premise sales restrictions on hours EN
SA_0000001528_ARCHIVED Off-premise sales restrictions on outlet density EN
SA_0000001529 Off-premise sales restrictions at specific events EN
SA_0000001530 Off-premise sales restrictions at petrol stations EN
SA_0000001534 On-premise sales restrictions on outlet density EN
SA_0000001534_ARCHIVED On-premise sales restrictions on outlet density EN
SA_0000001535 On-premise sales restrictions at specific events EN
SA_0000001537 Restrictions on sponsorship of sporting events EN
RADON_Q702 Mandatory mitigation measures if legal value is exceeded (existing buildings) EN
R_Price_premium_ppp Premium brand of cigarettes - price in international dollars EN
R_VAT_estimate Most sold brand of cigarettes - taxes as a % of price - value added tax EN
RADON_Q304 Data in national radon database EN
RADON_Q402 Existence of national radon regulations EN
RADON_Q404 Radon in building regulations for existing buildings i.e. renovation/remodeling/major alteration EN
SA_0000001538_ARCHIVED Restrictions on sponsorship of youth events EN
SA_0000001696 Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities) EN
SA_0000001697 Adopted written national policy on alcohol, year adopted EN
SA_0000001698 Adopted written national policy on alcohol, year revised EN
TB_effective_treatment_coverage Tuberculosis effective treatment coverage (%) EN
TB_hivtest_pct TB patients with known HIV status (%) EN
TB_new_clindx New or unknown treatment history cases: Pulmonary, clinically diagnosed EN
TB_new_snsuoth New cases: Pulmonary, smear-negative/unknown/not done and other new cases EN
TB_new_sp New cases: Pulmonary, smear-positive EN
TB_ret_nrel Previously treated cases, excluding relapse EN
TB_ret_rel Relapse cases (pre-2013 definition) EN
RADON_Q603 Radon concentration measurements for existing buildings EN
RADON_Q701 Mandatory preventive measures (new buildings) EN
SA_0000001698_ARCHIVED Adopted written national policy on alcohol, year revised EN
SA_0000001700 Consumer information on alcohol and health at points of sale EN
SA_0000001701 Educational programmes involving target groups in school curriculum EN
SA_0000001703 Server training on a regular basis EN
SA_0000001707 Persons with alcohol use disorders receiving treatment (%) EN
SA_0000001708 Designation of alcohol tax revenues to health services EN
SA_0000001650_ARCHIVED Standard drink measures, in grams per unit EN
SA_0000001652 Interventions, projects, training EN
SA_0000001653 Treatment, services EN
SA_0000001655 Counselling EN
SA_0000001677 Imports in 1000s hectolitres EN
SA_0000001679 Exports of beer (barley) in 1000s hectolitres EN
SA_0000001683 Perceived trend in exports EN
SA_0000001686 Exports of wine (grape) in 1000s hectolitres EN
SA_0000001687 Exports of spirits in 1000s hectolitres EN
SA_0000001690 Age-standardized death rates, cerebrovascular disease, per 100,000 EN
SA_0000001691 Central coordinating entity for alcohol policy implementation EN
SA_0000001515_ARCHIVED Advertising restrictions on the internet EN
SA_0000001517_ARCHIVED Restrictions on product placement on cable television EN
SA_0000001519 Minimum legal drinking age EN
SA_0000001525 Off-premise sales restrictions on days EN
SA_0000001527 Off-premise sales restrictions on places EN
SA_0000001528 Off-premise sales restrictions on outlet density EN
SA_0000001529_ARCHIVED Off-premise sales restrictions at specific events EN
SA_0000001530_ARCHIVED Off-premise sales restrictions at petrol stations EN
SA_0000001531 On-premise sales restrictions on days EN
SA_0000001531_ARCHIVED On-premise sales restrictions on days EN
SA_0000001532 On-premise sales restrictions on hours EN
SA_0000001694 Sectors represented in national alcohol policy EN
SA_0000001695_ARCHIVED Cautions and arrests for public drunkenness, per 100,000 population EN
SA_0000001709 National surveys on drink-driving EN
R_admin_tax_stamps Tax administration: Tax stamps applied on tobacco products EN
R_excise_incr Tobacco excises increased over the survey period EN
R_excise_retail_price_base Tax structure: Retail price used as base of ad valorem component in ad valorem or mixed excise regime (or retail price exclusive of VAT) EN
SA_0000001462 Alcohol use disorders (15+), 12 month prevalence (%) with 95% EN
SA_0000001462_ARCHIVED Alcohol use disorders (15+), 12 month prevalence (%) with 95% EN
SA_0000001466 Hospital discharges, alcoholic liver disease, per 100,000 EN
SA_0000001468 Treatment admissions (inpatient), alcohol dependence, per 100,000 EN
SA_0000001474 Alcoholic excise tax revenue as a per cent of government revenue EN
SA_0000001474_ARCHIVED Alcoholic excise tax revenue as a per cent of government revenue EN
SA_0000001475_ARCHIVED Annual revenues from alcohol excise tax in millions US$ EN
SA_0000001477_ARCHIVED Social costs of alcohol use in millions US$ EN
GDO_q35 Estimated population-based prevalence of depression EN
GDO_q3x2 Existence of other laws that apply to the rights of people with dementia EN
SA_0000001542 Government monopoly on production EN
SA_0000001544 Licence required for production EN
SA_0000001546 Excise tax as a per cent of the retail price of alcoholic beverages EN
SA_0000001547 Excise duty (average) per hectolitre in Euros EN
SA_0000001548_ARCHIVED Excise tax as a per cent of the total retail price for 1 litre of pure alcohol EN
R_Other_average Average - taxes as a % of cigarette price - other taxes EN
R_Price_mp_estimate Most sold brand of cigarettes - price in currency reported EN
R_Price_premium_usd Premium brand of cigarettes - price in US$ at official exchange rates EN
SA_0000001538 Restrictions on sponsorship of youth events EN
SA_0000001540 Restrictions on sales promotion from retailers (sales below cost) EN
WHOSIS_000009 Children aged <5 years overweight (%) EN
WHS10_2 Number of cause-of-death registration years available EN
WHS10_3 Number of national population surveys - child anthropometry EN
WHS10_5 Number of national population surveys - maternal mortality EN
SA_0000001699_ARCHIVED Age limits off-premise sales EN
SA_0000001702 Brief interventions as health promotion/disease prevention EN
SA_0000001706 National treatment policy for alcohol use disorders EN
SA_0000001713 Interventions/projects actively involving young people and civil society EN
SA_0000001717 Prevention/counselling at workplaces for those with alcohol problems EN
SA_0000001724 National guidelines for implementing effective community-based interventions EN
SA_0000001539 Restrictions on sales promotion from producers (parties, events) EN
SA_0000001540_ARCHIVED Restrictions on sales promotion from retailers (sales below cost) EN
SA_0000001541 Restrictions on sales promotion from owners of pubs and bars (alcohol for free) EN
WHOSIS_000008 Children aged <5 years underweight (%) EN
WHOSIS_000014 Stillbirth rate (per 1000 total births) EN
WHS_PBR Preterm birth rate (per 100 live births) EN
WHS10_10 International Statistical Classification of Diseases and Related Health Problems (ICD) EN
WHS10_6 Number of national population surveys - HIV prevalence EN
WHS10_9 Ill-defined causes in cause-of-death registration (%) EN
WHS2_131 Age-standardized NCD mortality rate (per 100 000 population) EN
WHS2_152 Deaths due to malaria (per 100 000 population) EN
WHS2_160 Age-standardized mortality rate by cause (per 100 000 population) - Cancer EN
SA_0000001712 Community-based interventions/projects involving stakeholders EN
SA_0000001714 Training in screening and brief interventions for alcohol problems EN
SA_0000001715 Counselling to children in families with alcohol problems EN
SA_0000001716 Counselling to pregnant women with alcohol problems EN
SA_0000001720_ARCHIVED Restrictions on product placement in films/movies EN
SA_0000001533_ARCHIVED On-premise sales restrictions on places EN
SA_0000001536 On-premise sales restrictions to intoxicated persons EN
SA_0000001541_ARCHIVED Restrictions on sales promotion from owners of pubs and bars (alcohol for free) EN
WHS10_1 Most recent census (year) EN
WHS10_4 Number of national population surveys - child mortality EN
TB_hiv_art_pct HIV-positive TB patients on ART (antiretroviral therapy) (%) EN
TB_hiv_cpt_pct HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%) EN
TB_hivtest_pos_pct Tested TB patients HIV-positive (%) EN
TB_new_snuoth TB new snuoth EN
TB_ret_oth Retreatment cases: other EN
TB_ret_rel_labconf Relapse cases: Pulmonary, bacteriologically confirmed EN
TB_ret_tad Retreatment cases: treatment after default (pulmonary smear and/or culture positive) EN
TB_sldst_avail Second-line drug susceptibility testing (DST) available EN
TOBACCO_0000000209 Fines for violations EN
TOBACCO_0000000212 Dedicated funds for enforcement EN
TOBACCO_0000000213 Citizen complaints and investigations EN
SA_0000001720 Restrictions on product placement in films/movies EN
SA_0000001721 Importance of measures for enhancing compliance with age limits EN
SA_0000001721_ARCHIVED Importance of measures for enhancing compliance with age limits EN
SA_0000001723 Community-based interventions involving stakeholders EN
RADON_Q405 Radon in national drinking-water regulations EN
RADON_Q501 Existence of national reference level for dwellings and buildings with high public occupancy EN
RADON_Q502 Existence of national reference level for buildings with high public occupancy EN
SA_0000001510_ARCHIVED Advertising restrictions on local radio EN
SA_0000001511_ARCHIVED Advertising restrictions in print media EN
SA_0000001514 Advertising restrictions at point-of-sale EN
SA_0000001515 Advertising restrictions on the internet EN
SA_0000001516_ARCHIVED Restrictions on product placement on national television EN
SA_0000001517 Restrictions on product placement on cable television EN
SA_0000001518 Age limits on-premise service EN
SA_0000001518_ARCHIVED Age limits on-premise service EN
SA_0000001520 Legal blood alcohol concentration (BAC) limits EN
SA_0000001520_ARCHIVED Legal blood alcohol concentration (BAC) limits EN
SA_0000001521_ARCHIVED Random breath testing (RBT) use EN
SA_0000001551_ARCHIVED Value-added tax (VAT) on alcohol (%) EN
SA_0000001554 Health warning labels on alcohol advertising EN
SA_0000001554_ARCHIVED Health warning labels on alcohol advertising EN
SA_0000001555 Health warning labels on alcohol containers EN
SA_0000001650 Standard drink measures, in grams per unit EN
SA_0000001651 Monitoring EN
SA_0000001678 Sales of beer in 1000s hectolitres EN
SA_0000001682 Perceived trend in sales EN
SA_0000001688 Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (SDG Indicator 3.5.2) EN
RADON_Q602 Radon concentration measurements for new buildings EN
RADON_Q703 Financial support provided for mitigation (existing dwellings) EN
RADON_Q704 Authorization/accreditation required for prevention/mitigation service providers EN
RADON_Q705 Official standards/guidelines for prevention/mitigation EN
TB_mdr Confirmed cases of MDR-TB EN
TB_new_ep New cases: extrapulmonary EN
TB_new_labconf New or unknown treatment history cases: Pulmonary, bacteriologically confirmed EN
TB_new_sn New cases: pulmonary smear-negative EN
WHS2_138 Deaths due to HIV/AIDS (per 100 000 population) EN
WHS3_47 Meningitis - number of reported cases EN
WHS3_51 H5N1 influenza - number of reported cases EN
SA_0000001727 Sobriety checkpoints EN
SA_0000001727_ARCHIVED Sobriety checkpoints EN
SA_0000001728 Detection of marketing infringements EN
SA_0000001728_ARCHIVED Detection of marketing infringements EN
SA_0000001729_ARCHIVED Penalties for marketing infringements EN
SA_0000001730_ARCHIVED Price measures EN
WHS3_55 Congenital Rubella Syndrome - number of reported cases EN
TOBACCO_0000000192 Prevalence of smoking any tobacco product among persons aged >= 15 years EN
TOBACCO_0000000344 Prevalence of current tobacco use among adolescents aged 13-15 years EN
TOBACCO_0000000346 Exposure to smoke at home EN
TOBACCO_0000000347 Exposure to smoke outside home EN
TOBACCO_0000000362 Smoking cessation support is available in hospitals EN
TOBACCO_0000000365 Smoking cessation support is available in the community EN
TOBACCO_0000000371 Varenicline - legally sold EN
TOBACCO_0000000389 Number of health warnings approved by the law for other smoked tobacco packaging EN
SA_0000001724_ARCHIVED National guidelines for implementing effective community-based interventions EN
SA_0000001725 National alcohol policy specifically involves young people activities EN
SA_0000001732_ARCHIVED New types of alcoholic beverages emerging EN
SA_0000001733 Consumer information about calories, additives, etc on containers EN
SA_0000001733_ARCHIVED Consumer information about calories, additives, etc on containers EN
SA_0000001734_ARCHIVED Number of standard alcoholic drinks displayed on containers EN
WHS2_161 Age-standardized mortality rate by cause (per 100 000 population) - Cardiovascular EN
WHS2_171 Distribution of causes of death among children aged <5 years (%) - Other diseases EN
WHS2_515 Distribution of causes of death among children aged <5 years (%) - Neonatal sepsis EN
WHS2_516 Distribution of causes of death among children aged <5 years (%) - Congenital anomalies EN
WHS2_523 Distribution of causes of death among children aged <5 years (%) - Birth asphyxia EN
WHS3_42 Japanese encephalitis - number of reported cases EN
WHS3_45 Number of new leprosy cases EN
WHS3_49 Poliomyelitis - number of reported cases EN
WHS3_522 Number of reported cases of tuberculosis EN
WHS3_53 Mumps - number of reported cases EN
TOBACCO_0000000361 Access to a toll-free quit line EN
TOBACCO_0000000364 Smoking cessation support is available in offices of health professionals EN
TOBACCO_0000000366 Smoking cessation support is available in other settings EN
SA_0000001722_ARCHIVED Government support for community action EN
SA_0000001723_ARCHIVED Community-based interventions involving stakeholders EN
SA_0000001725_ARCHIVED National alcohol policy specifically involves young people activities EN
SA_0000001726_ARCHIVED Penalties for drink driving EN
SA_0000001729 Penalties for marketing infringements EN
SA_0000001736 Action Plan for implementation of alcohol policy EN
SA_0000001737_ARCHIVED Alcohol, regional per capita (15+) consumption (in litres of pure alcohol) EN
SA_0000001740_ARCHIVED Alcohol-attributable Years of Life Lost (YLL) score EN
TOBACCO_0000000390 Health warnings on other smoked tobacco packaging must be rotated EN
TB_rr_mdr Confirmed cases of RR-/MDR-TB EN
tfr Total fertility rate (per woman) EN
TOBACCO_0000000210 Fines on the establishment EN
TOBACCO_0000000342 Daily users of any smokeless tobacco product (crude rate) EN
TOBACCO_0000000345 Current smokers of cigarettes (youth rate) EN
TOBACCO_0000000363 Smoking cessation support is available in health clinics or other primary care facilities EN
TOBACCO_0000000369 Bupropion - legally sold EN
TOBACCO_0000000372 Varenicline - place available EN
TOBACCO_0000000391 Percentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packaging EN
WHS2_164 Distribution of causes of death among children aged <5 years (%) - Malaria EN
TOBACCO_0000000393 Health warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on health EN
TOBACCO_0000000505 Year of survey of youth EN
TOBACCO_0000000367 Nicotine replacement therapy - legally sold EN
TOBACCO_0000000368 Nicotine replacement therapy - place available EN
WHS2_165 Distribution of causes of death among children aged <5 years (%) - Pneumonia EN
WHS2_170 Distribution of causes of death among children aged <5 years (%) - HIV/AIDS EN
WHS2_174 Distribution of years of life lost by broader causes (%) - Injuries EN
WHS3_41 Diphtheria - number of reported cases EN
TOBACCO_0000000392 Health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale EN
TOBACCO_0000000395 Health warnings on other smoked tobacco packaging must be written in the principal language(s) of the country EN
WHS3_48 Malaria - number of reported confirmed cases EN
WHS3_50 Yellow fever - number of reported cases EN
WHS3_54 Number of reported cases of tuberculosis (DOTS) EN
WHS3_56 Neonatal tetanus - number of reported cases EN
WHS3_57 Rubella - number of reported cases EN
WHS3_62 Measles - number of reported cases EN
SA_0000001731 Level of taxation adjusted for inflation EN
SA_0000001731_ARCHIVED Level of taxation adjusted for inflation EN
SA_0000001732 New types of alcoholic beverages emerging EN
SA_0000001735 Alcohol content displayed on containers EN
SA_0000001735_ARCHIVED Alcohol content displayed on containers EN
SA_0000001736_ARCHIVED Action Plan for implementation of alcohol policy EN
SA_0000001737 Alcohol, regional per capita (15+) consumption (in litres of pure alcohol) EN
SA_0000001739 Alcohol, heavy episodic drinking (15+) past 30 days (%), age-standardized with 95%CI EN
SA_0000001739_ARCHIVED Alcohol, heavy episodic drinking (15+) past 30 days (%), age-standardized with 95%CI EN
TB_ret_rel_ep Relapse cases: extrapulmonary EN
SA_0000001526_ARCHIVED Off-premise sales restrictions on hours EN
SA_0000001527_ARCHIVED Off-premise sales restrictions on places EN
SA_0000001532_ARCHIVED On-premise sales restrictions on hours EN
SA_0000001533 On-premise sales restrictions on places EN
SA_0000001535_ARCHIVED On-premise sales restrictions at specific events EN
SA_0000001536_ARCHIVED On-premise sales restrictions to intoxicated persons EN
SA_0000001537_ARCHIVED Restrictions on sponsorship of sporting events EN
SA_0000001539_ARCHIVED Restrictions on sales promotion from producers (parties, events) EN
SA_0000001692_ARCHIVED Framework of national alcohol policy EN
SA_0000001695 Cautions and arrests for public drunkenness, per 100,000 population EN
SA_0000001699 Age limits off-premise sales EN
SA_0000001704 Data collection on alcohol-related health indicators EN
SA_0000001705 System for monitoring alcohol-related harm EN
SA_0000001710 Public-funded alcohol research/monitoring programmes EN
SA_0000001711 Public funds designated for alcohol research/monitoring programmes, in Euros EN
WHOSIS_000010 Adults aged ≥ 20 years who are obese (%) EN
WHOSIS_000012 Prevalence of smoking any tobacco product among adults (≥15 years) (%) EN
WHOSIS_000013 Prevalence of current tobacco use among adolescents (13-15 years) (%) EN
WHOSIS_000015 Life expectancy at age 60 (years) EN
WHS10_7 Number of national population surveys - adult health EN
WHS10_8 Civil registration coverage of cause-of-death (%) EN
WHS2_126 Distribution of years of life lost by major cause group EN
TOTENV_1 Deaths attributable to the environment EN
TOTENV_6 Disability-adjusted life years (DALYs) attributable to the environment (%) EN
SA_0000001743 Alcohol-attributable fractions, all-cause deaths (%) EN
SA_0000001744_ARCHIVED Alcohol, regional prevalence of alcohol dependence (%) EN
SA_0000001745 Alcohol, regional prevalence of alcohol use disorders (%) EN
SA_0000001741_ARCHIVED Alcohol-attributable fractions (15+), liver cirrhosis deaths (%) EN
SA_0000001742 Alcohol-attributable fractions (15+), road traffic crash deaths (%) EN
SA_0000001744 Alcohol, regional prevalence of alcohol dependence (%) EN
SA_0000001745_ARCHIVED Alcohol, regional prevalence of alcohol use disorders (%) EN
SA_0000001746 Alcohol, total (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2025 EN
SA_0000001746_ARCHIVED Alcohol, total (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2025 EN
SA_0000001747_ARCHIVED Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average with 95%CI EN
SA_0000001748 Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI EN
SA_0000001748_ARCHIVED Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI EN
SA_0000001749_ARCHIVED Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CI EN
SA_0000001751 Alcohol, average daily intake in grams among drinkers with 95%CI EN
SA_0000001751_ARCHIVED Alcohol, average daily intake in grams among drinkers with 95%CI EN
WHS4_107 Children aged <5 years with diarrhoea receiving ORT (%) EN
WHS4_129 Hib (Hib3) immunization coverage among 1-year-olds (%) EN
WHS4_154 Antenatal care coverage - at least four visits (%) EN
WHS5_512 Population using solid fuels (%) EN
WHS6_101 Median availability of selected generic medicines (%) - Private EN
WHS6_116 Median consumer price ratio of selected generic medicines - Private EN
WHS4_111_AGE1519 Antenatal care coverage - at least one visit, among girls aged 15-19 (%) EN
WHS4_117 Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) EN
WHS4_544 Polio (Pol3) immunization coverage among 1-year-olds (%) EN
WHS4_99 Antiretroviral therapy coverage among HIV-infected pregnant women for PMTCT (%) EN
WHS6_100 Radiotherapy units (per 1 000 000 population) EN
WHS6_102 Hospital beds (per 10 000 population) EN
WHS6_144 Dentistry personnel density (per 10 000 population) EN
TOTENV_11 Deaths attributable to the environment in children under 5 years (%) EN
WHS6_148 Nursing and midwifery personnel density (per 10 000 population) EN
TOTENV_70 Total environment attributable deaths in children under 5 years EN
TOTENV_8 Total environment attributable deaths per 100’000 children under 5 years EN
u5mr Under-five mortality rate (deaths per 1000 live births) EN
UHC_AVAILABILITY_SCORE Primary data availability for UHC Service Coverage Index (SDG 3.8.1) (%) EN
UHC_IHR Compliance with international health regulations EN
UHC_SCI_NCD UHC Service Coverage sub-index on noncommunicable diseases EN
UHC_TB_DT Tuberculosis detection and treatment EN
UV_1 UV radiation EN
TOTENV_5 Deaths attributable to the environment (%) EN
UHC_INDEX_ACTUAL Index of Essential Service Coverage (Actual) EN
SA_0000001752 Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016 EN
SA_0000001752_ARCHIVED Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016 EN
TOBACCO_0000000396 Health warnings on other smoked tobacco packaging must include a photograph or graphic EN
TOBACCO_0000000506 Representativeness of youth survey EN
TOTENV_4 Age-standardized DALYs attributable to the environment (per 100 000 population) EN
UHC_INDEX_REPORTED UHC Service Coverage Index (SDG 3.8.1) EN
UHC_NCD_NONELEVBP Prevalence of non-elevated blood pressure (%) EN
TOTENV_9 Total environment attributable DALYs (’000) in children under 5 years EN
SA_0000001754_ARCHIVED Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI EN
SA_0000001755 15-19 years old heavy episodic drinkers (population), % with 95%CI EN
SA_0000001759 15-19 years old, current drinkers (%) EN
SA_0000001760 15-19 years old total alcohol consumption in litres of pure alcohol EN
SA_0000001761 National guidelines for the prevention and reduction of alcohol-related harm in schools EN
SA_0000001756_ARCHIVED 15-19 years old heavy episodic drinkers (drinkers only), % EN
SA_0000001757 15-19 years old abstainers, lifetime (%) EN
SA_0000001757_ARCHIVED 15-19 years old abstainers, lifetime (%) EN
SA_0000001759_ARCHIVED 15-19 years old, current drinkers (%) EN
SA_0000001760_ARCHIVED 15-19 years old total alcohol consumption in litres of pure alcohol EN
WHS2_166 Distribution of causes of death among children aged <5 years (%) - Injuries EN
SA_0000001719 Advertising restrictions on social media EN
SA_0000001719_ARCHIVED Advertising restrictions on social media EN
SA_0000001722 Government support for community action EN
SA_0000001726 Penalties for drink driving EN
SA_0000001730 Price measures EN
SA_0000001734 Number of standard alcoholic drinks displayed on containers EN
SA_0000001761_ARCHIVED National guidelines for the prevention and reduction of alcohol-related harm in schools EN
SA_0000001763_ARCHIVED Workplace representatives nationally involved to prevent and address alcohol-related harm EN
WHS4_108 Children aged <5 years with ARI symptoms who took antibiotic treatment (%) EN
WHS4_115 Births by caesarean section (%) EN
WHS4_124 Children aged 6-59 months who received vitamin A supplementation (%) EN
WHS4_128 Neonates protected at birth against neonatal tetanus (PAB) (%) EN
TB_ret_taf Retreatment cases: treatment after failure (pulmonary smear and/or culture positive) EN
TB_tot_newrel Tuberculosis - new and relapse cases EN
TB_treatment_coverage xxx EN
TOBACCO_0000000211 Fines on the patron EN
WHS6_140 Number of community health workers EN
WHS6_520 Density of environment and public health workers (per 10 000 population) EN
WHS7_103 Private prepaid plans as a percentage of private expenditure on health EN
TOBACCO_0000000370 Bupropion - place available EN
TOBACCO_0000000386 Percentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packaging EN
WHS2_167 Distribution of causes of death among children aged <5 years (%) - Diarrhoea EN
uweight3 Underweight prevalence in children aged < 3 years (%) EN
uweight5 Underweight prevalence in children aged < 5 years (%) EN
VIOLENCE_BULLIED Bullied, past 30 days (%) EN
SA_0000001753_ARCHIVED Alcohol use disorders (15+), 12 month prevalence (%), age standardized, with 95%CI EN
SA_0000001756 15-19 years old heavy episodic drinkers (drinkers only), % EN
SA_0000001758 15-19 years old former drinkers (%) EN
SA_0000001758_ARCHIVED 15-19 years old former drinkers (%) EN
SA_0000001764 Server training EN
SA_0000001764_ARCHIVED Server training EN
SA_0000001765 Legal obligation for schools to include alcohol use prevention EN
WHS7_105 Per capita total expenditure on health (PPP int. \() |EN | |WHS9_87 |Net primary school enrolment ratio (%) |EN | |WHS9_88 |Population median age (years) |EN | |WHS9_94 |Civil registration coverage of causes of deaths (%) |EN | |WHS9_95 |Total fertility rate (per woman) |EN | |WHS9_CS |Cellular subscribers (per 100 population) |EN | |WHS7_120 |External resources for health as a percentage of total expenditure on health |EN | |UHC_SCI_INFECT |UHC Service Coverage sub-index on infectious diseases |EN | |UNICEF_PNCMOTHER |Women age 15-49 years who received a health check within 2 days after delivery of their most recent live birth in the last 2 years (%) |EN | |UV_2 |UV radiation attributable deaths |EN | |SA_0000001763 |Workplace representatives nationally involved to prevent and address alcohol-related harm |EN | |WHS7_104 |Per capita government expenditure on health at average exchange rate (US\)) EN
WHS7_108 Per capita government expenditure on health (PPP int. \() |EN | |WHS7_149 |General government expenditure on health as a percentage of total expenditure on health |EN | |WHS7_150 |Out-of-pocket expenditure as a percentage of total expenditure on health |EN | |WHS7_156 |Per capita total expenditure on health at average exchange rate (US\)) EN
WHS9_86 Population (in thousands) total EN
WSH_1 SDG 3.9.2 WASH deaths EN
WSH_10_HYG Number of diarrhoea deaths from inadequate hygiene EN
WSH_10_SAN Number of diarrhoea deaths from inadequate sanitation EN
WSH_10_WAT Number of diarrhoea deaths from inadequate water EN
SA_0000001768_ARCHIVED Standard drink defined EN
SA_0000001773_ARCHIVED National surveys on adult alcohol consumption EN
SA_0000001767_ARCHIVED Legislation on alcohol testing at workplaces EN
SA_0000001769 National systems for monitoring alcohol consumption and harms EN
SA_0000001769_ARCHIVED National systems for monitoring alcohol consumption and harms EN
SA_0000001774 National surveys on youth alcohol consumption EN
SA_0000001781 15-years old any alcoholic beverage consumed in past 12 months, (%) EN
SA_0000001771_ARCHIVED Comprehensive and regular reporting of alcohol situation EN
SA_0000001779 Level of enforcement of BAC limits EN
WSH_10 Number of diarrhoea deaths from inadequate water, sanitation and hygiene EN
UHC_TOBACCONO Prevalence of non-use of tobacco EN
UNICEF_ORS Children aged <5 years with diarrhoea receiving ORS (%) EN
UNICEF_PNCNEWBORN Proportion of newborns who have postnatal contact with a health provider within 2 days of delivery (%) EN
UV_3 UV radiation attributable DALYs (’000) EN
UV_5 UV radiation attributable DALYs per 100’000 capita EN
VIOLENCE_CHILD_EMOTIONAL Lifetime prevalence of child emotional abuse (%) EN
VIOLENCE_CHILD_PHYSICAL Lifetime prevalence of child physical abuse (%) EN
VIOLENCE_CHILD_SEXUAL Lifetime prevalence of child sexual abuse (%) EN
VIOLENCE_EXTENTIMP_CHILDHOMEVISIT Child maltreatment: Extent of implementation of home-visiting programmes EN
SA_0000001767 Legislation on alcohol testing at workplaces EN
SA_0000001768 Standard drink defined EN
WHS2_168 Distribution of causes of death among children aged <5 years (%) - Measles EN
WHS2_514 Distribution of causes of death among children aged <5 years (%) - Prematurity EN
WHS3_40 Cholera - number of reported cases EN
WHS3_43 Pertussis - number of reported cases EN
WHS3_46 Total tetanus - number of reported cases EN
WHS3_52 Plague - number of reported cases EN
WHS4_100 Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%) EN
WHS4_106 Care-seeking for children with symptoms of acute respiratory infection (%) EN
WHS4_111 Antenatal care coverage - at least one visit (%) EN
SA_0000001740 Alcohol-attributable Years of Life Lost (YLL) score EN
SA_0000001741 Alcohol-attributable fractions (15+), liver cirrhosis deaths (%) EN
SA_0000001742_ARCHIVED Alcohol-attributable fractions (15+), road traffic crash deaths (%) EN
SA_0000001743_ARCHIVED Alcohol-attributable fractions, all-cause deaths (%) EN
TOBACCO_0000000387 Percentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packaging EN
TOBACCO_0000000388 Specific health warnings are mandated for other smoked tobacco packaging EN
TOBACCO_0000000394 Font style, font size and colour of health warnings are mandated for other smoked tobacco packaging EN
WHS7_134 Social security expenditure on health as a percentage of general government expenditure on health EN
WHS7_139 Out-of-pocket expenditure as a percentage of private expenditure on health EN
WHS8_110 Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) EN
WHS9_91 Civil registration coverage of births (%) EN
TOBACCO_0000000507 Repeating interval for survey of youth (years) EN
TOTENV_10 Total environment attributable DALYs per 100’000 children under 5 years EN
TOTENV_12 DALYs attributable to the environment in children under 5 years (%) EN
TOTENV_2 Age-standardized deaths attributable to the environment (per 100 000 population) EN
TOTENV_3 Disability-adjusted life years (DALYs) attributable to the environment EN
TOTENV_7 Total environment attributable deaths (’000) in children under 5 years EN
W-MM_Group Anti-tobacco mass media campaigns EN
WSH_20 Attributable fraction of diarrhoea to inadequate water, sanitation and hygiene EN
WSH_20_HYG Attributable fraction of diarrhoea to inadequate hygiene EN
WSH_20_WAT Attributable fraction of diarrhoea to inadequate water EN
SA_0000001770 Regular reports from national monitoring systems EN
SA_0000001771 Comprehensive and regular reporting of alcohol situation EN
SA_0000001772 Clinical guidelines for brief interventions EN
SA_0000001772_ARCHIVED Clinical guidelines for brief interventions EN
SA_0000001773 National surveys on adult alcohol consumption EN
SA_0000001775 National surveys on heavy espisodic drinking EN
SA_0000001777 Data collected on harm from alcohol at workplace EN
WSH_30 Number of diarrhoea DALYs from inadequate water, sanitation and hygiene EN
VIOLENCE_EXTENTIMP_VICTIMSMEDICOLEGAL Extent of implementation of medico-legal services for victims of sexual violence EN
VIOLENCE_EXTENTIMP_YOUTHLIFESKILLS Youth violence: Extent of implementation of life-skills and social development programmes EN
VIOLENCE_HOMICIDENUM Estimates of number of homicides EN
VIOLENCE_HOMICIDERATE Estimates of rates of homicides per 100 000 population EN
W1_HW_law_A Law mandates that health warnings appear on tobacco packages EN
W11_outside_pack_A Do health warnings appear on each cigarette package and any outside packaging and labelling used in the retail sale? EN
SA_0000001777_ARCHIVED Data collected on harm from alcohol at workplace EN
W10_graphic_A Do the health warnings on cigarette packaging include a photograph or graphic? EN
W11_outside_pack_B Do health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale? EN
W12_imports_dutyfree_A Health warnings on cigarette packaging law applys to products whether manufactured domestically imported AND for duty-free sale EN
SA_0000001781_ARCHIVED 15-years old any alcoholic beverage consumed in past 12 months, (%) EN
SA_0000001782 15-years old first drink at 13 years or younger, (%) EN
SA_0000001784 15-years old, any alcoholic beverage consumed at least once a week, (%) EN
SA_0000001786 13-15-years old any alcoholic beverage consumed in past 30 days, (%) EN
SA_0000001786_ARCHIVED 13-15-years old any alcoholic beverage consumed in past 30 days, (%) EN
W13_ind_liability_A Health warnings on cigarette packaging do not remove or diminish the liability of the tobacco industry EN
W13_ind_liability_B Health warnings on other smoked tobacco packaging do not remove or diminish the liability of the tobacco industry EN
W14_harm_effects_C Do health warnings on smokeless tobacco packaging describe the harmful effects of tobacco use on health? EN
W15_specific_hw_C Does the law mandate specific health warnings on smokeless tobacco packaging? EN
SA_0000001784_ARCHIVED 15-years old, any alcoholic beverage consumed at least once a week, (%) EN
SA_0000001787_ARCHIVED 13-15-years old first drink before age 14, (%) EN
SA_0000001790 National drinking guidelines EN
SA_0000001791 Graduated licensing EN
SA_0000001793 Penalties for drink driving, repeated offense EN
SA_0000001795 Licensing required for imports of alcoholic beverages EN
W14_harm_effects_A Do health warnings on cigarette packaging describe the harmful effects of tobacco use on health? EN
W15_specific_hw_A Does the law mandate specific health warnings on cigarette packaging? EN
W15_specific_hw_B Does the law mandate specific health warnings on other smoked tobacco packaging? EN
WHS4_543 BCG immunization coverage among 1-year-olds (%) EN
WHS6_123 Number of dentistry personnel EN
WHS6_127 Number of nursing and midwifery personnel EN
WHS6_150 Community health workers density (per 10 000 population) EN
WHS6_517 Number of pharmaceutical personnel EN
WHS6_518 Number of environment and public health workers EN
WHS6_519 Density of pharmaceutical personnel (per 10 000 population) EN
SA_0000001749 Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CI EN
SA_0000001754 Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI EN
SA_0000001755_ARCHIVED 15-19 years old heavy episodic drinkers (population), % with 95%CI EN
SA_0000001762 National guidelines for alcohol problem prevention and counselling at workplaces EN
SA_0000001762_ARCHIVED National guidelines for alcohol problem prevention and counselling at workplaces EN
SA_0000001765_ARCHIVED Legal obligation for schools to include alcohol use prevention EN
TOTENV_90 Total environment attributable DALYs in children under 5 years EN
UHC_DATA_AVAIL_CODE Data availability for UHC index of essential service coverage (ranking) EN
UHC_HRHSURGEONDENSITY Surgeons (per 100 000) EN
UHC_NCD_FPG Mean fasting plasma glucose EN
UHC_SCI_CAPACITY UHC Service Coverage sub-index on service capacity and access EN
UHC_SCI_RMNCH UHC Service Coverage sub-index on reproductive, maternal, newborn and child health EN
UV_4 UV radiation attributable deaths per 100’000 capita EN
WHS7_113 General government expenditure on health as a percentage of total government expenditure EN
WHS7_143 Total expenditure on health as a percentage of gross domestic product EN
SA_0000001799 Licenses issued for wholesale/distribution, change since 2010 EN
SA_0000001804 Health warning labels on under-age drinking EN
SA_0000001807 Cancer, age-standardized death rates (15+), per 100,000 population EN
SA_0000001809 National system of epidemiological data collection for alcohol use EN
SA_0000001810 National system of data collection based on health service delivery EN
W17_fines_C Health warnings on smokeless tobacco packaging law requires or establishes fines for violations EN
W18_misleading_terms_A Ban on deceitful terms on cigarette packaging EN
W18_misleading_terms_B Ban on deceitful terms on other smoked tobacco packaging EN
W20_flavours_A Cigarette packaging and labelling must not use descriptors depicting flavours EN
W21_emissions_quant_B Other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark EN
W17_fines_A Health warnings on cigarette packaging law requires or establishes fines for violations EN
W17_fines_B Health warnings on other smoked tobacco packaging law requires or establishes fines for violations EN
W2_pc_front_back_B Percentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packaging EN
W20_flavours_C Smokeless tobacco packaging and labelling must not use descriptors depicting flavours EN
W24_exp_date_C Smokeless tobacco packaging and labelling must not display expiry dates EN
W25_quitline_number_A The quit line number must appear on cigarette packaging or labelling EN
W25_quitline_number_B The quit line number must appear on other smoked tobacco packaging or labelling EN
W21_emissions_B Other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark EN
SA_0000001797 Licenses issued for production, change since 2010 EN
SA_0000001802 Monopoly on wholesale /distribution of alcoholic beverages EN
W26_plain_packaging_B Plain packaging of other smoked tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited). EN
W3_pc_front_A Percentage of principal display area mandated to be covered by health warnings - front of cigarette packaging EN
SA_0000001813 National organization for monitoring alcohol EN
SA_0000001806 Legal requirement for size of health warning labels EN
SA_0000001811 Report with epidemiological data on lcohol use and AUDs EN
SA_0000001815 Ethanol tax deducted from excise tax EN
SA_0000001818 Alcohol, total  (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2020 and 2025 EN
SA_0000001821_ARCHIVED Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI EN
W22_emissions_qual_B Other smoked tobacco packaging and labelling must display qualitative information on relevant constituents and emissions EN
W22_emissions_qual_C Smokeless tobacco packaging and labelling must display qualitative information on relevant constituents and emissions EN
W24_exp_date_A Cigarette packaging and labelling must not display expiry dates EN
W25_quitline_number_C The quit line number must appear on smokeless tobacco packaging or labelling EN
W26_plainSPACEpackaging_A Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited). EN
W3_pc_front_C Percentage of principal display area mandated to be covered by health warnings - front of smokeless tobacco packaging EN
SA_0000001822 Alcohol, total per capita (15+) consumption (in litres of pure alcohol) with 95%CI EN
SA_0000001826 Regional prevalence, AAFs (15+), road traffic crash deaths (%) EN
SA_0000001831 Average price 500 mls Spirits in US$ EN
WHS7_147 Private expenditure on health as a percentage of total expenditure on health EN
WHS9_85 Literacy rate among adults aged >= 15 years (%) EN
WHS9_89 Population proportion under 15 (%) EN
WHS9_90 Population living on <$1 (PPP int. $) a day (%) EN
WHS9_92 Population proportion over 60 (%) EN
WHS9_93 Gross national income per capita (PPP int. \() |EN | |WHS9_96 |Population living in urban areas (%) |EN | |VIOLENCE_CHILD_NEGLECT |Lifetime prevalence of child physical neglect (%) |EN | |VIOLENCE_EXTENTIMP_ALLTYPES |Extent of implementation of mental health services for victims of all types of violence |EN | |VIOLENCE_PHYSICAL_FIGHTING |Physical fighting, past 12 months (%) |EN | |W_Group |Warning about the dangers of tobacco |EN | |W10_graphic_B |Do the health warnings on other smoked tobacco packaging include a photograph or graphic? |EN | |W10_graphic_C |Do the health warnings on smokeless tobacco packaging include a photograph or graphic? |EN | |W11_outside_pack_C |Do health warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail sale? |EN | |SA_0000001766 |Legal obligation for schools to interact with parents regarding education and well-being |EN | |SA_0000001766_ARCHIVED |Legal obligation for schools to interact with parents regarding education and well-being |EN | |SA_0000001770_ARCHIVED |Regular reports from national monitoring systems |EN | |SA_0000001774_ARCHIVED |National surveys on youth alcohol consumption |EN | |SA_0000001775_ARCHIVED |National surveys on heavy espisodic drinking |EN | |SA_0000001776 |Data collection on Foetal Alcohol Syndome |EN | |SA_0000001776_ARCHIVED |Data collection on Foetal Alcohol Syndome |EN | |SA_0000001782_ARCHIVED |15-years old first drink at 13 years or younger, (%) |EN | |SA_0000001783 |15-years old any alcoholic beverage consumed in past 30 days, (%) |EN | |SA_0000001783_ARCHIVED |15-years old any alcoholic beverage consumed in past 30 days, (%) |EN | |W12_imports_dutyfree_B |Health warnings on other smoked tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale |EN | |W13_ind_liability_C |Health warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industry |EN | |W14_harm_effects_B |Do health warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on health? |EN | |W4_pc_back_B |Percentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packaging |EN | |SA_0000001823_ARCHIVED |Alcohol, tourist consumption (in litres of pure alcohol) |EN | |SA_0000001824 |Alcohol, regional alcohol per capita (15+) consumption (in litres of pure alcohol) |EN | |SA_0000001827 |Regional prevalence, AAFs (15+), cancer |EN | |SA_0000001829 |Average price 500 mls Beer in US\) EN
SA_0000001830 Average price 750 mls Wine in US$ EN
sba5 Births attended by skilled health personnel (in the five years preceding the survey) (%) EN
SDGAIRBODA Ambient and household air pollution attributable death rate (per 100 000 population, age-standardized) EN
SDGCONFLICT Estimated direct deaths from major conflicts (per 100 000 population) EN
SDGHIV New HIV infections (per 1000 uninfected population) EN
W16_number_hw_B How many health warnings are approved by the law for other smoked tobacco packaging? EN
W16_number_hw_C How many health warnings are approved by the law for smokeless tobacco packaging? EN
W18_misleading_terms_C Ban on deceitful terms on smokeless tobacco packaging EN
W19_colours_numbers_B Other smoked tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors EN
SA_0000001787 13-15-years old first drink before age 14, (%) EN
SA_0000001788 Alcohol-related road traffic crashes with fatalities, per 100,000 population EN
SA_0000001788_ARCHIVED Alcohol-related road traffic crashes with fatalities, per 100,000 population EN
SA_0000001789_ARCHIVED Alcohol-related crimes (% of all crimes) EN
SA_0000001792 National legislation to prevent illegal alcohol sales EN
SA_0000001796 Licensing required for wholesale/distribution of alcoholic beverages EN
SA_0000001798 Licenses issued for retail sale, change since 2010 EN
SA_0000001801 Monopoly on imports of alcoholic beverages EN
SA_0000001803 Health warning labels on pregnancy EN
W19_colours_numbers_C Smokeless tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors EN
W2_pc_front_back_C Percentage of principal display area mandated to be covered by health warnings - front and back of smokeless tobacco packaging EN
W21_emissions_A Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark EN
W22_emissions_qual_A Cigarette packaging and labelling must display qualitative information on relevant constituents and emissions EN
W23_emissions_front_back_A Cigarette packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas EN
W23_emissions_front_back_B Other smoked tobacco packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas EN
W24_exp_date_B Other smoked tobacco packaging and labelling must not display expiry dates EN
W26_plain_packaging_A Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited). EN
SDGMALARIA Malaria incidence (per 1 000 population at risk) EN
WSH_2 Water, sanitation and hygiene attributable deaths (’000) in children under 5 years EN
WSH_30_WAT Number of diarrhoea DALYs from inadequate water EN
SDGAIRBOD Ambient and household air pollution attributable death rate (per 100 000 population) EN
WSH_4 Water, sanitation and hygiene attributable deaths per 100’000 children under 5 years EN
WSH_SANITATION_SAFELY_MANAGED Population using safely managed sanitation services (%) EN
VIOLENCE_EXTENTIMP_CHILDPROTECTION Extent of implementation of child protection services EN
VIOLENCE_EXTENTIMP_ELDERCAREGIVER Elder abuse: Extent of implementation of caregiver-support programmes EN
VIOLENCE_EXTENTIMP_PARTNERVIOLPREVENTION Intimate partner violence: Extent of implementation of dating violence prevention programmes EN
vita Children aged 6-59 months who received vitamin A supplementation (%) EN
W1_HW_law_B Law mandates that health warnings appear on other smoked tobacco packages EN
W1_HW_law_C Law mandates that health warnings appear on smokeless tobacco packages EN
W12_imports_dutyfree_C Health warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale EN
W16_number_hw_A How many health warnings are approved by the law for cigarette packaging? EN
W19_colours_numbers_A Cigarette packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors EN
W2_pc_front_back_A Percentage of principal display area mandated to be covered by health warnings - front and back of cigarette packaging EN
SA_0000001789 Alcohol-related crimes (% of all crimes) EN
SA_0000001794 Licensing required for exports of alcoholic beverages EN
SA_0000001800 Monopoly on exports of alcoholic beverages EN
SA_0000001805 Health warning labels on drink-driving EN
SA_0000001808 Alcohol-attributable fractions (15+), cancer deaths EN
SA_0000001812 Report with data from health services on alcohol use and AUDs EN
SA_0000001814 Taxation of ethanol production EN
W20_flavours_B Other smoked tobacco packaging and labelling must not use descriptors depicting flavours EN
W21_emissions_quant_C Smokeless tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark EN
W23_emissions_front_back_C Smokeless tobacco packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas EN
W26_plain_packaging_C Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited). EN
W27_smokeless_prod_ban The sale of all smokeless tobacco products is completely banned EN
W3_pc_front_B Percentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packaging EN
W4_pc_back_A Percentage of principal display area mandated to be covered by health warnings - back of cigarette packaging EN
W5_top_side_A Health warnings on cigarette packaging must be placed at the top of the principal display areas of the package EN
SA_0000001816 Tax incentives for production low/no alcohol content beer EN
SA_0000001817 Tax incentives for production of other alcoholic beverages EN
SA_0000001819 Heavy episodic drinking (youth 15 -19 years) past 30 days (%) EN
SA_0000001821 Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI EN
SA_0000001823 Alcohol, tourist consumption (in litres of pure alcohol) EN
SDGDISASTER Average death rate due to natural disasters (per 100 000 population) EN
SDGHEPHBSAGPRV Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%) EN
SDGHPVRECEIVED HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%) EN
SDGIHR Average of 13 International Health Regulations core capacity scores EN
SDGNTDTREATMENT Reported number of people requiring interventions against NTDs EN
SDGODA Total net official development assistance to medical research and basic health sectors per capita (constant 2014 US\(), by recipient |EN | |SDGSUICIDE |Crude suicide rates (per 100 000 population) |EN | |W6_font_B |Does the law mandate font style, font size and colour of health warnings on other smoked tobacco packaging? |EN | |W8_princ_langs_C |Are the health warnings on smokeless tobacco packaging written in the principal language(s) of the country? |EN | |W9_no_obscure_A |Health warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stamps |EN | |SDGCODCOMPLETENESS |Completeness of cause-of-death data (%) |EN | |SDGHIV1524 |New HIV infections among adults 15-24 years old (per 1000 uninfected population) |EN | |SDGODA01 |Total net official development assistance to medical research and basic health sectors per capita (US\)), by recipient country EN
WSH_8 Water, sanitation and hygiene attributable DALYs per 100’000 children under 5 years EN
WSH_WATER_BASIC Population using at least basic drinking-water services (%) EN
SDGODA02 Official development assistance for medical research and basic health sectors as a percentage of GNI (%), by donor country EN
SDGPOISON Mortality rate attributed to unintentional poisoning (per 100 000 population) EN
SDGROADAGE Age-standardized road traffic mortality (per 100 000 population) EN
SDGSHP Skilled health professionals density (per 10 000 population) EN
WSH_20_SAN Attributable fraction of diarrhoea to inadequate sanitation EN
WSH_3 Water, sanitation and hygiene attributable deaths per 100’000 capita EN
WSH_30_HYG Number of diarrhoea DALYs from inadequate hygiene EN
wast5 Wasting prevalence in children aged < 5 years (%) EN
WHOSIS_000003 Neonatal mortality rate (per 1000 live births) EN
WHOSIS_000006 Infants exclusively breastfed for the first six months of life (%) EN
SE_LSC_RDNG Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in reading (%) EN
SDGOOP Out-of-pocket expenditure as a percentage of total expenditure on health EN
SDGPM25 Concentrations of fine particulate matter (PM2.5) EN
SE_DEV_ONTRK Children aged 36-59 months who are developmentally on track in at least three of the following domains: literacy-numeracy, physical development, social-emotional development and learning (%) EN
WSH_5 Water, sanitation and hygiene attributable DALYs (’000) EN
WSH_6 Water, sanitation and hygiene attributable DALYs (’000) in children under 5 years EN
WSH_7 Water, sanitation and hygiene attributable DALYs per 100’000 capita EN
WSH_SANITATION_BASIC Population using at least basic sanitation services (%) EN
WSH_WATER_SAFELY_MANAGED Population using safely managed drinking-water services (%) EN
SHS_10 Second-hand smoke attributable DALYs (’000) in children under 5 years EN
SHS_11 Second-hand smoke attributable DALYs per 100’000 children under 5 years EN
SE_G23_MATH Proportion of children in grades 2/3 achieving at least a minimum proficiency level in mathematics (%) EN
SG_DMK_SRCR_FN_ZS Proportion of women aged 15-49 years who make their own informed decisions regarding sexual relations, contraceptive use and reproductive health care (%) EN
W6_font_C Does the law mandate font style, font size and colour of health warnings on smokeless tobacco packaging? EN
W7_rotation_B Are the health warnings on other smoked tobacco packaging rotating? EN
W7_rotation_C Are the health warnings on smokeless tobacco packaging rotating? EN
W8_princ_langs_A Are the health warnings on cigarette packaging written in the principal language(s) of the country? EN
SHS_5 Second-hand smoke attributable DALYs (’000) EN
SHS_7 Second-hand smoke attributable DALYs per 100’000 capita EN
stunt3 Stunting prevalence in children aged < 3 years (%) EN
stunt5 Stunting prevalence in children aged < 5 years (%) EN
W8_princ_langs_B Are the health warnings on other smoked tobacco packaging written in the principal language(s) of the country? EN
W9_no_obscure_C Health warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stamps EN
wast3 Wasting prevalence in children aged < 3 years (%) EN
WHOSIS_000002 Healthy life expectancy (HALE) at birth (years) EN
WHOSIS_000005 Low-birth-weight newborns (%) EN
TB_1 Tuberculosis treatment coverage EN
TB_c_dst_rlt_ret_pct Previously treated cases tested for RR-/MDR-TB (%) EN
TB_c_lab_cul_5m Laboratories providing tuberculosis diagnostic services using culture (per 5 million population) EN
TB_c_lab_dst_5m Laboratories providing drug susceptibility testing (DST) (per 5 million population) EN
TB_c_mdr_tx Cases started on MDR-TB treatment EN
WHOSIS_000001 Life expectancy at birth (years) EN
WHOSIS_000004 Adult mortality rate (probability of dying between 15 and 60 years per 1000 population) EN
SG_REG_BRTH Proportion of children under 5 years of age whose births have been registered with a civil authority EN
TB_c_new_snep_tsr Treatment success rate for new pulmonary smear-negative and extrapulmonary tuberculosis cases EN
TB_c_newinc Tuberculosis - new and relapse cases EN
TB_e_inc_num Number of incident tuberculosis cases EN
TB_e_mort_exc_tbhiv_num Number of deaths due to tuberculosis, excluding HIV EN
SE_LSC_MATH Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in mathematics (%) EN
SE_PRE_PARTN Participation rate in organized learning (one year before the official primary entry age) (%) EN
SG_REG_CENSUS Proportion of countries that have conducted at least one population and housing census in the last 10 years (%) EN
SG_REG_CENSUSN Number of countries that have conducted at least one population and housing census in the last 10 years EN
SI_POV_DAY1 Proportion of population below the international poverty line of US$1.90 per day (%) EN
SH_STA_FGMS Proportion of girls and women aged 15-49 years who have undergone female genital mutilation/cutting (FMG/C) (%) EN
SHS_1 Percentage of children under 15 years exposed to second-hand smoke EN
SHS_8 Second-hand smoke attributable deaths (’000) in children under 5 years EN
SHS_9 Second-hand smoke attributable deaths per 100’000 children under 5 years EN
SUNBEDEXISTSUBNATIONAL Existence of subnational regulation EN
SUNBEDREG_CONTROL Restriction and inspection of facilities EN
SI_POV_EMP1 Employed population below the international poverty line of US\(1.90 per day (the working poor) (%) |EN | |SP_DYN_MRBF15 |Proportion of women aged 20-24 years who were married or in a union by age 15 (%) |EN | |SUNBEDEXIST |Existence of national regulation |EN | |SUNBEDREG_SAFETY |Safety requirements |EN | |TB_c_lab_sm_100k |Laboratories providing tuberculosis diagnostic services using sputum smear microscopy (per 100 000 population) |EN | |TB_c_notified |Total number of notified TB cases |EN | |TB_c_ret_tsr |Treatment success rate: previously treated TB cases |EN | |TB_c_xdr_tsr |Treatment success rate: XDR-TB cases |EN | |TB_conf_mdr_tx_pct |Confirmed cases of MDR-TB started treatment for MDR-TB (%) |EN | |TB_e_inc_tbhiv_num |Number of incident tuberculosis cases, (HIV-positive cases) |EN | |TB_c_mdr_tsr |Treatment success rate for patients treated for MDR-TB (%) |EN | |W4_pc_back_C |Percentage of principal display area mandated to be covered by health warnings - back of smokeless tobacco packaging |EN | |W5_top_side_B |Health warnings on other smoked tobacco packaging must be placed at the top of the principal display areas of the package |EN | |W5_top_side_C |Health warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the package |EN | |W6_font_A |Does the law mandate font style, font size and colour of health warnings on cigarette packaging? |EN | |SA_0000001820 |Heavy episodic drinking (youth 15 -19 years), drinkers only, past 30 days (%) |EN | |SA_0000001822_ARCHIVED |Alcohol, total per capita (15+) consumption (in litres of pure alcohol) with 95%CI |EN | |SA_0000001825 |Regional prevalence, AAFs (15+), liver cirrhosis deaths (%) |EN | |SA_0000001828 |Regional prevalence, AAFs ,all-cause deaths (%) |EN | |sba |Births attended by skilled health personnel (in the two or three years preceding the survey) (%) |EN | |SDG_SH_DTH_RNCOM |Number of deaths attributed to non-communicable diseases, by type of disease and sex |EN | |SDG_SH_STA_SCIDEN |Number of suicide deaths |EN | |WSH_30_SAN |Number of diarrhoea DALYs from inadequate sanitation |EN | |WSH_HYGIENE_BASIC |Population with basic handwashing facilities at home (%) |EN | |WSH_SANITATION_OD |Population practising open defecation (%) |EN | |SDGTOBACCO |Age-standardized prevalence of current tobacco smoking among persons aged 15 years and older |EN | |SDGWSHBOD |Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2) |EN | |SE_G23_RDG |Proportion of children in grades 2/3 achieving at least a minimum proficiency level in reading (%) |EN | |W7_rotation_A |Are the health warnings on cigarette packaging rotating? |EN | |W9_no_obscure_B |Health warnings on other smoked tobacco packaging must not be obscured in any way including by required markings such as tax stamps |EN | |WHOSIS_000007 |Healthy life expectancy (HALE) at age 60 (years) |EN | |SE_PRM_MATH |Proportion of children at the end of primary achieving at least a minimum proficiency level in mathematics (%) |EN | |SE_PRM_RDNG |Proportion of children at the end of primary achieving at least a minimum proficiency level in reading (%) |EN | |SHS_2 |Percentage of women (15+ years) exposed to second-hand smoke |EN | |SHS_3 |Percentage of men (15+ years) exposed to second-hand smoke |EN | |SHS_4 |Second-hand smoke attributable deaths |EN | |SHS_6 |Second-hand smoke attributable deaths per 100'000 capita |EN | |SP_DYN_MRBF18 |Proportion of women aged 20-24 years who were married or in a union by age 18 (%) |EN | |SUNBEDEXISTYEAR |Year of national implementation of regulation |EN | |SUNBEDREG_ACCESS |Access restrictions |EN | |SUNBEDREG_INFO |Information requirements |EN | |SUNBEDREG_TRAINING |Training requirements |EN | |TB_c_dst_rlt_new_pct |New cases tested for RR-/MDR-TB (%) |EN | |TB_c_new_tsr |Treatment success rate: new TB cases |EN | |TB_c_tbhiv_tsr |Treatment success rate: HIV-positive TB cases |EN | |TB_e_inc_num_014 |Number of incident tuberculosis cases in children aged 0 - 14 |EN | |TB_e_inc_tbhiv_100k |Incidence of tuberculosis (per 100 000 population) (HIV-positive cases) |EN | |GDO_q8x3_1 |Accessibility of diagnostic services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] |EN | |GDO_q8x3_6 |Accessibility of social and financial protection for dementia [Capital/capital and main cities/capital, main cities, rural areas] |EN | |GDO_q8x4_1 |Majority provider of diagnostic services in community for dementia [public, private] |EN | |GDO_q8x3_3 |Accessibility of psychosocial and rehabilitation services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] |EN | |GDO_q8x3_4 |Accessibility of activities of daily living support services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] |EN | |GDO_q8x4_3 |Majority provider of psychosocial and rehabilitation services in community for dementia [public, private] |EN | |GDO_q8x5_2 |Estimated number of people receiving behaviour and psychological management services in community for dementia |EN | |GDO_q8x5_5 |Estimated number of people receiving palliative and end-of-life care services in community for dementia |EN | |GDO_q9_6 |Outpatient social centres |EN | |GDO_q9x2_5 |Estimated percentage of residential long-term care facilities following national dementia standards |EN | |GDO_q8x5_4 |Estimated number of people receiving activities of daily living support services in community for dementia |EN | |GDO_q8x5_6 |Estimated number of people with dementia receiving social and financial protection for dementia |EN | |GDO_q9_2 |Care facilities [long-term care] |EN | |GDO_q9_4 |Adult day centres |EN | |GDO_q9x1_4 |Geriatric-specific hospital beds (per 10,000 population) |EN | |GDO_q9x2_3 |Dementia-specific residential long-term care beds (per 10,000 population) |EN | |GDO_q9x2_4 |Estimated number of people with dementia living in residential long-term care |EN | |GDO_q9x5_1 |Density of outpatient health centres (per 100,000 population) |EN | |GDO_q9x4_1 |Density of adult day centres (per 100,000 population) |EN | |GDO_q9x4_3 |Dementia-specific adult day centre places (per 10,000 population) |EN | |GDO_q9x6_2 |Estimated number of people with dementia receiving services at outpatient social centre |EN | |GHED_CHE_pc_US_SHA2011 |Current health expenditure (CHE) per capita in US\) EN
GHED_CHEGDP_SHA2011 Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%) EN
TB_e_mdr_num Estimated MDR-TB cases among notified pulmonary TB cases EN
TB_e_prev_num Number of prevalent tuberculosis cases EN
GDO_q9_1 Dementia care facilities [hospitals] EN
GDO_q9_3 Care facilities [hospice centres] EN
GDO_q9_5 Outpatient health centres EN
GDO_q9x1_3 Dementia-specific hospital beds (per 10,000 population) EN
GDO_q9x1_5 Total dementia hospital admissions (per 100,000) EN
GDO_q9x1_7 Estimated percentage of hospitals following national dementia standards EN
GDO_q9x2_1 Density of residential long-term care facilities (per 100,000 population) EN
GDO_q9x4_2 Adult day centre places (per 10,000 population) EN
GDO_q9x6_1 Density of outpatient social centres (per 100,000 population) EN
GHE_YLLNUM Years of life lost from mortality (YLLs) EN
GHE_YLLRATE Years of life lost from mortality (YLLs) (per 100 000 population) EN
GHED_CHE_pc_PPP_SHA2011 Current health expenditure (CHE) per capita in PPP int$ EN
GHED_EXT_pc_PPP_SHA2011 External health expenditure (EXT) per capita in PPP int$ EN
GHED_PVT-D_pc_PPP_SHA2011 Domestic private health expenditure (PVT-D) per capita in PPP int$ EN
GOE_Q007 Public funding for eHealth EN
GOE_Q011 Strategy implementation funding available for eHealth EN
GOE_Q014 Proportion of donor/non public development funding EN
GHED_EXTCHE_SHA2011 External health expenditure (EXT) as percentage of current health expenditure (CHE) (%) EN
GHED_GGHE-DCHE_SHA2011 Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE) (%) EN
GHED_OOPSCHE_SHA2011 Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%) EN
GDO_q9x5_2 Estimated number of people with dementia receiving services at outpatient health centre EN
GHE_YLDNUM Years of healthy life lost due to disability (YLDs) EN
GHED_EXT_pc_US_SHA2011 External health expenditure (EXT) per capita in US$ EN
GOE_Q030_3 Providing guidance on privacy and security EN
GOE_Q030_4 Providing oversight and enforcement of data ownership EN
GOE_Q058 Infrastructure EN
GOE_Q059 Funding EN
GOE_Q061 Cost-effectiveness EN
GOE_Q063 Legal EN
GOE_Q069 Country has telehealth policy or strategy EN
GOE_Q070 Strategy includes objectives as to how telehealth contributes to UHC EN
GOE_Q081 Evaluation of any government-sponsored telehealth programmes EN
GOE_Q104_2 Improving access to content and experts EN
GOE_Q104_3 Enabling access to education where learning facilities are limited EN
GOE_Q118 eLearning used for in-service training of health professionals EN
GOE_Q120 eLearning courses accredited by continuing medical education or professional licensing bodies EN
GOE_Q132 Lack of infrastructure EN
GOE_Q001 National universal health coverage strategy EN
GOE_Q003 National eHealth strategy EN
GOE_Q006 National health information system (HIS) policy or strategy EN
GOE_Q008 Private funding for eHealth EN
GOE_Q009 Donor/ non-public development funding for eHealth EN
GOE_Q017 Government-supported health internet sites provide information in multiple languages EN
GHED_GGHE-D_pc_US_SHA2011 Domestic general government health expenditure (GGHE-D) per capita in US$ EN
GHED_GGHE-DGGE_SHA2011 Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%) EN
GHED_PVT-DCHE_SHA2011 Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%) EN
GOE_Q153 Lack of capacity EN
GOE_Q155 Lack of funding EN
GOE_Q156 lack of evidence showing effectiveness of EHR EN
GOE_Q157 Lack of evidence showing cost-effectiveness or EHR EN
GOE_Q028 mHealth programmes are sponsored by government EN
GOE_Q031 Regulatory oversight of mobile apps for quality, safety and reliability EN
GOE_Q047 Government-sponsored mHealth programmes are being evaluated EN
GOE_Q065 Priorities EN
GOE_Q103 eLearning is used in pre-service education to teach health sciences students EN
GOE_Q002 strategy refers to the use of ICT to support UHC EN
GOE_Q004 National eHealth strategy refers to objectives of UHC EN
GOE_Q013 Proportion of private funding EN
GOE_Q018 Tertiary institutions provide students of health sciences with training on eHealth EN
GOE_Q022 Institutions offer in-service training to health professionals on ICT for health EN
GOE_Q030_2 Promoting standards and interoperability EN
GOE_Q030_5 Promoting the development and adoption of mHealth EN
GOE_Q032 Providing incentives and guidance for innovation research and evaluation of health EN
GOE_Q057 Capacity EN
GOE_Q171 To protect the privacy of individuals’ health-related data held in electronic format as an EHR EN
GOE_Q104_1 Reducing cost of delivering content EN
GOE_Q119_2 Improving access to content and experts EN
GOE_Q133 Lack of funding EN
GOE_Q135 Lack of evidence that eLearning is effective EN
GOE_Q137 Lack of demand for eLearning programmes EN
GOE_Q140 Competing educational priorities EN
GOE_Q159 Lack of legislation or regulations covering use of EHR EN
GOE_Q162 Competing health system priorities EN
GOE_Q170 To protect privacy of personally identifiable data of individuals irrespective of whether it is paper or digital format EN
GOE_Q174 Which allows for the sharing of personal and health data between research entities EN
GOE_Q109 Pre-service eLearning programmes have been evaluated EN
GOE_Q119_1 Reducing cost of delivering content EN
GOE_Q122 eLearning programmes for in-service training of health professionals have been evaluated EN
GOE_Q131 Lack of capacity EN
GOE_Q138 Lack of suitable courses available EN
GOE_Q139 Insitutional educational policy does not include eLearning as an approach to teaching health sciences EN
GOE_Q144 Country has national EHR EN
GOE_Q146 Country has specific legislation governing the use of national EHR system EN
GOE_Q154 Lack of infrastructure EN
GOE_Q160 National strategy does not promote the adoption of EHR EN
GOE_Q178 Individuals have the legal right to specify which health-related data from their EHR can be shared with health professionals of their choice EN
GOE_Q181 Country has national policy or strategy on the use of social media by government organizations EN
GOE_Q201 Privacy and security laws need to be in place EN
GOE_Q202 Research into new analytical methods needs occur to meet the challenges of working with big data EN
GOE_Q203 Lack of integration between various health services EN
GOE_Q176 Which allows individuals to demand that their own data be corrected when held in an EHR if it is known to be inaccurate EN
GOE_Q173 Which governs the sharing of digital data between health professionals in health services in other countries through the use of an EHR EN
GOE_Q175 Which allows individuals electronic access to their own health-related data when held in an EHR EN
GOE_Q177 Which allows individuals to demand the deletion of health-related data from their EHR EN
GOE_Q198 Effective standards and best practices for data capture not fully established EN
HIV_0000000009 Reported number of people receiving antiretroviral therapy EN
HCF_REL_ELECTRICITY Percentage of health-care facilities with reliable electricity supply (%) EN
HIV_0000000007 Testing and counselling facilities, reported number EN
HIV_0000000008 Testing and counselling facilities, estimated number per 100 000 adult population EN
GOE_Q199 Insufficient incentives for data sharing EN
HCF_NO_ELECTRICITY Percentage of health-care facilities with no access to any electricity supply (%) EN
HIV_0000000006 Number of people dying from HIV-related causes EN
HIV_0000000011 Reported number of children receiving antiretroviral therapy EN
HRH_05 Number of pharmaceutical technicians/assistants EN
HIV_0000000012 Reported number of children receiving antiretroviral therapy, month and year of report EN
HIV_0000000020 Estimated number of pregnant women living with HIV EN
HIV_0000000021 Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission EN
HIV_0000000023 Estimated number of children needing antiretroviral therapy based on WHO methods EN
HIV_0000000024 Estimated antiretroviral therapy coverage among children EN
HIV_ARTCOVERAGE Estimated antiretroviral therapy coverage among people living with HIV (%) EN
HRH_01 Number of nursing personnel EN
HRH_02 Number of physicians EN
HRH_03 Number of midwifery personnel EN
HIV_0000000015 Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission EN
HIV_0000000016 Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission, reporting period EN
HIV_0000000022 Estimated number of people eligible for antiretroviral therapy according to 2010 guidelines EN
HIV_0000000025 Testing and counselling facilities, reporting period EN
HRH_04 Number of pharmacists EN
HRH_08 Number of radiographers EN
HRH_09 Number of other health workers EN
HRH_13 Number of laboratory scientists EN
HRH_15 Number of dentists EN
HRH_18 Number of personal care workers EN
HRH_33 Nursing and midwifery personnel density (per 1000 population) EN
HSS_COMPREHENSIVEHEALTHPOLICY Countries that have a comprehensive national health sector policy/ strategy/ plan with goals and targets updated within the last 5 years EN
HWF_0004 Specialist medical practitioners (number) EN
HWF_0006 Nursing and midwifery personnel (per 10,000) EN
HWF_0008 Nursing personnel (number) EN
HWF_0016 Pharmaceutical Technicians and Assistants (number) EN
HWF_0021 Physiotherapists (number) EN
HWF_0022 Physiotherapy Technicians and Assistants (number) EN
HWWS_1 Handwashing with soap after using the toilet (%) EN
IHR01 Legislation EN
HRH_10 Number of dental technicians/assistants EN
HRH_11 Number of health management & support workers EN
HRH_12 Number of environment and public health workers EN
HRH_14 Number of laboratory technicians/assistants EN
HRH_19 Number of pharmaceutical personnel EN
HRH_16 Number of traditional medicine practitioners EN
HRH_17 Number of medical assistants EN
HRH_20 Number of laboratory health workers EN
HRH_21 Number of dentistry personnel EN
HRH_22 Number of community and traditional health workers EN
HRH_23 Number of other health workers EN
HRH_24 Number of nursing and midwifery personnel EN
HRH_28 Dentistry personnel density (per 1000 population) EN
HRH_29 Community and traditional health workers density (per 1000 population) EN
IHR04 Response EN
IHR10 Zoonosis EN
IR_CARBAMATE_PRESENCE Carbamate resistance reported for at least one site EN
IR_PYRETHROID_PRESENCE Pyrethroid resistance reported for at least one site EN
HRH_26 Physicians density (per 1000 population) EN
HRH_27 Laboratory health workers density (per 1000 population) EN
HRH_30 Other health workers density (per 1000 population) EN
HRH_31 Environmental and public health workers density (per 1000 population) EN
HRH_32 Health management & support workers density (per 1000 population) EN
HRH_40 Biomedical engineers density (per 10 000 population) EN
HRH_41 Number of licensed qualified surgeons actively working EN
HRH_42 Number of licensed qualified obstetricians actively working EN
HRH_44 Number of biomedical engineers EN
ITU_IDI_RANK ICT Development Index (IDI) rank EN
LEAD_3 Percentage of the adults (15+ years) with blood lead levels above 5ug/dl EN
LEAD_5 Lead attributable deaths EN
HWF_0013 Dental Prosthetic Technicians (number) EN
HWF_0015 Pharmacists (number) EN
HWF_0019 Medical and Pathology Laboratory scientists (number) EN
HWF_0020 Medical and Pathology Laboratory Technicians (number) EN
HWF_0024 Community Health Workers (number) EN
IHR05 Preparedness EN
IR_CARBAMATE_EXTENT Percentage of sites for which carbamate resistance was reported EN
IR_INSECTICIDERESISTANCE_PREV Number of insecticide classes to which resistance was reported EN
ITU_ICT_1 Percentage of individuals using the Internet EN
HRH_46 Number of biomedical technicians EN
HWF_0001 Medical doctors (per 10,000) EN
HWF_0002 Medical doctors (number) EN
HWF_0007 Nursing and midwifery personnel (number) EN
ITU_ICT_2 Mobile-cellular telephone subscriptions per 100 inhabitants EN
ITU_IDI ICT Development Index (IDI) EN
LEAD_4 Percentage of the adults (15+ years) with blood lead levels above 10ug/dl EN
LEAD_6 Lead attributable DALYs (’000) EN
LEAD_9 Lead attributable DALYs (’000) in children under 5 years EN
HWF_0010 Dentists (per 10,000) EN
HWF_0014 Pharmacists (per 10,000) EN
HWF_0018 Environmental and Occupational Health Inspectors and Associates (number) EN
HWF_0023 Traditional and Complementary Medicine Professionals (number) EN
HWWS_2 Handwashing with soap after cleaning child’s stool (%) EN
IHR02 Coordination EN
IHR06 Risk communication EN
IHR08 Laboratory EN
IHR11 Food safety EN
IHR13 Radionuclear EN
imr Infant mortality rate (deaths per 1000 live births) EN
IR_ORGANOCHLORINE_EXTENT Percentage of sites for which organochlorine resistance was reported EN
IR_ORGANOPHOSPHATE_EXTENT Percentage of sites for which organophosphate resistance was reported EN
IR_ORGANOPHOSPHATE_PRESENCE Organophosphate resistance reported for at least one site EN
IR_PYRETHROID_EXTENT Percentage of sites for which pyrethroid resistance was reported EN
LEAD_10 Lead attributable DALYs per 100’000 children under 5 years EN
LEAD_2 Percentage of the children under 15 years with blood lead levels above 10ug/dl EN
LEAD_7 Lead attributable deaths per 100’000 capita EN
LEAD_8 Lead attributable DALYs per 100’000 capita EN
GDO_q9x2_2 Residential long-term care beds (per 10 000 population) EN
GDO_q9x3_1 Density of hospice centres (per 100,000 population) EN
GDO_q9x3_2 Hospice centre beds (per 10 000 population) EN
GDO_q9x3_3 Dementia-specific hospice care beds (per 10,000 population) EN
GHE_DALYNUM Disability-adjusted life years (DALYs) EN
GHE_DALYRATE Disability-adjusted life years (DALYs) (per 100 000 population) EN
GHE_YLDRATE Years of healthy life lost due to disability (YLDs) (per 100 000 population) EN
GHED_GGHE-D_pc_PPP_SHA2011 Domestic general government health expenditure (GGHE-D) per capita in PPP int$ EN
GHED_GGHE-DGDP_SHA2011 Domestic general government health expenditure (GGHE-D) as percentage of gross domestic product (GDP) (%) EN
GHED_OOP_pc_PPP_SHA2011 Out-of-pocket expenditure (OOP) per capita in PPP int$ EN
GHED_OOP_pc_US_SHA2011 Out-of-pocket expenditure (OOP) per capita in US$ EN
GHED_PVT-D_pc_US_SHA2011 Domestic private health expenditure (PVT-D) per capita in US$ EN
GOE_Q010 Public-private partnerships for eHealth EN
GOE_Q012 Proportion of public funding EN
GOE_Q015 Proportion ofpublic private partnerships funding EN
GOE_Q030_1 Regulating mobile devices and software EN
GOE_Q060 Effectiveness EN
GOE_Q062 Demand EN
GOE_Q064 Policy EN
GOE_Q119_3 Enabling access to education where learning facilities are limited EN
GOE_Q134 Not possible to gain a health sciences degree entirely through eLearning EN
GOE_Q136 Lack of evidence over cost-effectiveness EN
LEPTO_DALY Disability-adjusted life years (DALYs) due to leptospirosis EN
LEPTO_DALY100K Disability-adjusted life years (DALYs) (per 100 000 population) due to leptospirosis EN
LEPTO_MORBIDITY Estimated leptospirosis incidence (per 100 000 population) EN
LIFE_0000000032 ndx - number of people dying between ages x and x+n EN
LEPTO_YLL100K Years of life lost (YLLs) (per 100 000 population) due to leptospirosis EN
LIFE_0000000029 nMx - age-specific death rate between ages x and x+n EN
LIFE_0000000034 Tx - person-years lived above age x EN
LIFE_0000000035 ex - expectation of life at age x EN
M_def_1_prev_youth Youth indicator 1 rate EN
M_def_1_text_adult Adult indicator 1 definition EN
LEPTO_YLD100K Years of healthy life lost to disability (YLDs) (per 100 000 population) due to leptospirosis EN
M_def_1_text_youth Youth indicator 1 definition EN
M_def_2_prev_adult Adult indicator 2 rate EN
M_Est_cig_curr_crude Current cigarette smoking, crude adjusted EN
M_Est_cig_daily Estimate of daily cigarette smoking prevalence (%) EN
M_smkless_age_range_youth Youth survey age range - smokeless EN
M_Est_tob_daily Estimate of daily tobacco use prevalence (%) EN
M_Est_tob_daily_crude Daily tobacco smoking, crude adjusted EN
M_Group Monitoring tobacco use and prevention policies EN
M_smkless_age_range_adult Adult survey age range - smokeless EN
M_smkless_def_text_adult Adult smokeless tobacco use indicator definition EN
M_smkless_def_text_youth Youth smokeless tobacco use indicator definition EN
M_smkless_survey_title_youth Name of survey of youth - smokeless EN
M_smkless_svy_yr_adult Year of survey of adults - smokeless EN
M_survey_title_youth Name of survey of youth EN
M_svy_national_adult Representativeness of survey of adults EN
CARE_SOURCE Care-seeking by type of patient and source of care (%) EN
FOODBORNE_DTH_GE5 Foodborne deaths, aged 5 years and above EN
M_smkless_svy_national_youth Representativeness of survey of youth - smokeless EN
M_survey_title_adult Name of survey of adults EN
M_svy_national_youth Representativeness of youth survey EN
M_svy_yr_adult Year of latest adult prevalence survey EN
RADON_Q501_1 Reference level for dwellings (Bq/m3) EN
FINPROTECTION_IMP_P_215_LEVEL_SH Total population pushed further below the $2.15 a day poverty line by household health expenditures (%, regional, global) EN
M_def_2_prev_youth Youth indicator 2 rate EN
M_def_2_text_adult Adult indicator 2 definition EN
M_def_2_text_youth Youth indicator 2 definition EN
M_Est_tob_curr Estimate of current tobacco use prevalence (%) EN
M_smkless_prev_adult Adult smokeless tobacco use indicator rate EN
M_smkless_prev_youth Youth smokeless tobacco use indicator rate EN
M_smkless_survey_title_adult Name of survey of adults - smokeless EN
PRISON_D4_CARDIOVASC_DIAG_TOT In-prison cardiovascular disease diagnosis (number of diagnoses) EN
R_admin_unique_identifier Tax administration - Unique identifier EN
Yth_nonsmoked_svy_yr Year of latest youth prevalence survey (nonsmoked) EN
STI_GONORRHOEA_PREVALENCE_PER100 Prevalence of gonorrhoea in individuals (%) EN
O_Cytisine_sold Cytisine - legally sold EN
HEPB_HBSAG_CARRIER Hepatitis B surface antigen (HBsAG) carriers (per 100 000 population) EN
NCD_CCS_PA_GUIDELINES_OLDADULTS Existence of national guidelines for physical activity for older adults EN
IHRSPAR_CAPACITY13 Radiation Emergencies EN
PHE_HHAIR_POP_CATEGORY_FUELS Population with primary reliance on fuels and technologies for cooking, by fuel type (in millions) EN
M_svy_age_youth Youth survey age range EN
M_svy_yr_youth Year of survey of youth EN
NCD_CCS_ARB General availability of Angiotensin II receptor blockers (ARBs) in the public health sector EN
NUT_BF_EIBF Early Initiation of Breastfeeding, Children born in the last 24 months EN
NCD_CCS_MORT_TARGET Existence of a national target on NCD mortality EN
PRISON_D4_HIV_DIAG_TOT In-prison HIV diagnosis (number of diagnoses) EN
NCD_CCS_PA_SVY Has conducted a recent, national adult risk factor survey covering physical inactivity EN
NCD_CCS_PA_POL_WALKBIKE Existence of policy promoting physical activity: walking and cycling EN
MALARIA_IMPORTED Number of imported malaria cases EN
R_earmarking Reported use of earmarked tobacco taxes EN
Rev_import Tobacco tax revenues - import duties EN
TB_ps_prev_bc_100k_sp Prevalence of bacteriologically-confirmed pulmonary TB who are smear positive among those aged ≥15 years, per 100,000 population EN
IHRSPAR_CAPACITY03 Zoonotic Events and the Human-animal Interface EN
NCD_CCS_TOB_SVY Has conducted a recent, national adult risk factor survey covering tobacco use EN
NUT_CF_ZVF Zero vegetable or fruit consumption, 6-23 months EN
E_compl_e14 Compliance with ban on appearance of tobacco products in TV and/or films (score) EN
bfearly Early initiation of breastfeeding (in the two years preceding the survey) (%) EN
FINPROTECTION_IMP_P310_LEVEL_MILLION Total population pushed further below the $3.20 a day poverty line by household health expenditures (millions, regional, global) EN
TB_cc_prct_Q5 Percentage of TB-affected households facing costs >20% of household income or expenditure due to TB among Q5 (highest) income or expenditure quantile. EN
FINPROTECTION_IMP_BNLFHU_FURIMP_HH Households impoverished by out-of-pocket payments (relative poverty line reflecting basic needs: food, housing, utilities - developed by WHO/Europe) (%, national) EN
Yth_curr_cig_smoking Prevalence of current cigarette smoking among adolescents (%) EN
MALARIA_EST_DEATHS Estimated number of malaria deaths EN
SA_0000001836 Alcohol-related road traffic deaths (% of all road traffic deaths) EN
PRISON_B16_SUICIDERISK In-prison standardized protocol for suicide EN
E_compl_e10 Compliance with ban on promotional discounts (score) EN
ASSISTIVETECH_SOURCESOFAT Sources of assistive products (%) EN
MALARIA_PF_INDIG Number of indigenous P. falciparum malaria cases EN
FOODBORNE_DALY_100k_LT5 Foodborne disability-adjusted life years per 100,000, aged less than 5 years EN
PRISON_D4_MH_DIAG_TOT In-prison mental disorder diagnosis (number of diagnoses) EN
ORALHEALTH_UNTREATEDCARIESPERMANENT Prevalence of untreated caries of permanent teeth in people 5+ years (%) EN
MALARIA_EST_INCIDENCE Estimated malaria incidence (per 1000 population at risk) EN
E23_vending_machines Ban on tobacco vending machines EN
FINPROTECTION_IMP_P365_POP Population pushed further below the $3.65 a day poverty line by household health expenditures (%, national, rural, urban) EN
AIR_71 Ambient air pollution attributable DALYs in children under 15 years EN
TAXBEV_TOTALTAXES Total taxes on beverages (%) EN
WHOSIS_000016 Mortality rate among children ages 5 to 9 years (per 1000 children aged 5) EN
FINPROTECTION_IMP_P_365_LEVEL_MILLION Total population pushed further below the $3.65 a day poverty line by household health expenditures (millions, regional, global) EN
TB_notif_num Number of people notified with new episode of TB in a given year EN
Yth_nonsmoked_svy_title Name of latest youth prevalence survey (nonsmoked) EN
SDGHEALTHFACILITIESESSENTIALMEDS Proportion of health facilities with a core set of relevant essential medicines available and affordable on a sustainable basis EN
TB_cc_prct_Q1 Percentage of TB-affected households facing costs >20% of household income or expenditure due to TB among Q1 (lowest) income or expenditure quantile. EN
PRISON_B9_1_NURSES_RATIO Nurses in prisons (FTEs per 1000 prisoners) EN
FINPROTECTION_IMP_P_215_LEVEL_MILLION Total population pushed further below the $2.15 a day poverty line by household health expenditures (millions, regional, global) EN
FOODBORNE_ILL_TOTAL Foodborne illnesses, all ages EN
ASSISTIVETECH_Q06 Workforce availability for assistive technology EN
PRISON_D4_HEPB_DIAG_TOT In-prison Hepatitis B diagnosis (number of diagnoses) EN
PRISON_C16_LABTESTS In-prison laboratory tests EN
M2_adult_representative Most recent survey among adults was representative of the national population EN
SA_0000001833 Alcohol-attributable DALYs per 100,000 people (age standardized) EN
PRISON_F1_DRUGUSERS_TOT In-prison people who use/have used drugs (number of prisoners, in the last 12 months) EN
NCD_CCS_bone_marrow General availability of bone marrow transplantation in the public health system EN
PRISON_D4_MDRTB_DIAG_TOT In-prison MDR-TB diagnosis (number of diagnoses) EN
TAXBEV_PRICE Beverage price EN
NCD_CCS_CHOL_SVY Has conducted a recent, national adult risk factor survey covering raised total cholesterol EN
FOODBORNE_DALY_CASE_GE5 Foodborne disability-adjusted life years per case, aged 5 years and above EN
HEMOGLOBINLEVEL_PREGNANT_MEAN Mean hemoglobin level of pregnant women (aged 15-49 years) EN
RADON_Q202 Existence of any subnational radon activity EN
FOODBORNE_DALY_TOTAL Foodborne disability-adjusted life years, all ages EN
PRISON_D4_TB_DIAG_TOT In-prison TB diagnosis (number of diagnoses) EN
STI_CHLAMYDIA_PREVALENTCASES Prevalent cases of chlamydia in individuals (in millions) EN
TAXBEV_VATSALES Value-added/sales tax on beverages (%) EN
SDGIHR2021 Average of 15 International Health Regulations core capacity scores, SPAR version, 2nd edition EN
cpmowho Contraceptive prevalence - use of modern methods (%) EN
FOODBORNE_DALY_LT5 Foodborne disability-adjusted life years, aged less than 5 years EN
HAZARD_YLD_GE5 Years lived with disability caused by hazards, aged 5 years and above EN
STI_GONORRHOEA_INCIDENCE_PER1000 Incident cases of gonorrhoea in individuals (per 1000) EN
P_compl_p5 Compliance with smoke-free indoor offices law (score) EN
IHRSPAR_CAPACITY02 IHR Coordination and National IHR Focal Point Functions EN
MALARIA_MICR_TEST Number of malaria suspects examined by microscopy EN
HEMOGLOBINLEVEL_CHILDREN_MEAN Mean hemoglobin level of children aged 6-59 months EN
MALARIA_EST_CASES Estimated number of malaria cases EN
FOODBORNE_YLL_CASE_LT5 Foodborne years of life lost per case, aged less than 5 years EN
IHRSPAR_CAPACITY12 Chemical Events EN
TB_e_inc_rr_num Estimated number of MDR/RR-TB incident cases EN
Adult_curr_e-cig Prevalence of current e-cigarette use among adults (%) EN
FINPROTECTION_IMP_PRELPL_POP Population pushed further below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (%, national, rural, urban) EN
CCH_SURVEY_AGREEMENT_MOH_OTHERSECTORS Agreement in place between the Ministry of Health and other sector(s) in relation to health and climate change policy or programs EN
NCD_CCS_ALC_TARGET Existence of a national target on alcohol EN
FINPROTECTION_IMP_P310_POP Population pushed further below the \(3.20 a day poverty line by household health expenditures (%, national, rural, urban) |EN | |TB_cc_prct_DRTB |Percentage of TB-affected households facing costs >20% of household income or expenditure due to DR-TB. |EN | |ORALHEALTH_SUGAR_AVAILABILITY |Per capita availability of refined sugar (g/day) |EN | |NLIS_NU_CA_114 |NLIS: Continued breastfeeding at 1 year in infants 12-15 months (%) |EN | |R_Price_lowest_cost_estimate |Cheapest brand of cigarettes - price in currency reported |EN | |CCH_SURVEY_PLAN_STRATEGY_DEVELOPED |National health and climate change plan or strategy developed |EN | |TB_notif_num_newrel_ep |Number of people diagnosed with new episode of pulmonary TB who have extrapulmonary TB. |EN | |IHRSPAR_CAPACITY08 |National Health Emergency Framework |EN | |E_compl_e6 |Compliance with ban on advertising at point of sale (score) |EN | |NCD_HYP_PREVALENCE_C |Prevalence of hypertension among adults aged 30-79 years, crude |EN | |GLASSAMC_GPW13_T4B |Target ≥60% of total antibiotic consumption being Access group antibiotics (GPW13 target 4b) |EN | |MALARIA_RDT_TEST |Number of malaria suspects examined by rapid diagnostic test (RDT) |EN | |TB_cc_prct_Q4 |Percentage of TB-affected households facing costs >20% of household income or expenditure due to TB among Q4 income or expenditure quantile. |EN | |NCD_CCS_TEL_HYDRO_COMBO |General availability of Fixed dose combination avail (telmisartan + hydrochlorothiazide) in the public health sector |EN | |CCH_SURVEY_MOH_FOCALPOINT |Designation of a focal point responsible for health and climate change within the Ministry of Health |EN | |TAXBEV_EARMARKEDEXCISETAX |Use of earmarked excise tax on beverages |EN | |CCH_SURVEY_MULTISTAKEHOLDER_MECHANISM_EXISTS |Existence of a multi-stakeholder mechanism on health and climate change |EN | |IHRSPAR_CAPACITY07 |Human Resources (SPAR) |EN | |PHE_HHAIR_POP_POLLUTING_FUELS |Population with primary reliance on polluting fuels and technologies for cooking (in millions) |EN | |ORALHEALTH_HWF_DENTALPROSTHETICTECH_10K |Dental prosthetic technicians (per 10 000 population) |EN | |IHRSPAR_CAPACITY06 |Surveillance (SPAR) |EN | |SA_0000001832 |Alcohol-attributable all-cause deaths per 100,000, age standardized |EN | |MALARIA_ITN_COVERAGE |Population with access to an insecticide-treated bed net (ITN) for malaria protection (%), modelled |EN | |Adult_curr_smokeless |Prevalence of current smokeless tobacco use among adults (%) |EN | |E22_subnational_authority_exists |Subnational bans on tobacco advertising, promotion and sponsorship authority exists |EN | |IHRSPAR_CAPACITY05 |Laboratory (SPAR) |EN | |STI_CHLAMYDIA_INCIDENCE_PER1000 |Incident cases of chlamydia in individuals (per 1000) |EN | |ASSISTIVETECH_SATISFACTIONACTIVITIES |Satisfaction with assistive products for different environments and activities (%) |EN | |NCD_CCS_BPmsmt |General availability of blood pressure measurement at the primary health care level |EN | |vbcg |BCG immunization coverage among one-year-olds (%) |EN | |NCD_CCS_FOOD_TAX |Existence of tax on foods high in fat, sugars or salt |EN | |NCD_CCS_BP_SVY |Has conducted a recent, national adult risk factor survey covering raised blood pressure/hypertension |EN | |uwgt5 |Underweight prevalence in children aged < 5 years (%) (Health inequality monitor) |EN | |CARE_SEEK |Care-seeking by type of patient and source of care (%) (see CARE_SOURCE) |EN | |ORALHEALTH_UHC_ADVANCE_CURATIVE |Oral health interventions as part of health benefit packages: Advanced curative oral health care |EN | |PRISON_D3_DEATHS_TOT |In-prison total deaths |EN | |TOB_R_PRICE |Retail price for tobacco and other nicotine products |EN | |R_admin_overt_marking |Tax administration - Marking is overt |EN | |R_afford_price_gap_decreased |Price gap decreased over the last two years |EN | |NCD_HYP_DIAGNOSIS_A |Prevalence of previous diagnosis of hypertension among adults aged 30-79 with hypertension, age-standardized |EN | |R_afford_trend_growth_rate |Affordability - trend growth rate |EN | |HAZARD_ILL_LT5 |Illnesses caused by hazards, aged less than 5 years |EN | |Yth_daily_smokeless |Prevalence of daily smokeless tobacco use among adolescents (%) |EN | |ASSISTIVETECH_Q07 |Availability of education/training for assistive technology |EN | |MH_27 |Publication year of the policy or plan (latest revision) |EN | |NLIS_NU_CA_095 |NLIS: Minimum acceptable diet (MAD) in children 6-23 months (%) |EN | |FOODBORNE_DTH_100K_LT5 |Foodborne deaths per 100,000, aged less than 5 years |EN | |TAXBEV_EXCISE |Excise taxes on beverages (%) |EN | |HIV_0000000028 |Estimated number of tests performed where results were received by a person (testing volume), estimated number per 1000 population |EN | |NCD_CCS_EyePlan |Existence of operational policy/strategy/action plan for eye health |EN | |NCD_CCS_CANCER_GUIDE |Existence of evidence-based national guidelines/protocols/standards for the management of cancer |EN | |TAXBEV_ABV |Alcohol content in beverage in percent of volume, (alcohol by volume) (ABV %) |EN | |MALARIA_INDIG |Number of indigenous malaria cases |EN | |GHE_YLD_NUMERIC |Years of healthy life lost due to disability (YLDs) |EN | |Adult_daily_smokeless |Prevalence of daily smokeless tobacco use among adults (%) |EN | |NCD_CCS_PA_POL_CHILDCARE |Existence of policy promoting physical activity: childcare settings |EN | |TAXBEV_OTHERTAXES |Other taxes on beverages (%) |EN | |MALARIA_CONF_CASES |Number of confirmed malaria cases |EN | |NCD_CCS_ALC_MGMT_GUIDE |Existence of evidence-based national guidelines/protocols/standards for the management of alcohol use disorders |EN | |FOODBORNE_YLL_100K_TOTAL |Foodborne years of life lost per 100,000, all ages |EN | |IMMUNIZATION_VACCINATIONCARDSSEEN |Proportion of vaccination cards seen (%) |EN | |NUT_BF_CBF |Continued breastfeeding 12-23 months |EN | |TB_Notification_agesex_num |The number of new and relapse cases of tuberculosis detected in a given year by age and sex |EN | |ORALHEALTH_DENTALHEALTHCARE_EXP_PERCAP |Per capita expenditure on dental healthcare (US\)) EN
RADON_Q502_1 Reference level for buildings with high public occupancy (Bq/m3) EN
ASSISTIVETECH_Q08 Existence of financial mechanisms for assistive technology EN
PRISON_B17_INVOLVEMENT In-prison patient involvement in healthcare planning and reform EN
NCD_CCS_PBCR Existence of population-based cancer registry EN
FAMILYPLANNINGUNPDUHC Women of reproductive age (15−49 years) who are married or in-union who have their need for family planning satisfied with modern methods (%), UNPD EN
E_compl_e5 Compliance with ban on billboard and outdoor advertising (score) EN
AMR_INFECT_ECOLI Proportion of bloodstream infection due to Escherichia coli resistant to third-generation cephalosporins (%) EN
SDGFPALL Women of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods (%) EN
R_Ad_val Taxes as a % of price - ad valorem excise EN
FINPROTECTION_IMP_BNLFHU_P_HH Households further impoverished by out-of-pocket payments (relative poverty line reflecting basic needs: food, housing, utilities - developed by WHO/Europe) (%, national) EN
ORAL_HEALTH_CANCER_LIPORALCAVITY_NEWCASE_NUMBER Number of new cases of lip and oral cavity cancer EN
FOODBORNE_YLD_LT5 Foodborne years lived with disability, aged less than 5 years EN
FOODBORNE_YLD_TOTAL Foodborne years lived with disability, all ages EN
NUTRITION_ANAEMIA_NONPREGNANT_PREV Prevalence of anaemia in non-pregnant women (aged 15-49) (%) EN
NCD_CHOL_MEANHDL_A Mean HDL cholesterol, age-standardized EN
STI_SYPHILIS_INCIDENTCASES Incident cases of syphilis in individuals (in millions) EN
PRISON_F1_INJECTDRUGUSERS_TOT In-prison people who inject/have injected drugs (number of prisoners, over the last 12 months) EN
Adult_nonsmoked_age_grp Age range of latest adult prevalence survey (nonsmoked) EN
ORALHEALTH_UHC_PREVENTIVE Oral health interventions as part of health benefit packages: Routine and preventive oral health care EN
ORALHEALTH_AVAILABILITY_URGENTCARE Oral health: Urgent treatment for providing emergency oral care and pain relief EN
TAXBEV_EXCISE_AUTOADJUST Automatic adjustment of specific excise on beverage EN
LBW_NUMBER Low birth weight number (in thousands) EN
NCD_CCS_PA_POL_PUBLIC Existence of policy promoting physical activity: public open spaces EN
ASSISTIVETECH_SATISFACTIONSERVICES Satisfaction with assistive products and related services (%) EN
ASSISTIVETECH_BARRIERAT Barriers to accessing assistive products (%) EN
NCD_HYP_CONTROL_C Prevalence of controlled hypertension among adults aged 30-79 years with hypertension, crude EN
M1_adult_recent Most recent survey among adults was recent (in the past 5 years) EN
NUT_CF_MDD Minimum dietary diversity 6-23 months EN
PRISON_D3_DEATHS_SUICIDE_MRATE In-prison suicide mortality rate (per 100 000 incarcerated persons per year) EN
SDGIPVLT Proportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in their lifetime EN
NUTRITION_ANAEMIA_REPRODUCTIVEAGE_PREV Prevalence of anaemia in women of reproductive age (aged 15-49) (%) EN
STI_TRICHOMONIASIS_PREVALENTCASES Prevalent cases of trichomoniasis in individuals (in millions) EN
NCD_CCS_OVWT_SVY Has conducted a recent, national adult risk factor survey covering overweight and obesity EN
FOODBORNE_YLL_LT5 Foodborne years of life lost, aged less than 5 years EN
FOODBORNE_YLD_CASE_LT5 Foodborne years lived with disability per case, aged less than 5 years EN
HAZARD_YLL_LT5 Years of life lost caused by hazards, aged less than 5 years EN
TAXBEV_MOSTSOLDSPIRIT Most sold type of spirit EN
E_compl_e3 Compliance with ban on advertising in local magazines and newspapers (score) EN
Youth_svy_age_range Age range of most recent adolescent survey EN
NCD_CHOL_MEANHDL_C Mean HDL cholesterol, crude EN
DEVICES25 National Health Technology Assessment (HTA) unit including the assessment of medical devices, and diagnostics EN
FINPROTECTION_IMP_NP_REL_LEVEL_MILLION Total population pushed below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (millions, regional, global) EN
FINPROTECTION_IMP_PREL_LEVEL_MILLION Total population pushed further below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (millions, regional, global) EN
NCD_HYP_CONTROL_A Prevalence of controlled hypertension among adults aged 30-79 years with hypertension, age-standardized EN
NTD_BU_END Status of endemicity of buruli ulcer EN
P_compl_p6 Compliance with smoke-free restaurants law (score) EN
TB_cc_prct_Q3 Percentage of TB-affected households facing costs >20% of household income or expenditure due to TB among Q3 income or expenditure quantile. EN
AMR_INFECT_MRSA Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%) EN
TB_notif_num_labconf Number of people diagnosed with new episode of pulmonary TB who are bacteriologically confirmed. EN
ASSISTIVETECH_TRAVELDISTANCEAT Travel distance to obtain assistive products (%) EN
FOODBORNE_YLD_CASE_TOTAL Foodborne years lived with disability per case, all ages EN
Yth_curr_smokeless Prevalence of current smokeless tobacco use among adolescents (%) EN
STI_GONORRHOEA_INCIDENTCASES Incident cases of gonorrhoea in individuals (in millions) EN
NCD_CCS_OBES_TARGET Existence of a national target on obesity EN
GHE_DALY_NUMERIC Disability-adjusted life years (DALYs) EN
RADON_Q707 Inclusion of radon education for building professionals EN
STI_GONORRHOEA_PREVALENTCASES Prevalent cases of gonorrhoea in individuals (in millions) EN
RADON_Q605 Authorization/accreditation required for official radon measurement providers EN
PRISON_F1_TOBACCO_TOT In-prison people who currently use tobacco (number of prisoners) EN
ASSISTIVETECH_Q10 Existence of initiatives/collaborations on assistive technology EN
TB_cc_prct_DSTB Percentage of TB-affected households facing costs >20% of household income or expenditure due to DS-TB. EN
Adult_curr_cig_smoking Prevalence of current cigarette smoking among adults (%) EN
TB_notif_num_agesex Number of people diagnosed with new episode TB who by age group and sex. EN
Camp_media_monitor Process evaluation was employed to assess implementation of the campaign EN
NCD_CCS_HearingPlan Existence of operational policy/strategy/action plan for hearing health EN
PRISON_B14_ERRORS In-prison standardized process for medication errors EN
HIV_0000000027 Reported number of tests performed where results were received by a person (testing volume) EN
GHE_DEATHS_NUMERIC GHE Deaths EN
NCD_CCS_CVD_GUIDE Existence of evidence-based national guidelines/protocols/standards for the management of cardiovascular diseases EN
R_Sp_excise Taxes as a % of price - specific excise EN
M_Est_cig_daily_std Estimate of daily cigarette smoking prevalence (%) (age-standardized rate) EN
NCD_HYP_TREATMENT_A Prevalence of treatment (taking medicine) for hypertension among adults aged 30-79 with hypertension, age-standardized EN
FOODBORNE_YLL_100K_GE5 Foodborne years of life lost per 100,000, aged 5 years and above EN
vzdpt One-year-old children who have not received any doses of the DTP vaccine (%) EN
E_compl_e12 Compliance with ban on indentifying non-tobacco products with tobacco brand names (score) EN
NCD_CCS_diab_retin General availability of diabetic retinopathy screening in the public health system EN
NUTRITION_ANAEMIA_REPRODUCTIVEAGE_NUM Number of women of reproductive age (aged 15-49 years) with anaemia (thousands) EN
R_admin_covert_marking Tax administration - Marking is covert EN
M_Est_cig_curr_std Estimate of current cigarette smoking prevalence (%) (age-standardized rate) EN
FINPROTECTION_IMP_PG_215_STD Increase in poverty gap due to household health expenditures, expressed as a proportion of the $2.15 a-day poverty line (%, national, rural, urban) EN
TAXBEV_ALCOHOLSALESTATUS Status of alcohol sale EN
ORALHEALTH_UHC_GOVSCHEME Oral health interventions as part of health benefit packages: Coverage of the largest government health financing scheme (%) EN
NCD_CCS_PA_GUIDELINES_UNDER5 Existence of national guidelines for physical activity for children under 5 EN
TB_ps_prev_bc_100k Prevalence of bacteriologically-confirmed pulmonary TB among those aged ≥15 years, per 100,000 population EN
MALARIA_ACT_TREATED Number of malaria cases treated with artemisinin-based combination therapies (ACTs) EN
NUT_BF_EBF2D Exclusively breastfed for the first two days after birth EN
Adult_curr_tob_use Prevalence of current tobacco use among adults (%) EN
FOODBORNE_YLD_GE5 Foodborne years lived with disability, aged 5 years and above EN
PRISON_F1_ALCOHOL_TOT In-prison people who drink/drank alcohol (number of prisoners, in the last 12 months) EN
PRISON_F1_BMI30_TOT In-prison people who have BMI >= 30 (number of prisoners who are obese) EN
PRISON_D4_CANCER_DIAG_TOT In-prison cancer diagnosis (number of diagnoses) EN
TB_ps_prev_bc_100k_bysex_sp Prevalence of bacteriologically-confirmed pulmonary TB who are smear positive among those aged ≥15 years, per 100,000 population by sex. EN
TAXBEV_EXCISE_UNIFORMTIERED_NONALCOHOLIC Uniform or tiered excise tax system applied on non-alcoholic beverage EN
FOODBORNE_ILL_LT5 Foodborne illnesses, aged less than 5 years EN
R_type_variant Most sold brand of other tobacco type EN
ORALHEALTH_UHC_ESSENTIAL_CURATIVE Oral health interventions as part of health benefit packages: Essential curative oral health care EN
P_comprehensive_subnat Subnational smoking bans - at least one jurisdiction has a comprehensive ban in place EN
FOODBORNE_DALY_CASE_TOTAL Foodborne disability-adjusted life years per case, all ages EN
NCD_CCS_TOB_MGMT_GUIDE Existence of evidence-based national guidelines/protocols/standards for the management of tobacco dependence EN
TAXBEV_ALCOHOLBASEDTIERED If tiered on the beverage, the tiers are alcohol-based EN
HAZARD_DALY_GE5 Disability-adjusted life years caused by hazards, aged 5 years and above EN
AMRGLASS_SURVL04 Number of surveillance sites reporting to GLASS: In- and outpatient facilities EN
P_compl_p7 Compliance with smoke-free pubs and bars law (score) EN
M5_youth_representative Most recent school-based survey among adolescents was representative of the national population EN
LBW_PREVALENCE Low birth weight prevalence (%) EN
ASSISTIVETECH_TOTALNEED Prevalence of need of assistive products (%) EN
HAZARD_YLL_GE5 Years of life lost caused by hazards, aged 5 years and above EN
NCD_CCS_PA_TARGET Existence of a national target on physical inactivity EN
FINPROTECTION_IMP_NP_215_LEVEL_SH Total population pushed below the \(2.15 a day poverty line by household health expenditures (%, regional, global) |EN | |ORALHEALTH_UHC_REHABILITATION |Oral health interventions as part of health benefit packages: Rehabilitatative oral health care |EN | |FOODBORNE_DTH_100K_GE5 |Foodborne deaths per 100,000, aged 5 years and above |EN | |R_Price_lowest_cost_usd |Cheapest brand of cigarettes - price in US\) at official exchange rates EN
PRISON_B9_1_PHYCHIATRISTS_RATIO Psychiatrists in prisons (FTEs per 1000 prisoners) EN
NCD_CHOL_MEANNONHDL_C Mean Non-HDL cholesterol, crude EN
Yth_daily_cig_smoking Prevalence of daily cigarette smoking among adolescents (%) EN
ASSISTIVETECH_Q04 Existence of responsible ministry/authority on assistive technology EN
GASPRSCRO Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP EN
Yth_nonsmoked_national Representation of latest youth prevalence survey (nonsmoked) EN
NUTRITION_ANAEMIA_PREGNANT_NUM Number of pregnant women (aged 15-49 years) with anaemia (thousands) EN
SDGODAWS Amount of water- and sanitation-related official development assistance that is part of a government-coordinated spending plan (current US$ millions) EN
P_compl_p2 Compliance with smoke-free education facilities except universities law (score) EN
ORALHEALTH_PRODLOSS_ORALDISEASES Total productivity losses due to 5 oral diseases in million (US$) EN
FINPROTECTION_IMP_P190_LEVEL_SH Total population pushed further below the $1.90 a day poverty line by household health expenditures (%, regional, global) EN
Adult_survey_title Title of most recent survey of adults EN
RADON_Q305 Existence of national radon map EN
PRISON_A2_PRISIONERS_N Number of prisoners EN
PRISON_B11_VACPREV_DTP In-prison vaccination for DTP EN
MALARIA_1STLINE_TREATED Number of malaria cases treated with any first  line tx courses (including artemisinin-based combination therapies (ACTs)) EN
RADON_Q503_1 Reference level for workplaces (Bq/m3) EN
HEMOGLOBINLEVEL_REPRODUCTIVEAGE_MEAN Mean hemoglobin level of women of reproductive age (aged 15-49 years) EN
HAZARD_DTH_LT5 Deaths caused by hazards, aged less than 5 years EN
TAXBEV_ADVALOREMBASE Base for ad valorem excise tax on beverage EN
P_compl_p8 Compliance with smoke-free public transport law (score) EN
NCD_CHOL_MEANTOTALCHOL_A Mean total cholesterol, age-standardized EN
CM_04 Number of deaths among children ages 5 to 9 years EN
ORALHEALTH_AFFORDABILITY_FLUORIDETOOTHPASTE Affordability of fluoride toothpaste EN
AIR_73 Ambient air pollution attributable YLL in children under 15 years EN
FINPROTECTION_IMP_NPRELPL_POP Population pushed below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (%, national, rural, urban) EN
PRISON_B11_VACPREV_MMR In-prison vaccination for MMR EN
HAZARD_ILL_TOTAL Illnesses caused by hazards, all ages EN
FOODBORNE_ILL_100K_LT5 Foodborne illnesses per 100,000, aged less than 5 years EN
FINPROTECTION_IMP_P310_LEVEL_SH Total population pushed further below the $3.20 a day poverty line by household health expenditures (%, regional, global) EN
TB_ps_prev_bc_100k_byagegroup Prevalence of bacteriologically-confirmed pulmonary TB among those aged ≥15 years, per 100,000 population by age group EN
GASPRSCIP Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP EN
SRH_ABORTION_RATE Abortion rate (model-estimated) EN
Adult_nonsmoked_svy_title Name of latest adult prevalence survey (nonsmoked) EN
NCD_CCS_PA_TAX Existence of tax incentives to promote physical activity EN
vfull Full immunization coverage among one-year-olds (%) EN
FINPROTECTION_IMP_P215_POP Population pushed further below the $2.15 a day poverty line by household health expenditures (%, national, rural, urban) EN
PHE_HHAIR_PROP_POP_POLLUTING_FUELS Proportion of population with primary reliance on polluting fuels and technologies for cooking (%) EN
ORALHEALTH_NOMA Oral health: Noma recognized as a national public health problem EN
R_admin_tax_stamps_cig Tax stamps, fiscal marks, banderole or other types of marking are applied on cigarettes EN
CHILDVIOL Indicator 16.2.1: Proportion of children aged 1-17 years who experienced any physical punishment and/or psychological aggression by caregivers in the past month EN
NUT_CF_MAD Minimum Acceptable Diet 6-23 months EN
FOODBORNE_YLL_TOTAL Foodborne years of life lost, all ages EN
NCD_CCS_path_lab General availability of pathology services (laboratories) in the public sector EN
PRISON_B11_VACPREV_HEPA In-prison vaccination for Hepatitis A EN
FINPROTECTION_IMP_PG_365_STD Increase in poverty gap due to household health expenditures, expressed as a proportion of the $3.65 a-day poverty line (%, national, rural, urban) EN
ASSISTIVETECH_Q01 Existence of legislation on access to assistive technology EN
HAZARD_DALY_LT5 Disability-adjusted life years caused by hazards, aged less than 5 years EN
TAXBEV_EXCISE_APPLIED_YN Excise taxes are applied on beverages EN
GASPRSAZM Proportion of isolates with resistance to azithromycin reported to WHO-GASP EN
Yth_daily_e-cig Prevalence of daily e-cigarette use among adolescents (%) EN
ORALHEALTH_NCD_STAFF Presence of dedicated staff for oral health working on NCDs at the MoH EN
AIR_72 Ambient air pollution attributable deaths in children under 15 years EN
FINPROTECTION_IMP_NP_365_LEVEL_MILLION Total population pushed below the $3.65 a day poverty line by household health expenditures (millions, regional, global) EN
FOODBORNE_ILL_GE5 Foodborne illnesses, aged 5 years and above EN
FINPROTECTION_IMP_P_365_LEVEL_SH Total population pushed further below the $3.65 a day poverty line by household health expenditures (%, regional, global) EN
FINPROTECTION_IMP_PG_RELPL_STD Increase in poverty gap due to household health expenditures, expressed as a proportion of a relative poverty line - 60% of median daily per capita consumption or income (%, national, rural, urban) EN
PHE_HHAIR_POP_CLEAN_FUELS Population with primary reliance on clean fuels and technologies for cooking (in millions) EN
NCD_CCS_dilated_fundus General availability of dilated fundus examination at the primary health care level EN
STI_TRICHOMONIASIS_PREVALENCE_PER100 Prevalence of trichomoniasis in individuals (%) EN
Yth_curr_tob_smoking Prevalence of current tobacco smoking among adolescents (%) EN
PRISON_B11_VACPREV_HPV In-prison vaccination for HPV EN
Adult_curr_tob_smoking Prevalence of current tobacco smoking among adults (%) EN
MALARIA_MICR_POS Number of malaria positive cases by microscopy EN
ORALHEALTH_FLUORIDETOOTHPHASTE_LABOURDAYS Number of labour days needed to buy annual supply of fluoride toothpaste per person EN
NCD_CCS_TransFat Existence of national policies on trans-fatty acid elimination EN
PRISON_D3_DEATHS_COVID_MRATE In-prison COVID-19 mortality rate (per 100 000 incarcerated persons per year) EN
NCD_CCS_TOB_TARGET Existence of a national target on tobacco EN
FINPROTECTION_IMP_BNLFHU_TOT_HH Households pushed below or further below a relative poverty line (reflecting basic needs: food, housing, utilities - developed by WHO/Europe) by out-of-pocket payments (%, national) EN
TAXBEV_SUGARCONTENT Sugar-content of beverage per 100ml EN
R_admin_tax_stamps_other Tax stamps, fiscal marks, banderole or other types of marking are applied on other tobacco products EN
MALARIA_EST_MORTALITY Estimated malaria mortality rate (per 100 000 population) EN
Yth_curr_tob_use Prevalence of current tobacco use among adolescents (%) EN
R_admin_identifier_track_and_trace Tax administration - Marking/unique identifier contains data for track and tracing purposes EN
NCD_CCS_SALT_TARGET Existence of a national target on salt EN
NUTRITION_WH_2_NUM Wasting among children under 5 years of age (weight-for-height <-2 SD), number (in thousands), survey-based estimates EN
AMRGLASS_SURVL05 Total number of surveillance sites reporting to GLASS EN
STI_CHLAMYDIA_PREVALENCE_PER100 Prevalence of chlamydia in individuals (%) EN
NCD_CCS_PA_MGMT_GUIDE Existence of evidence-based national guidelines/protocols/standards for the management of physical inactivity EN
NCD_HYP_TREATMENT_C Prevalence of treatment (taking medicine) for hypertension among adults aged 30-79 with hypertension, crude EN
ASSISTIVETECH_Q02 Coverage of people in need of assistive technology by legislation EN
CHILDMORT10TO19 Adolescent mortality rate (per 1 000 age specific cohort) EN
NCD_HYP_DIAGNOSIS_C Prevalence of previous diagnosis of hypertension among adults aged 30-79 with hypertension, crude EN
E_compl_e13 Compliance with ban on appearance of tobacco brands in TV and/or films (score) EN
O_Cytisine_ins Cytisine - cost covered EN
FOODBORNE_DTH_LT5 Foodborne deaths, aged less than 5 years EN
PRISON_B9_1_DENTISTS_RATIO Dentists in prisons (FTEs per 1000 prisoners) EN
HWF_0026 Nursing personnel (%) EN
NCD_CCS_PA_POL_AGEING Existence of policy promoting physical activity: active ageing EN
E_comprehensive_subnat Subnational bans on advertising, promotion and sponsorship - at least one jurisdiction has a comprehensive ban in place EN
PRISON_C8_CONDOMS In-prison condoms free of charge EN
E17c_csr_promo_others Ban on entities other than tobacco companies/the tobacco industry publicizing the CSR activities of the tobacco companies/industry EN
NTD_YAWSNUM_SUSP Number of suspected yaws cases reported EN
NCD_CCS_DIAB_TARGET Existence of a national target on diabetes EN
FOODBORNE_YLL_CASE_GE5 Foodborne years of life lost per case, aged 5 years and above EN
M4_youth_recent Most recent school-based survey among adolescents was recent (in the past 5 years) EN
M3_adult_periodic Survey previous to the most recent survey among adults was within the 5 years prior EN
FOODBORNE_YLD_100K_TOTAL Foodborne years lived with disability per 100,000, all ages EN
NCD_CCS_DIET_AWARE Implementation of a nutrition public awareness program EN
TB_rdst_num_prct The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage. EN
GASPTICIP Number of isolates tested for ciprofloxacin EN
ORALHEALTH_UNTREATEDCARIESDECIDUOUS Prevalence of untreated caries of deciduous teeth in children 1-9 years (%) EN
FOODBORNE_YLD_100K_LT5 Foodborne years lived with disability per 100,000, aged less than 5 years EN
E_compl_e15 Compliance with ban on sponsorship (contributions and/or publicity of contributions) (score) EN
STI_TRICHOMONIASIS_INCIDENTCASES Incident cases of trichomoniasis in individuals (in millions) EN
E_compl_e1 Compliance with ban on advertising on national television and radio (score) EN
ICD11_IMPL_LVL ICD-11 implementation progress level EN
PRISON_B11_VACPREV_HEPB In-prison vaccination for Hepatitis B EN
FOODBORNE_DALY_CASE_LT5 Foodborne disability-adjusted life years per case, aged less than 5 years EN
GASPTIESC Number of isolates tested for extended-spectrum cephalosporins EN
TB_cc_prct_Q2 Percentage of TB-affected households facing costs >20% of household income or expenditure due to TB among Q2 income or expenditure quantile. EN
NCD_CCS_SALT_SVY Has conducted a recent, national adult risk factor survey covering salt/sodium intake EN
MALARIA_TOTAL_CASES Total number of  malaria cases (presumed + confirmed cases) EN
NCD_CCS_PA_GUIDELINES Existence of national guidelines for physical activity EN
E6a_pt_of_sale Ban on advertising at point of sale EN
NCD_CCS_SatTransFat Existence of national policies on saturated fatty acids / trans-fats EN
NCD_CCS_alteplase General availability of alteplase for acute stroke management in the public health system EN
NCD_CCS_TEL_AML_COMBO General availability of Fixed dose combination avail (telmisartan + amlodipine) in the public health sector EN
TAXBEV_IMPORTDUTIES Import duties on beverages (%) EN
R_afford_cat Affordability – category of change 2010-2020 (Yes (less affordable), No (more affordable), No change). EN
Yth_nonsmoked_age_grp Age range of latest youth prevalence survey (nonsmoked) EN
bmi30wm Obesity prevalence in non-pregnant women aged 15-49 years, BMI >= 30 (%) EN
R_contains_nicotine Cheapest brand of e-liquid of contains nicotine or not EN
AIR_75 Household air pollution attributable DALYs in children under 15 years EN
MALARIA_PRES_CASES Number of presumed malaria cases EN
FINPROTECTION_IMP_NP_REL_LEVEL_SH Total population pushed below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (%, regional, global) EN
GLASSAMC_TC Total consumption of antibacterials expressed as DDD per 1000 inhabitants per day EN
Youth_survey_title Title of most recent adolescent survey EN
NCD_CCS_OBES_MGMT_GUIDE Existence of evidence-based national guidelines/protocols/standards for the management of overweight/obesity EN
PRISON_A1_CAPACITY Official prison capacity (count) EN
PRISON_D4_HEPC_DIAG_TOT In-prison Hepatitis C diagnosis (number of diagnoses) EN
R_afford_inflation_adjusted_price_lcu Price in local currency adjusted by year on year changes in average consumer prices in each country EN
CHILDMORT_MORTALITY_10TO14 Mortality rate among children ages 10 to 14 years (per 1000 children aged 10) EN
NCD_CCS_ComboInhaler General availability of combination budesonide formoterol inhaler in the public health sector EN
ASSISTIVETECH_PAYERSAT Funding for assistive products (%) EN
ORAL_HEALTH_CANCER_LIPORALCAVITY_100K Incidence rate of lip and oral cavity cancer (per 100 000 population) EN
Yth_curr_e-cig Prevalence of current e-cigarette use among adolescents (%) EN
Adult_nonsmoked_svy_yr Year of latest adult prevalence survey (nonsmoked) EN
FINPROTECTION_IMP_NP_215_LEVEL_MILLION Total population pushed below the \(2.15 a day poverty line by household health expenditures (millions, regional, global) |EN | |R_admin_duty_free_banned |Ban on sale of duty-free or excise-free cigarettes |EN | |P_compl_all_sfe |Overall compliance with regulations on smoke-free environments (score) |EN | |ORALHEALTH_DENTALHEALTHCARE_EXP_TOTAL |Total expenditure on dental healthcare in million (US\)) EN
R_min_price_policy A minimum price policy is implemented EN
HAZARD_YLL_TOTAL Years of life lost caused by hazards, all ages EN
PRISON_D4_SUD_DIAG_TOT In-prison active drug use diagnosis (number of diagnoses) EN
FOODBORNE_DALY_100k_TOTAL Foodborne disability-adjusted life years per 100,000, all ages EN
NUT_BF_EBF_NUMTH Exclusive breastfeeding under six months (in thousands) EN
NCD_CCS_radio General availability of radiotherapy in the public sector EN
M_Est_smk_daily_std Estimate of daily tobacco smoking prevalence (%) (age-standardized rate) EN
R_Total_tax Taxes as a % of price - total tax EN
HWF_0025 Medical doctors (%) EN
NLIS_NU_CA_003 NLIS: Early initiation of breastfeeding within 1 hour of birth (%) EN
GHE_YLL_NUMERIC Years of life lost from mortality (YLLs) EN
NLIS_NU_CA_115 NLIS: Continued breastfeeding at 2 years in infants 20-23 months (%) EN
PRISON_C8_NEEDLES In-prison needles free of charge EN
NUT_CF_EFF Egg and/or Flesh Food Consumption 6-23 months EN
NCD_CCS_DIET_SVY Has conducted a recent, national adult risk factor survey covering unhealthy diet EN
ORALHEALTH_AVAILABILITY_RESTORATIVE Oral health: Basic restorative dental procedures to treat existing dental decay EN
fpsmowho Demand for family planning satisfied - use of modern methods (%) EN
PRETERMBIRTH_NUMBER Preterm birth (number) EN
ORALHEALTH_DENOMINATOR_TTLPOP Total population in thousands (oral health) EN
STI_TRICHOMONIASIS_INCIDENCE_PER1000 Incident cases of trichomoniasis in individuals (per 1000) EN
FINPROTECTION_IMP_NP_365_LEVEL_SH Total population pushed below the \(3.65 a day poverty line by household health expenditures (%, regional, global) |EN | |IHRSPAR_CAPACITY04 |Food Safety (SPAR) |EN | |vmsl |Measles immunization coverage among one-year-olds (%) |EN | |NCD_CCS_BP_TARGET |Existence of a national target on blood pressure / hypertension |EN | |O_mCessation |Provision of a mobile cessation service |EN | |HIV_0000000029 |Reported number of tests performed where results were received by a person (testing volume), reporting period |EN | |TB_notif_num_newrel_clindx |Number of people diagnosed with new episode of pulmonary TB who are clinically diagnosed. |EN | |FOODBORNE_DTH_TOTAL |Foodborne deaths, all ages |EN | |ASSISTIVETECH_USEPREVALENCE |Prevalence of use of assistive products (%) |EN | |FOODBORNE_DALY_100k_GE5 |Foodborne disability-adjusted life years per 100,000, aged 5 years and above |EN | |Adult_svy_age_range |Age range of most recent survey of adults |EN | |NUTRITION_ANAEMIA_NONPREGNANT_NUM |Number of non-pregnant women (aged 15-49 years) with anaemia (thousands) |EN | |FINPROTECTION_IMP_PREL_LEVEL_SH |Total population pushed further below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (%, regional, global) |EN | |SE_PRM_PRSL_ZS |Persistence to last grade of primary (% of cohort) |EN | |ORALHEALTH_SEVEREPERIODONTALDISEASE |Prevalence of severe periodontal disease in people 15+ year (%) |EN | |ASSISTIVETECH_Q03 |Availability of public funding for assistive technology |EN | |NUT_BF_EBF |Exclusive breastfeeding under six months |EN | |TAXBEV_SUGARBASEDTIERED |If tiered on the beverage, the tiers are sugar-content-based |EN | |Adult_svy_yr |Year of most recent survey of adults |EN | |M6_youth_periodic |Survey previous to the most recent school-based survey among adolescents was within the 5 years prior |EN | |PRISON_B11_VACPREV_FLU |In-prison vaccination for seasonal flu |EN | |Youth_svy_national |Representativeness of most recent adolescent survey |EN | |TB_drs_rr_prct |Prevalence of rifampicin resistance among pulmonary TB cases. |EN | |PRISON_F1_EXERCISE_TOT |In-prison people who regularly exercise for a minimum of 150 minutes/week (number of prisoners) |EN | |PRISON_D4_STI_DIAG_TOT |In-prison STIs diagnosis (number of diagnoses) |EN | |PRISON_D3_DEATHS_DRUG_MRATE |In-prison drug overdose mortality rate (per 100 000 incarcerated persons per year) |EN | |AIR_74 |Household air pollution attributable deaths in children under 15 years |EN | |GASPTICFM |Number of isolates tested for cefixime |EN | |P_compl_p3 |Compliance with smoke-free universities law (score) |EN | |E21a_direct_ad_fines |Law requires fines for violations of advertising bans |EN | |NCD_CCS_urine_strips_gluc_ketone |General availability of urine strips for glucose and ketone measurement at the primary health care level |EN | |E21b_indirect_ad_fines |Law requires fines for violations of promotion and sponsorship bans |EN | |FOODBORNE_YLD_100K_GE5 |Foodborne years lived with disability per 100,000, aged 5 years and above |EN | |FOODBORNE_YLL_CASE_TOTAL |Foodborne years of life lost per case, all ages |EN | |TB_sb |Standards and benchmarks for TB and vital registration system surveillance |EN | |PRISON_B15_REPDRUGEVENTS |In-prison standardized process for adverse drug events |EN | |M_Est_tob_curr_std |Estimate of current tobacco use prevalence (%) (age-standardized rate) |EN | |ORALHEALTH_AVAILABILITY_SCREENING |Oral health screening for early detection of oral diseases |EN | |CCH_SURVEY_VULNERABILITY_ADAPTATION_ASSESSMENT |Climate change and health vulnerability and adaptation assessment conducted |EN | |RADON_Q401_1 |Existence of national radon action plan - Years covered |EN | |ORALHEALTH_DENOMINATOR_CHEPPP |Per capita current health expenditure in PPP (oral health) |EN | |FINPROTECTION_CATA_CTPFHU_40_HH |Households with out-of-pocket payments greater than 40% of capacity to pay for health care (food, housing and utilities approach - developed by WHO/Europe) (%, national) |EN | |NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD |Prevalence of cervical cancer screening among women aged 30-49 years (%) |EN | |NCD_CCS_PA_GUIDELINES_ADULTS |Existence of national guidelines for physical activity for adults |EN | |NCD_CCS_DIAB_GUIDE |Existence of evidence-based national guidelines/protocols/standards for the management of diabetes |EN | |MALARIA_IRS_COVERAGE |Number of people protected from malaria by indoor residual spraying (IRS) |EN | |PRISON_D4_DIABETES_DIAG_TOT |In-prison diabetes mellitus diagnosis (number of diagnoses) |EN | |STI_SYPHILIS_PREVALENCE_PER100 |Prevalence of active syphilis in individuals (%) |EN | |FOODBORNE_DTH_100K_TOTAL |Foodborne deaths per 100,000, all ages |EN | |TB_rdst_num |The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients. |EN | |SDGIHR2018 |Average of 13 International Health Regulations core capacity scores, SPAR version, 1st edition |EN | |vpolio |Polio immunization coverage among one-year-olds (%) |EN | |UHCTRANSFATS |Best-practice policy implemented for industrially produced trans-fatty acids (TFA) (Y/N) |EN | |PHE_HHAIR_PROP_POP_CATEGORY_FUELS |Proportion of population with primary reliance on fuels and technologies for cooking, by fuel type (%) |EN | |E_compl_e11 |Compliance with ban on use of brand name of non-tobacco product for tobacco product (score) |EN | |GOE_Q158 |Lack of demand by health professionals and patients |EN | |GOE_Q161 |Lack of national or international standards for interoperability of EHR |EN | |GOE_Q168 |To define medical jurisdiction, liability or reimbursement of eHealth services such as telehealth |EN | |GOE_Q169 |To address patient safety and quality of care based on data quality, data transmission standards, or clinical competency criteria |EN | |GOE_Q172 |Which governs the sharing of digital data between health professionals in other health services in the same country through the use of an EHR |EN | |GOE_Q182 |Policy or strategy makes specific reference tothe use of social media in the health domain |EN | |GOE_Q196 |Country has national policy or strategy regulating the use of big data in the health sector |EN | |GOE_Q197 |Country has national policy or strategy regulating the use of big data by private companies |EN | |GOE_Q200 |Capacity building required for new skills |EN | |HIV_0000000001 |Estimated number of people (all ages) living with HIV |EN | |HIV_0000000026 |Number of new HIV infections |EN | |HRH_06 |Number of community health workers |EN | |HRH_07 |Number of traditional birth attendants |EN | |HRH_25 |Pharmaceutical personnel density (per 1000 population) |EN | |HRH_43 |Number of licensed qualified anaesthesiologists actively working |EN | |HRH_45 |Biomedical technicians density (per 10 000 population) |EN | |HSS_MONITORPROGRESS |Countries that have monitored the progress of their national health policy/strategy/plan regularly |EN | |HSS_UHCLEGISLATION |Countries that have passed legislation on Universal Health Coverage (UHC) |EN | |HWF_0003 |Generalist medical practitioners (number) |EN | |HWF_0005 |Medical doctors not further defined (number) |EN | |HWF_0009 |Midwifery personnel (number) |EN | |HWF_0011 |Dentists (number) |EN | |HWF_0012 |Dental Assistants and Therapists (number) |EN | |HWF_0017 |Environmental and Occupational Health and Hygiene Professionals (number) |EN | |IHR03 |Surveillance |EN | |IHR07 |Human resources |EN | |IHR09 |Points of entry |EN | |IHR12 |Chemical |EN | |IR_ORGANOCHLORINE_PRESENCE |Organochlorine resistance reported for at least one site |EN | |itnch |Children aged < 5 years sleeping under insecticide-treated nets (%) |EN | |itnwm |Pregnant women sleeping under insecticide-treated nets (%) |EN | |LEAD_1 |Percentage of the children under 15 years with blood lead levels above 5ug/dl |EN | |LEADCONTROL |Legally-binding controls on lead paint |EN | |LEPTO_MORTALITY |Estimated leptospirosis deaths (per 100 000 population) |EN | |LEPTO_YLD |Years of healthy life lost to disability (YLDs) due to leptospirosis |EN | |LEPTO_YLL |Years of life lost (YLLs) due to leptospirosis |EN | |LIFE_0000000030 |nqx - probability of dying between ages x and x+n |EN | |LIFE_0000000031 |lx - number of people left alive at age x |EN | |LIFE_0000000033 |nLx - person-years lived between ages x and x+n |EN | |M_def_1_prev_adult |Adult indicator 1 rate |EN | |M_Est_cig_curr |Estimate of current cigarette smoking prevalence (%) |EN | |M_Est_cig_daily_crude |Daily cigarette smoking, crude adjusted |EN | |M_Est_tob_curr_crude |Current tobacco smoking, crude adjusted |EN | |M_smkless_svy_national_adult |Representativeness of survey of adults - smokeless |EN | |M_smkless_svy_yr_youth |Year of survey of youth - smokeless |EN | |M_svy_age_adult |Adult survey age range |EN | |NCD_CCS_CRD_GUIDE |Existence of evidence-based national guidelines/protocols/standards for the management of chronic respiratory diseases |EN | |HCF_UNREL_ELECTRICITY |Percentage of health-care facilities with unreliable electricity supply (%) |EN | |IHRSPAR_CAPACITY01 |Legislation and Financing |EN | |Adult_nonsmoked_national |Representation of latest adult prevalence survey (nonsmoked) |EN | |R_Price_lowest_cost_ppp |Cheapest brand of cigarettes - price in PPP\) EN
NCD_CCS_PA_POL_WORK Existence of policy promoting physical activity: workplace initiatives EN
PRETERMBIRTH_RATE Preterm birth rate (per 100 live births) EN
NUT_BF_EVBF Ever breastfed EN
P_compl_p1 Compliance with smoke-free health-care facilities law (score) EN
RADON_Q503 Existence of national reference level for workplaces EN
HAZARD_DTH_GE5 Deaths caused by hazards, aged 5 years and above EN
NCD_CCS_ESS_MEDS_TECH_TARGET Existence of a national target on essential medicines and technologies EN
R_Price_mp_estimate_ppp Most sold brand of cigarettes - price in PPP$ EN
P_compl_p4 Compliance with smoke-free government facilities law (score) EN
W21_emissions_quant_A Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark EN
HAZARD_DTH_TOTAL Deaths caused by hazards, all ages EN
IHRSPAR_CAPACITY10 Risk Communication (SPAR) EN
SDGIPV Proportion of ever-partnered women and girls aged 15-49 years subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months EN
PRISON_F1_BMI25_TOT In-prison people who have BMI >= 25 (number of prisoners who are overweight) EN
E_compl_e_all_indir Overall compliance with bans on promotion and sponsorship (score) EN
NCD_CCS_DRUG_THERAPY_TARGET Existence of a national target on drug therapy and counselling EN
NUT_CF_MMF Minimum Meal Frequency 6-23 months EN
IHRSPAR_CAPACITY11 Points of Entry (SPAR) EN
FOODBORNE_DALY_GE5 Foodborne disability-adjusted life years, aged 5 years and above EN
TB_ps_prev_bc_100k_byagegroup_sp Prevalence of bacteriologically-confirmed pulmonary TB who are smear positive among those aged ≥15 years, per 100,000 population by age group EN
E_compl_all_dir Overall compliance with bans on direct advertising (score) EN
Adult_svy_national Representativeness of most recent survey of adults EN
FINPROTECTION_IMP_NP215_POP Population pushed below the \(2.15 a day poverty line by household health expenditures (%, national, rural, urban) |EN | |GASPRP |Reporting countries |EN | |HAZARD_YLD_TOTAL |Years lived with disability caused by hazards, all ages |EN | |NUT_CF_ISSSF |Introduction of solid, semi-solid or soft foods 6-8 months |EN | |STI_CHLAMYDIA_INCIDENTCASES |Incident cases of chlamydia in individuals (in millions) |EN | |MALARIA_SUSPECTS |Number of suspected malaria cases |EN | |NCD_HYP_PREVALENCE_A |Prevalence of hypertension among adults aged 30-79 years, age-standardized |EN | |O_Cytisine_where |Cytisine - place available |EN | |SDGIPV12M |Proportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months |EN | |MALARIA_INDIG_STATUS |Status of indigenous malaria cases |EN | |R_VAT |Taxes as a % of price - value added tax |EN | |MALARIA_PV_INDIG |Number of indigenous P. vivax malaria cases |EN | |NCD_CCS_PA_GUIDELINES_5to19 |Existence of national guidelines for physical activity for children and adolescents aged 5-19 |EN | |HAZARD_YLD_LT5 |Years lived with disability caused by hazards, aged less than 5 years |EN | |FOODBORNE_ILL_100K_GE5 |Foodborne illnesses per 100,000, aged 5 years and above |EN | |M_Est_smk_curr |Estimate of current tobacco smoking prevalence (%) |EN | |GASPRSCFM |Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP |EN | |NCD_CHOL_MEANTOTALCHOL_C |Mean total cholesterol, crude |EN | |STI_SYPHILIS_PREVALENTCASES |Prevalent cases of active syphilis (in millions) |EN | |E17a_csr_ban |Ban on Corporate Social Responsibility activities (CSR) |EN | |SA_0000001837 |Alcohol poisoning deaths, per 100,000 population |EN | |SRH_PREGNANCY_UNINTENDED_RATE |Unintended pregnancy rate (model-estimated) |EN | |SA_0000001838 |Alcohol-related cardiomyopathy deaths (% of all cardiomyopathy deaths) |EN | |HAZARD_DALY_TOTAL |Disability-adjusted life years caused by hazards, all ages |EN | |TB_ps_prev_bc_100k_bysex |Prevalence of bacteriologically-confirmed pulmonary TB among those aged ≥15 years, per 100,000 population by sex. |EN | |E_compl_e9 |Compliance with ban on free distribution in mail or through other means (score) |EN | |Yth_daily_tob_smoking |Prevalence of daily tobacco smoking among adolescents (%) |EN | |R_afford_inflation_adjusted_price_ppp |Prices in purchasing power parity adjusted by year on year changes in average consumer prices in the United States of America |EN | |FOODBORNE_ILL_100K_TOTAL |Foodborne illnesses per 100,000, all ages |EN | |PRISON_B20_CLINICALREP |In-prison clinical health records |EN | |NLIS_NU_CA_049 |NLIS: Children with diarrhoea receiving zinc and ORS (%) |EN | |OHS_POLICYSTATUS |Existence of national policy instruments for occupational health and safety for health workers |EN | |NCD_CCS_PA_MASS_PART |Implementation of a recent mass participation event |EN | |TAXBEV_EXCISE_UNIFORMTIERED_ALCOHOLIC |Uniform or tiered excise tax system applied on alcoholic beverage |EN | |SRHINSTITUTIONALBIRTH |Institutional Births (birth taken place in a facility) (%) |EN | |PRISON_D4_COVID_TOT |In-prison COVID-19 diagnosis (number of diagnoses) |EN | |TB_cc_prct |Percentage of TB-affected households facing costs >20% of household income or expenditure due to TB. |EN | |Rev_other |Tobacco tax revenues - other |EN | |NCD_CCS_cancer_surgery |General availability of cancer surgery in the public sector |EN | |STI_SYPHILIS_INCIDENCE_PER1000 |Incident rate of active syphilis (per 1000) |EN | |GASPRSESC |Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP |EN | |NLIS_NU_CA_041 |NLIS: Children with diarrhoea <5 y receiving oral rehydration therapy (ORT) and continued feeding (%) |EN | |NCD_CCS_CANCER_DEPT |General availability of cancer centres or cancer departments at tertiary level in the public sector |EN | |Youth_svy_yr |Year of most recent adolescent survey |EN | |M_Est_smk_daily |Estimate of daily tobacco smoking prevalence (%) |EN | |IHRSPAR_CAPACITY09 |Health Service Provision |EN | |PRISON_A2_PRISIONERS_PER100KPOP |Number of prisoners (per 100 000 inhabitants) |EN | |HAZARD_ILL_GE5 |Illnesses caused by hazards, aged 5 years and above |EN | |NUTRITION_ANAEMIA_CHILDREN_NUM |Number of children aged 6-59 months with anaemia (thousands) |EN | |NCD_CCS_PA_POL_COMM_BASED |Existence of policy promoting physical activity: community-based and sports initiatives |EN | |E17b_csr_promo_self |Ban on tobacco companies/the tobacco industry publicizing their CSR activities |EN | |VACCINEPREVENTABLE_WILDPOLIO |Number of reported cases of poliomyelitis by wild poliovirus (WPV) |EN | |NUTRITION_ANAEMIA_CHILDREN_PREV |Prevalence of anaemia in children aged 6-59 months (%) |EN | |CCH_SURVEY_SURVEILLANCE_WHICH_METEOROLOGICAL |Existence of a health surveillance system which includes meteorological information |EN | |Yth_daily_tob_use |Prevalence of daily tobacco use among adolescents (%) |EN | |FOODBORNE_YLD_CASE_GE5 |Foodborne years lived with disability per case, aged 5 years and above |EN | |DEVICES24 |National authority responsible for regulating medical devices |EN | |R_afford_cat_2 |Affordability - category of change over past 2 years |EN | |NCD_CCS_LIS_AML_COMBO |General availability of Fixed dose combination avail (lisinopril + amlodipine) in the public health sector |EN | |NCD_CCS_DIAB_SVY |Has conducted a recent, national adult risk factor survey covering raised blood glucose/diabetes |EN | |PRISON_B3_DELIVHEALTHCARE |Agencies responsible for delivering prison healthcare |EN | |CCH_SURVEY_SURVEILLANCE_SYSTEM_EXISTS |Existence of an health surveillance system |EN | |CHILDMORT_DEATHS_10TO14 |Number of deaths among children ages 10 to 14 years |EN | |NCD_CCS_ALC_SVY |Has conducted a recent, national adult risk factor survey covering harmful alcohol use |EN | |MH_26 |Year the law was enacted (latest revision) |EN | |MALARIA_RDT_POS |Number of malaria positive cases by rapid diagnostic test (RDT) |EN | |WSH_DOMESTIC_WASTE_SAFELY_TREATED |SDG 6.3.1 Proportion of safely treated domestic wastewater flows (%) |EN | |ASSISTIVETECH_Q05 |Availability of government/registered services for assistive technology |EN | |R_Price_mp_estimate_usd |Most sold brand of cigarettes - price in US\) at official exchange rates EN
FINPROTECTION_IMP_P190_LEVEL_MILLION Total population pushed further below the $1.90 a day poverty line by household health expenditures (millions, regional, global) EN
NTD_YAWSNUM_CONF Number of confirmed yaws cases reported EN
FINPROTECTION_IMP_NP365_POP Population pushed below the $3.65 a day poverty line by household health expenditures (%, national, rural, urban) EN
FINPROTECTION_IMP_P190_POP Population pushed further below the $1.90 a day poverty line by household health expenditures (%, national, rural, urban) EN
FOODBORNE_YLL_GE5 Foodborne years of life lost, aged 5 years and above EN
PRISON_B9_STAFF_RATIO Healthcare staff in prisons (FTEs per 1000 prisoners) EN
PRISON_B9_1_PHYSICIANS_RATIO Physicians in prisons (FTEs per 1000 prisoners) EN
PHE_HHAIR_PROP_POP_CLEAN_FUELS Proportion of population with primary reliance on clean fuels and technologies for cooking (%) EN
NCD_CCS_LIS_HYDRO_COMBO General availability of Fixed dose combination avail (lisinopril + hydrochlorothiazide) in the public health sector EN
FOODBORNE_YLL_100K_LT5 Foodborne years of life lost per 100,000, aged less than 5 years EN
sevwast5 Severe wasting prevalence in children aged < 5 years (%) EN
MALARIA_IPTP3_COVERAGE Pregnant women attending antenatal care  at least once and receiving at least 3 doses of Intermittent Preventive Treatment of Malaria for Pregnant Women (IPTp3) (%) EN
ORALHEALTH_EDENTULISM_PREVALENCE Prevalence of edentulism in people 20+ years (%) EN
NCD_CCS_OvwtPlan Existence of operational policy/strategy/action plan to reduce overweight/obesity EN
R_Imp_duty Taxes as a % of price - import duties EN
R_tax_other Taxes as a % of price - other taxes EN
GLASSAMC_AWARE Pattern of antibiotic consumption at national level (relative consumption by AWaRe classification) EN
SA_0000001834 Percent of all DALYs attributable to alcohol EN
NCD_CHOL_MEANNONHDL_A Mean Non-HDL cholesterol, age-standardized EN
NCD_CCS_PRICE_SUBS Existence of price subsidies for healthy foods EN
NTD_LEPR13 New leprosy child case detection rate (less than 15 years of age) per 1 000 000 child population EN
PRISON_B13_ASSESSMENTS In-prison regular assessments of essential medicines EN
GASPTIAZM Number of isolates tested for azithromycin EN
TAXBEV_EXCISE_TYPE Type of excise tax applied on beverage EN
SA_0000001835 Alcohol-related road traffic deaths, per 100,000 population EN
Adult_daily_cig_smoking Prevalence of daily cigarette smoking among adults (%) EN
GASPTICRO Number of isolates tested for ceftriaxone EN
ASSISTIVETECH_Q09 Existence of regulations/standards/guidelines/protocols on assistive technology EN
Adult_daily_tob_use Prevalence of daily tobacco use among adults (%) EN
M_Est_smk_curr_std Estimate of current tobacco smoking prevalence (%) (age-standardized rate) EN
PRISON_A4_NEWPRISONERS_PER100KPOP Number of people newly-admitted to prison (per 100 000 inhabitants) EN
Adult_daily_tob_smoking Prevalence of daily tobacco smoking among adults (%) EN
M_Est_tob_daily_std Estimate of daily tobacco use prevalence (%) (age-standardized rate) EN
Adult_daily_e-cig Prevalence of daily e-cigarette use among adults (%) EN
NLIS_NU_CA_053 NLIS: Introduction to solid, semisolid or soft foods in infants 6-8 months (%) EN
NUTRITION_ANAEMIA_PREGNANT_PREV Prevalence of anaemia in pregnant women (aged 15-49) (%) EN
HEMOGLOBINLEVEL_NONPREGNANT_MEAN Mean hemoglobin level of non-pregnant women (aged 15-49 years) EN
NCD_CCS_foot_vibr General availability of foot vibration perception by tuning fork at the primary health care level EN
NLIS_NU_CA_116 NLIS: Minimum dietary diversity (MDD) in children 6-23 months (%) EN
vdpt DTP3 immunization coverage among one-year-olds (%) EN